
<html lang="en"     class="pb-page"  data-request-id="f8fcce62-4981-4926-8bee-4c6cf3cda2b4"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2013.56.issue-9;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm4002692"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Monocarbonyl Curcumin Analogues: Heterocyclic Pleiotropic Kinase Inhibitors That Mediate Anticancer Properties" /></meta><meta name="dc.Creator" content="Andrew  Brown" /></meta><meta name="dc.Creator" content="Qi  Shi" /></meta><meta name="dc.Creator" content="Terry W.  Moore" /></meta><meta name="dc.Creator" content="Younghyoun  Yoon" /></meta><meta name="dc.Creator" content="Andrew  Prussia" /></meta><meta name="dc.Creator" content="Clinton  Maddox" /></meta><meta name="dc.Creator" content="Dennis C.  Liotta" /></meta><meta name="dc.Creator" content="Hyunsuk  Shim" /></meta><meta name="dc.Creator" content="James P.  Snyder" /></meta><meta name="dc.Description" content="Curcumin is a biologically active component of curry powder. A structurally related class of mimetics possesses similar anti-inflammatory and anticancer properties. Mechanism has been examined by e..." /></meta><meta name="Description" content="Curcumin is a biologically active component of curry powder. A structurally related class of mimetics possesses similar anti-inflammatory and anticancer properties. Mechanism has been examined by e..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 23, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm4002692" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm4002692" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm4002692" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm4002692" /></link>
        
    
    

<title>Monocarbonyl Curcumin Analogues: Heterocyclic Pleiotropic Kinase Inhibitors That Mediate Anticancer Properties | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm4002692" /></meta><meta property="og:title" content="Monocarbonyl Curcumin Analogues: Heterocyclic Pleiotropic Kinase Inhibitors That Mediate Anticancer Properties" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0013.jpeg" /></meta><meta property="og:description" content="Curcumin is a biologically active component of curry powder. A structurally related class of mimetics possesses similar anti-inflammatory and anticancer properties. Mechanism has been examined by exploring kinase inhibition trends. In a screen of 50 kinases relevant to many forms of cancer, one member of the series (4, EF31) showed ≥85% inhibition for 10 of the enzymes at 5 μM, while 22 of the proteins were blocked at ≥40%. IC50 values for an expanded set of curcumin analogues established a rank order of potencies, and analyses of IKKβ and AKT2 enzyme kinetics for 4 revealed a mixed inhibition model, ATP competition dominating. Our curcumin mimetics are generally selective for Ser/Thr kinases. Both selectivity and potency trends are compatible with protein sequence comparisons, while modeled kinase binding site geometries deliver a reasonable correlation with mixed inhibition. Overall, these analogues are shown to be pleiotropic inhibitors that operate at multiple points along cell signaling pathways." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm4002692"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm4002692">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm4002692&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm4002692&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm4002692&amp;href=/doi/10.1021/jm4002692" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 9</span><span class="cit-fg-pageRange">, 3456-3466</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/9" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm400140q" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm400351a" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Monocarbonyl Curcumin Analogues: Heterocyclic Pleiotropic Kinase Inhibitors That Mediate Anticancer Properties</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew++Brown">Andrew Brown</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Qi++Shi">Qi Shi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Terry+W.++Moore">Terry W. Moore</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Younghyoun++Yoon">Younghyoun Yoon</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew++Prussia">Andrew Prussia</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Clinton++Maddox">Clinton Maddox</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dennis+C.++Liotta">Dennis C. Liotta</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hyunsuk++Shim">Hyunsuk Shim</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James+P.++Snyder">James P. Snyder</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Winship Cancer Institute, <sup>‡</sup>Department of Chemistry, <sup>§</sup>Emory Institute for Drug Development (EIDD), and <sup>∥</sup>Department of Radiology and Imaging Sciences, Emory University, Atlanta, Georgia 30322, United States</span></div><div class="corresp-info"><strong>*</strong>For H.S.: phone, 404-778-4564; fax, 404-778-5550; e-mail, <a href="/cdn-cgi/l/email-protection#543c273c3d391431393b262d7a313021"><span class="__cf_email__" data-cfemail="f59d869d9c98b590989a878cdb909180">[email protected]</span></a>; address, Department of Radiology and Imaging Sciences, Winship Cancer Institute, Emory University, 1365C Clifton Road, NE, C5008, Atlanta, GA 30322. For J.P.S.: phone, 404-727-2415; fax, 404-727-6586; e-mail, <a href="/cdn-cgi/l/email-protection#3c564f524558594e7c5951534e4512595849"><span class="__cf_email__" data-cfemail="751f061b0c1110073510181a070c5b101100">[email protected]</span></a>; address, Department of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, GA 30322.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm4002692&amp;href=/doi/10.1021%2Fjm4002692" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 9</span><span class="cit-pageRange">, 3456–3466</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 3, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>24 September 2012</li><li><span class="item_label"><b>Published</b> online</span>23 April 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 May 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm4002692" title="DOI URL">https://doi.org/10.1021/jm4002692</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3456%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAndrew%2BBrown%252C%2BQi%2BShi%252C%2BTerry%2BW.%2BMoore%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D9%26contentID%3Djm4002692%26title%3DMonocarbonyl%2BCurcumin%2BAnalogues%253A%2BHeterocyclic%2BPleiotropic%2BKinase%2BInhibitors%2BThat%2BMediate%2BAnticancer%2BProperties%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3466%26publicationDate%3DMay%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm4002692"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2039</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">31</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm4002692" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Monocarbonyl Curcumin Analogues: Heterocyclic Pleiotropic Kinase Inhibitors That Mediate Anticancer Properties&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;Brown&quot;},{&quot;first_name&quot;:&quot;Qi&quot;,&quot;last_name&quot;:&quot;Shi&quot;},{&quot;first_name&quot;:&quot;Terry&quot;,&quot;last_name&quot;:&quot;W. Moore&quot;},{&quot;first_name&quot;:&quot;Younghyoun&quot;,&quot;last_name&quot;:&quot;Yoon&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;Prussia&quot;},{&quot;first_name&quot;:&quot;Clinton&quot;,&quot;last_name&quot;:&quot;Maddox&quot;},{&quot;first_name&quot;:&quot;Dennis&quot;,&quot;last_name&quot;:&quot;C. Liotta&quot;},{&quot;first_name&quot;:&quot;Hyunsuk&quot;,&quot;last_name&quot;:&quot;Shim&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;P. Snyder&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;23&quot;,&quot;issue&quot;:&quot;9&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;3456-3466&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm4002692&quot;},&quot;abstract&quot;:&quot;Curcumin is a biologically active component of curry powder. A structurally related class of mimetics possesses similar anti-inflammatory and anticancer properties. Mechanism has been examined by exploring kinase inhibition trends. In a screen of 50 kinases relevant to many forms of cancer, one member of the series (4, EF31) showed ≥85% inhibition for 10 of the enzymes at 5 μM, while 22 of the proteins were blocked at ≥40%. IC50 values for an expanded set of curcumin analogues established a rank order of potencies, and analyses of IKKβ and AKT2 enzyme kinetics for 4 revealed a mixed inhibition model, ATP competition dominating. Our curcumin mimetics are generally selective for Ser/Thr kinases. Both selectivity and potency trends are compatible with protein sequence comparisons, while modeled kinase binding site geometries deliver a reasonable correlation with mixed inhibition. Overall, these analogues are shown to be pleiotropic inhibitors that operate at multiple points along cell signaling pathways.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4002692&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4002692" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4002692&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4002692" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4002692&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4002692" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm4002692&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4002692&amp;href=/doi/10.1021/jm4002692" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm4002692" /></input><a href="/doi/pdf/10.1021/jm4002692" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm4002692&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm4002692%26sid%3Dliteratum%253Aachs%26pmid%3D23550937%26genre%3Darticle%26aulast%3DBrown%26date%3D2013%26atitle%3DMonocarbonyl%2BCurcumin%2BAnalogues%253A%2BHeterocyclic%2BPleiotropic%2BKinase%2BInhibitors%2BThat%2BMediate%2BAnticancer%2BProperties%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D9%26spage%3D3456%26epage%3D3466%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290821" title="Dietary supplements">Dietary supplements</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291352" title="Screening assays">Screening assays</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/9" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jmcmar.2013.56.issue-9/production/jmcmar.2013.56.issue-9.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/medium/jm-2013-002692_0013.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4002692&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Curcumin is a biologically active component of curry powder. A structurally related class of mimetics possesses similar anti-inflammatory and anticancer properties. Mechanism has been examined by exploring kinase inhibition trends. In a screen of 50 kinases relevant to many forms of cancer, one member of the series (<b>4</b>, EF31) showed ≥85% inhibition for 10 of the enzymes at 5 μM, while 22 of the proteins were blocked at ≥40%. IC<sub>50</sub> values for an expanded set of curcumin analogues established a rank order of potencies, and analyses of IKKβ and AKT2 enzyme kinetics for <b>4</b> revealed a mixed inhibition model, ATP competition dominating. Our curcumin mimetics are generally selective for Ser/Thr kinases. Both selectivity and potency trends are compatible with protein sequence comparisons, while modeled kinase binding site geometries deliver a reasonable correlation with mixed inhibition. Overall, these analogues are shown to be pleiotropic inhibitors that operate at multiple points along cell signaling pathways.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74580" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74580" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><i>Curcuma longa</i> (turmeric) is a rhizomatous herbaceous perennial plant of the ginger family. The popular spice curry powder is isolated from the root of the plant to provide the universally distinctive flavor and yellow color. The primary reactive ingredient refined from turmeric is curcumin (<b>1</b>), a poorly soluble yellow-orange powder. The compound has been studied extensively as a therapeutic agent for its anti-inflammatory, antitumor, and antiangiogenesis properties in vitro and in cell culture.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4">(1-4)</a> However, its remarkable pleiotropic properties span a much wider range.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> In vivo, curcumin’s applications are unfortunately limited by its low oral bioavailability.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> Nonetheless, the substance is or has been the subject of clinical trials for the treatment of colon cancer,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> advanced pancreatic cancer,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> metastatic breast cancer,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> inflammatory bowel disease,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and cognitive impairment, among over 70 others.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/medium/jm-2013-002692_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Curcumin <b>1</b> modifications to generate a series of curcumin analogues <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4002692&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In attempts to improve the solubility, bioavailability, and stability characteristics displayed by curcumin, we previously prepared a panel of curcumin analogues in which both the central and terminal sectors of the molecule were modified to give series <b>2</b>, as illustrated in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>. Namely, the central keto–enol moiety of <b>1</b> was replaced by a monocarbonyl group embedded in a heterocyclic six-membered ring conjugated with the flanking C═C bonds. The terminal oxygenated aromatic rings in <b>1</b> were exchanged for fluorophenyl and pyridine moieties, among others.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> A representative set of analogues are portrayed by structures <b>3</b>–<b>7</b>. The conjugated curcumin mimics express Michael acceptor properties by delivering conjugates indefinitely stable at room temperature when treated with glutathione.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Recently, a convenient NMR assay has provided a simple way to detect Michael adducts and their reversibility,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> curcumin included, although stable conjugates of curcumin are rarely isolated.<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18-20)</a></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/medium/jm-2013-002692_0014.gif" alt="" id="fx1" /></img><div class="NLM_p">Initially, a set of novel curcumin analogues embodied by <b>2</b> were subjected to the National Cancer Institute in vitro cell line screen. The compounds exhibited anticancer and antiangiogenic activities in cell culture. Some revealed a high degree of cytotoxicity, while most of the agents inhibited tumor cell growth with potency greater than that of cisplatin, a well-established clinical chemotheraputic agent.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><div class="NLM_p last">There are many examples of constitutive or overactivated kinases associated with cancer, and a dozen small molecule kinase blockers have been approved by the FDA for treatment of the disease.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Full mapping of the kinome landscape is projected to have a major influence on personalized cancer treatment.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The objective of the present work is to survey the action of <b>4</b> on a panel of 50 phosphorylating proteins, including serine/threonine, tyrosine, dual and lipid kinases, in an effort to determine how broadly class <b>2</b> penetrates the kinome and to learn if there is a measure of selectivity. We follow up with IC<sub>50</sub> measurements on the most strongly blocked kinases with five diverse analogues (<b>3</b>–<b>7</b>), the selection of which is discussed below. Mechanism of action and SAR are pursued by both kinetic measurements with the most active analogue (<b>4</b> on AKT2) and molecular modeling of the analogues in the AKT2 binding site. Finally, we address the questions of selectivity and pleiotropism by comparing sequences of the ATP binding sites for the kinases screened in the panel of 50. The study does not include curcumin itself, since fluorescence interference from this parent molecule interferes with the readouts of the kinase assays employed (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>). However, a number of separate studies have shown that curcumin mimics <b>3</b>–<b>7</b> are routinely more potent than curcumin by 5- to 50-fold under a variety of circumstances: cytotoxicity toward human prostate and breast cancers,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> anticancer and antiangiogenesis effects,<a onclick="showRef(event, 'ref15 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref15 ref24 ref25">(15, 24, 25)</a> impairment of NF-kB nuclear translocation in mouse macrophages,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> TNF-α-induced NF-kB activation in osteoblastic MC3T3 precursors,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Fanconi anemia pathway inhibition,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and stabilization of microtubules in cells.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14034" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14034" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">To direct the project toward an appropriate selection of cancer kinases, we performed a preliminary screen of <b>3</b> and <b>4</b> against a small panel of kinases. The compounds had no measurable inhibition of receptor tyrosine kinase IGFR, a weak effect on the cytoplasmic tyrosine kinase Src, moderate inhibition of Ser/Thr kinases (IKKβ, RAF1, and MEK1), and a significantly increased blocking action on AKT1 and AKT2. Results from this screen led to the hypothesis that the current series of curcumin analogues are most likely pleiotropic and, as reported for curcumin, inhibit a range of different kinases.</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Kinase Panel Screen</h3><div class="NLM_p">To examine trends and to gain broader knowledge concerning the spread of kinases sensitive to curcumin analogues, we subjected the more potent <b>4</b> to screening by a panel of kinases at 5 μM. Since IKKβ and AKT1 were known to be inhibited by the compound prior to conducting the screen, they were inserted as positive controls. Compound <b>4</b> indeed proves to be a pleiotropic kinase inhibitor. Of the 50 kinases tested in the profile screen (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), 10 (20% of the kinases tested) were blocked by <b>4</b> at >85% and designated as hits. Compound <b>4</b> exhibited 40–80% inhibition against 12 kinases, which were categorized as modestly blocked. The other 28 phosphorylating enzymes (56% of the kinases tested) were inhibited by <b>4</b> at ≤40% and are likely to be only weakly influenced by the drug, if at all. In sum, <b>4</b> appears to be pleiotropic by blocking a range of kinases with varying potency at 5 μM.</div><div class="NLM_p">With regard to the selectivity of <b>4</b> for specific types of kinases, there is a definite trend. Of the top 10 screening hits, eight were Ser/Thr kinases (25% of Ser/Thr kinases tested), one was a dual function kinase (NEK1, 33% of the dual function kinases tested), and one was a Tyr kinase (KDR, 7% of all Tyr kinases tested). Thus, selectivity for Ser/Thr kinases emerges from this screen. Although the percentage of dual function kinases is higher, it likely results from the small sample size of this kinase class. Examination of the cross section of kinases with “low activity” reveals a somewhat different balance indicating a potential background role for Tyr kinases: five Ser/Thr kinases (10% of all kinases, 15% of Ser/Thr kinases), six Tyr kinases (12% of all kinases, 40% of Tyr kinases), and one dual function kinase (2% of all kinases, 33% of dual function kinases).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/medium/jm-2013-002692_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Screening of a 50-kinase panel by curcumin analogue <b>4</b> (EF31) by the Z′-LYTE in vitro kinase assay. (a) <b>4</b> was screened against the panel in duplicate at 5 μM with ATP concentrations at <i>K</i><sub>mapp</sub> for each individual kinase. Because of experimental error, values above 100% and below 0% are regarded as maximal or no inhibition, respectively: (∗) Adapta and (∗∗) kinase cascade assays. See <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. (b) Types of kinases among the 50 in both number and % of total. (c) Activity ranges: hits (>80% inhibition), modest activity 40–80% inhibition), and low activity (less than 40% inhibition).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4002692&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In the present study, any kinase eliciting ≥85% inhibition at 5 μM was evaluated further by determining IC<sub>50</sub> values for <b>3</b> (EF24), <b>4</b> (EF31), <b>5 (</b>UBS109), <b>6</b> (mono-C═C reduction product of <b>5</b>) and the sulfur analogue <b>7</b> (SEF31). Justification for this choice has its origin in <b>3</b>, a compound that performed particularly well in the NCI in vitro cell screen.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> It was subsequently shown to induce apoptosis in two different cancer cell lines<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and inhibit activation of the NF-κB pathway by blocking IKKβ kinase.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> This behavior has been posited to contribute to the compound’s anti-inflammatory properties. Analogue <b>4</b> has also been shown to inhibit inflammation pathways by inhibiting NF-κB binding in mouse RAW264.7 macrophages with a 10-fold greater potency than <b>3</b><a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and to inhibit the growth of head and neck squamous cell carcinoma xenografts ip.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The inclusion of <b>5</b> was based on the outcome of a successful oral efficacy study in mice bearing a human tumor xenograft,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> while addition of metabolite <b>6</b> resulted from its noteworthy but reduced cellular cytotoxicity relative to <b>5</b>. Both compounds show a modest suppressive effect on osteoclastogenesis.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Compound <b>7</b>, a phosphorylation inhibitor of proteins in the Fanconi anemia pathway,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> is an analogue that introduces a large heteroatom into the central ring that occasions a significant change in molecular polarity and simultaneously serves as a poor proton acceptor and weak electron donor by comparison with <b>3</b>–<b>6</b> (i.e., <b>2</b>, Y = NH and NMe). The selection permits evaluation of the importance of proton donor and acceptor interactions at the binding sites of the target kinases as well as the influence of protonation and molecular size. These points are taken up in the molecular modeling section below.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Calculated IC<sub>50</sub> Values from Graphs in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center">IC<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center"><b>3</b></th><th class="colsep0 rowsep0" align="center"><b>4</b></th><th class="colsep0 rowsep0" align="center"><b>5</b></th><th class="colsep0 rowsep0" align="center"><b>6</b></th><th class="colsep0 rowsep0" align="center"><b>7</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AKT1 (PKBα)</td><td class="colsep0 rowsep0" align="left">0.78</td><td class="colsep0 rowsep0" align="left">0.02</td><td class="colsep0 rowsep0" align="left">2.6</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">3.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AKT-2</td><td class="colsep0 rowsep0" align="left">0.72</td><td class="colsep0 rowsep0" align="left">0.02</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">3.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IKBKB (IKKβ)</td><td class="colsep0 rowsep0" align="left">72</td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RPS6K1</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AMPK (A1/B1/G1)</td><td class="colsep0 rowsep0" align="left">46</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RAF1<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">24</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">6.5</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">8.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MEK1<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">12.8</td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ERK2<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">27</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NEK1</td><td class="colsep0 rowsep0" align="left">77</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">3.5</td><td class="colsep0 rowsep0" align="left">83</td><td class="colsep0 rowsep0" align="left">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">KDR (VEGFR2)</td><td class="colsep0 rowsep0" align="left">0.77</td><td class="colsep0 rowsep0" align="left">0.66</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">6.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MAPK14 (p38α)</td><td class="colsep0 rowsep0" align="left">92</td><td class="colsep0 rowsep0" align="left">35</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MAPKAPK2</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">6.7</td><td class="colsep0 rowsep0" align="left">9.8</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">16</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Assays for RAF1 and MEK used the kinase cascade method diagrammed in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a> and discussed in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">The IC<sub>50</sub> values for ERK2 resulted from large experimental variability and should be regarded as only semiquantitative.</p></div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Kinase IC<sub>50</sub> Values and an Emerging SAR</h3><div class="NLM_p">Screened enzymes not previously reported as targets for <b>3</b>–<b>7</b> are listed in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> along with IC<sub>50</sub> values for each agent (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). As mentioned above, AKT1 and IKKβ were added as positive controls. The kinases represent a wide variety of cellular activities: regulation of protein synthesis and cell proliferation (RPS6KB1), energy sensing and sensitization of cancer cells to cisplatin treatment (AMPK), DNA damage repair and maintenance of mitochondrial membrane potential (NEK1), mediation of cellular responses to VEGF (KDR/VEGFR2), environmental stress relief and assistance of production of certain cytokines (MAPK14/p38α), cooperation with the latter kinase to expedite nuclear export, gene expression, and cell proliferation (MAPKAPK2), development, cell proliferation, and apoptosis regulation (RAF1, MEK1, and ERK2). Two kinases blocked by <b>4</b> (5 μM, ≥85%), but not examined by dose–response, are CHEK1 and PRKCβ1. The former mediates cell cycle arrest in response to DNA irregularities, while the latter, activated by diacylglycerol, phosphorylates a range of cellular proteins and serves as the receptor for phorbol esters, a class of tumor promoters. Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> captures the network of relationships among the 12 most readily blocked kinases portrayed in Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>. A somewhat more elaborate variation provided by IPA<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> is provided in the <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>. Given the tightly connected associations, simultaneous inhibition of these enzymes will exert pairwise-protein influence as well as a major network perturbation. As suggested by the multiple actions of the weaker parent curcumin, <b>4</b> is clearly a pleiotropic kinase blocker in addition to exhibiting a ≥10-fold greater kinase suppression by comparison with curumin.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> At the same time, on average, the molecule exhibits only modest potency across the range of enzymes (submicromolar to 7 μM, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), the exceptions being <b>4</b> against AKT and p53α (MAPK14; see kinase cascade sections below). Other analogues furnish a different profile (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), suggesting an opportunity for reduced toxicity coupled to variable pan-kinase outcomes.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/medium/jm-2013-002692_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. IC<sub>50</sub> values for inhibited kinases. (a) The analogues were tested at nine different concentrations using serial dilutions: (red triangle) <b>3</b> (EF24), (purple triangle) <b>4</b> (EF31), (gray diamond) <b>5</b> (UBS109), (yellow triangle) <b>6</b>, (green circle) <b>7</b>. Assays for RAF1 and MEK used the kinase cascade method diagrammed in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and discussed in <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4002692&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/medium/jm-2013-002692_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Phosphorylation and other interactions of transcription factors and enzymes leading to cell proliferation, differentiation, and survival. Kinases highlighted in blue have been studied in this work (Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Alternative kinase names are as follows: ERK2 = MAPK1 = MAPK2; p38 = MAPK14; MEK1 = MAP2K; COT = MAP3KB; RSK1 = RPS6KA1; AMPK = PRKAA1; IKKb = IKBKB; KDR = VEGFR-2; RPS6KB1 = S6K1; Chek1 = Chk1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4002692&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Not surprisingly, most of these cellular functions are involved in the promotion of cancer and inflammation. Without yet understanding the details linking the wide diversity of biological responses, modest pleiotropic blockade of this set of kinases appears at the heart of the ability of the curcumin analogues to arrest cancer, angiogenesis, and inflammation both in vitro<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and in vivo.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> A pertinent example is the behavior of NEK1, the only dual function kinase that is significantly inhibited by <b>4</b> in the kinase screen (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Among other functions, it contributes to maintenance of the mitochondrial membrane potential. Inhibition of NEK1 causes a decrease in phosphorylation of voltage-dependent anion-selective channel protein 1 (VDAC1), which leads to an uncoupling of the mitochondrial membrane potential.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Later stages in this event are identical to the manner in which <b>3</b> induces apoptosis in two cancer cell lines.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Blockade of Signal Transduction Pathways</h3><div class="NLM_p">We have commented on both individual kinase functions and the potential coupling of kinases in subsections of signaling pathways. The dose–response assays performed for the strongly inhibited kinases involve activation of a given kinase, phosphorylation of a peptide substrate, and disruption of a FRET signal upon cleavage of the peptide to provide the assay readout (Z′-LYTE in vitro kinase assay; see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> and Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). For example, in the measurement of inhibition of RAF1, the procedure takes advantage of the cellular mitogen activated protein (MAP) kinase cascade involving sequential phosphorylation and activation of inactive MEK1 and ERK2 followed by ERK2 phosphorylation of the substrate (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). By examination of individual kinases, it is clear that curcumin analogues <b>3</b>, <b>4</b>, <b>5</b>, and <b>7</b> block all three MAP kinases to within a factor of 3 (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). This leads to a damping of the entire pathway and eliminates dependence on one specific kinase.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/medium/jm-2013-002692_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Diagram of kinase cascade used in the Z′-LYTE kinase assay. The RAF1 assay is a three-tiered cascade initiated with RAF1, which subsequently phosphorylates and activates MEK1 and ERK2, leading to peptide substrate phosphorylation employed to measure reaction progress (see Z′-LYTE in vitro kinase assay in <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4002692&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A second example from the MAP kinase cascade concerns p38α (MAPK14) and its dependence on MAPKAPK2. Labeling p38α (MAPK14) as a hit in the kinase screen is somewhat misleading, since both kinases are pathway-linked in that screen (Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>a and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). Further examination of p38α (MAPK14) inhibition, however, using a direct kinase assay, shows its blockade to be significantly reduced (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> and Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Thus, identification of p38α (MAPK14) as a hit in the kinase screen is primarily due to the inhibition of MAPKAPK2 downstream of p38α (MAPK14) in the kinase cascade. It is presently unknown whether assay constitution precisely mirrors these actions in a living cell.</div><div class="NLM_p last">These examples highlight drug action against multiple steps in a localized kinase interaction network by a family of readily accessible curcumin analogues. They simultaneously demonstrate the pleiotropic nature of the analogues both within a select segment of a pathway and among kinases in a more diffuse network (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and <a class="ref internalNav" href="#notes-2" aria-label="Figure S1">Figure S1</a>). In a similar manner, the parent compound curcumin inhibits cell signaling cascades at multiple nodes. Since these cascades are involved in cell proliferation and apoptosis, curcumin affects the overall process of carcinogenesis<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> as do substances <b>3</b>–<b>5</b> and <b>7</b>.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Mechanism of Kinase Inhibition</h3><div class="NLM_p">The curcumin mimics can exert their effects as kinase inhibitors by several possible mechanisms: reversible or irreversible, competition with ATP or the peptide substrate, or allosteric modulation. Since a great many such inhibitors function by competing with ATP and occupying the ATP binding pocket, we sought to explore this possibility by analyzing reaction rates at different ATP and inhibitor concentrations. AKT2 and analogue <b>4</b> were selected to probe this question as the most potent combination among kinases and blockers (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). The corresponding Lineweaver–Burk plot (Figure S3 in <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>) reveals a clustering of lines on the <i>Y</i> axis indicative of a competitive inhibition model.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/medium/jm-2013-002692_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Analysis of enzyme kinetics data for <b>4</b> and AKT2: (a) Michaelis–Menten graph of kinetic data using a competitive model of inhibition; (b) Michaelis–Menten plot using a mixed model of inhibition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4002692&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To achieve a more quantitative evaluation, we plotted the data on a Michaelis–Menten graph. By selection of specific models that force shared parameters in the global analysis (<i>K</i><sub>m</sub>, <i>V</i><sub>max</sub>, <i>K</i><sub>i</sub>) with GraphPad Prism,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> a compromise solution applied to each model spreads the data across all the curves, providing a framework that allows mechanistic distinctions to be made, namely, competitive or mixed models.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div><div class="NLM_p">When performing a global analysis that fits the reaction rates to a Michaelis–Menten graph, the optimized value for <i>K</i><sub>i</sub> is shared by all inhibitor concentration curves. In a competitive model, in addition to the shared <i>K</i><sub>i</sub> constraint, all curves must also maintain a common optimized <i>V</i><sub>max</sub>. Furthermore, <i>K</i><sub>i</sub> and <i>V</i><sub>max</sub> must also be greater than zero in both models. Execution of the global analysis under the constraints of a competitive model as illustrated by the corresponding Michaelis–Menten graph significantly worsens the fit of the curves to the data (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>a). By contrast, casting the data in the context of a mixed mechanism provides a superior fit for the data (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>b). Comparison of these two models favors the mixed inhibition model with <i>p</i> < 0.01. This suggests that competitive reversible inhibition is not the only mechanistic path traveled by <b>4</b> in its inhibition of AKT2. The observation is consistent with a recent study reporting a mixed mechanism for the blockade of IKKβ by analogue <b>3</b>.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><div class="NLM_p">To measure the quantitative extent of parallel mechanisms and the impact of substrate concentration (ATP) on kinase inhibition, the parameter α must be examined in the global analysis.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Its value determines the degree to which the binding of inhibitor alters the affinity of the enzyme for its substrate and is always greater than zero. When α is very small (but greater than zero), binding of the inhibitor enhances substrate binding to the enzyme, and the mixed model becomes nearly identical to an uncompetitive model. When α = 1, the inhibitor does not alter binding of substrate to the enzyme, and the mixed-model is identical to noncompetitive inhibition. With increasing α, the inhibitor increasingly prevents binding of the substrate, and ultimately the mixed model becomes identical to competitive inhibition.</div><div class="NLM_p">Using global analysis of the Michaelis–Menten graph, we calculate an α of 31 for the inhibitory action of <b>4</b> on AKT2. This value of >1 demonstrates that while compound <b>4</b> has multiple mechanisms of inhibition, competition with ATP dominates action against this kinase under these experimental conditions. As mentioned, the mixed inhibition model has been reported for <b>3</b> and IKKβ by Kasinski et al.,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> although α was not calculated.</div><div class="NLM_p last">It is tempting to hypothesize that the other mode of inhibition may correspond to covalent binding of inhibitor to enzyme as a result of Michael addition of a free cysteine to the electrophilic enone moiety of <b>4</b>. This is consistent with our previous demonstration that two glutathione (GSH) molecules are able to combine with a single molecule of <b>3</b> and <b>4</b> rapidly and quantitatively in aqueous medium followed by isolation of the bis-GSH adducts.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The same study demonstrated reversibility<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> in water by exchange of GSH between the two compounds and by the equal effectiveness of the parents and their conjugates (<b>3</b>-(GSH)<sub>2</sub> and <b>4</b>-(GSH)<sub>2</sub>) to serve as cytotoxins against MDA-MB-435 human breast cancer cells. This mechanistic option is discussed below from the viewpoint of the explicit interaction between <b>4</b> and AKT2 kinase.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Analysis of IC<sub>50</sub> Data by Molecular Modeling</h3><div class="NLM_p">We have sought to understand the variation of the ligand IC<sub>50</sub> values (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) by assuming that they block the kinases primarily by occupying the ATP binding pocket. Both the kinetic measurements described above for <b>4</b> and AKT2 and the previously described action of <b>3</b> on IKKβ<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> support competitive displacement of ATP as the dominant inhibitory mechanism accompanied by a second action we ascribe to covalent coupling between cysteine and the inhibitor enones. Among the kinases sampled, AKT2 exhibits the lowest IC<sub>50</sub> values (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Accordingly, we selected the crystal structure of the corresponding kinase domain (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3E88">3E88</a>) for pose prediction, once adjusted by the Maestro Protein Preparation Wizard. Ligands <b>3</b>–<b>7</b> were docked by Glide into the ATP binding site and optimized by MacroModel.</div><div class="NLM_p">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>a illustrates the best-scored docking pose for <b>4</b> in the ATP binding pocket of AKT2 in which several noncovalent interactions anchor the ligand to the protein. Hydrogen bonds are established between one of the pyridine nitrogen atoms and Thr292 on the receptor and between the ligand carbonyl group and Lys181. A salt bridge is formed between Glu236 and the protonated nitrogen within the central ring of the ligand. One of the pyridine rings of <b>4</b> resides in a relatively hydrophobic pocket cirumscribed by Ala179, Met229, Glu230, Tyr231, Ala232, and Met282. For fluorinated <b>3</b>, the top Glide pose is similar to that of <b>4</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>b). H-bonds with Glu236 and Lys181 are maintained, and one of the phenyl rings resides in the same hydrophobic pocket. However, consistent with the higher IC<sub>50</sub> values of <b>3</b>, the favorable hydrogen bond with Thr292 is lost. To some extent the latter is compensated by electrostatic association between the aromatic fluorines and the proton of the axial NH<sup>+</sup> bond in the central ring, although the associations are weak (<i>r</i>(aro) F(δ)···Hδ(N) of 3.1 Å).</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/medium/jm-2013-002692_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Top predicted curcumin analogue poses from Glide docking of ligands on AKT2: (a) <b>4</b> (EF31); (b) <b>3</b> (EF24); (c) <b>5</b> (UBS109).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4002692&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>c shows that the <i>N</i>-methyl analogue of protonated <b>5</b>, like <b>4</b>, enjoys a hydrogen bond between one of the pyridine nitrogen atoms and Thr292. The <i>N</i>-Me group on the central ring assumes an equatorial conformation, causing the NH<sup>+</sup> to form a salt bridge with Glu236 from the axial position. The latter obligates the ligand to move toward Glu236 and away from Lys181 by comparison with <b>3</b> and <b>4</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>a,b), essentially deleting the hydrogen bond interaction with this residue. In addition, as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>c, two hydrogen atoms in <b>5</b> are separated by only 2.0 Å (black stipled line), somewhat below the sum of van der Waals radii (2.4 Å) and thereby introducing internal ligand strain energy. The same H···H distance for <b>4</b> (2.3 Å) is at the minimum acceptable van der Waals contact. The diminished hydrogen bonding and ligand strain energy can explain the relatively higher IC<sub>50</sub> values of <b>5</b> relative to <b>4</b>.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/medium/jm-2013-002692_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Top predicted curcumin analogue poses for enantiomers of <b>6</b>: (a) <b>6</b><i><b>R</b></i>; (b) <b>6</b><i><b>S</b></i>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4002692&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Partially saturated <b>6</b> exists as two enantiomers, <b>6</b><i><b>R</b></i> and <b>6</b><i><b>S</b></i>. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>a and Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>b, respectively, the left half of each ligand and the equatorial <i>N</i>-methyl orientations are identical to those of <b>5</b>. While the stereoisomer poses retain the noncovalent interactions with Thr292 and Glu236, the hydrogen bond with Lys181 is lost as observed for <b>5</b>. Critical new contacts arise, however, because the C═C saturation in <b>6</b> requires the CH<sub>2</sub>-pyridine moiety to be relocated, placing the relatively hydrophobic edge of the pyridine ring into a polar sector of the protein’s glycine-rich loop. Furthermore, in <b>6</b><i><b>R</b></i> the pendent CH<sub>2</sub>-pyridine group fits into the pocket only by adopting a near eclipsed conformation with the adjacent C–H bond of the central six-membered ring. Comparison of the Glide SP docking scores for <b>5</b> and <b>6</b><i><b>S</b></i>/<b>6</b><i><b>R</b></i> predicts the former to be more tightly bound by 2.1 and 2.4 kcal/mol, respectively. Thus, the loss of a key H-bond, the predicted placement of the benzylic pyridine rings into unfavorable pockets, in one case in an equally unfavorable conformation and the incorporation of only one electrophilic enone compared to the two present in <b>3</b>–<b>5</b> appear to contribute to the significantly reduced activity of the enantiomers of <b>6</b> on AKT2, as has been reported for prostaglandin enones and dienones.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/medium/jm-2013-002692_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Top predicted pose for <b>7</b> (SEF31) on AKT2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4002692&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Analogue <b>7</b> possesses a sulfur atom in the central ring instead of nitrogen. In the most favorable pose depicted by Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>, the hydrogen bond shared between ligand and Thr292 remains, while association between C═O and Lys181 NH increases to 2.7 Å, weakening the H-bond significantly. The NH to S replacement naturally not only eliminates the hydrogen bond with Glu236 but also causes the ligand to retreat as a consequence of the unfavorable electrostatic contact between the bulky electron-pair bearing sulfur atom and Glu236. The lack of two anchoring H-bonds and the electrostatic disconnect are believed to contribute to the increased IC<sub>50</sub> values of <b>7</b> compared to <b>4</b>. In sum, a semiquantitative explanation of the various IC<sub>50</sub> values for AKT2 inhibition can be developed by analysis of the docking poses.</div><div class="NLM_p">Since all the curcumin analogues carry an α,β-unsaturated ketone Michael acceptor, covalent bonds might be formed between kinase cysteines and these compounds. Previously, we reported the modification of cysteine-rich thioredoxin 1 by <b>3</b> in the presence of GSH.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Similarly, Yamakoshi and co-workers have labeled the nuclear fusion protein KSRP/FUBP2 with a biotinylated dienone related to <b>2</b> and identified the covalently bound cysteine.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> More recently, Taunton and colleagues have outlined a strategy for targeting noncatalytic cysteines in kinases with reversible covalent inhibitors, suggesting that it can be applied generally to this class of enzymes, assuming there is an exposed cysteine near the active site.<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42, 43)</a> Given the thiol reversibility of our analogues,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> this is a credible, albeit tentative, means to understand the mixed-inhibition observed herein. For example, Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a> shows that a cysteine (Cys311 AKT2) is located near the substrate binding site. Consistent with the design of the bioassay, the formation of a covalent bond between ligand and cysteine would most likely interrupt substrate binding, making the target peptide reagent susceptible to cleavage as monitored by subsequent separation of the FRET pairs. Under these circumstances, an apparent high IC<sub>50</sub> value will be observed. Unfortunately, such an event can hinder quantification of the noncovalent binding affinity of the ATP competitive inhibitor unless this mechanism is a small contribution to the overall blockade.</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/medium/jm-2013-002692_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Cys311 in the cleft where the substrate binds on AKT2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4002692&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Sequence Comparison of Kinase Binding Sites</h3><div class="NLM_p">We have attempted to understand the pleiotropic aspects of <b>4</b> by sequence alignment and identity/similarity comparison of the residues around the ATP binding sites for various kinases. The 3D structures of the proteins were aligned using the protein structure alignment tool in the Schrodinger Maestro software package. By employment of the docking pose of <b>4</b> in AKT2, key residues within the ATP binding sites were selected for identity comparison with the corresponding residues in other kinases: Ala179, Met229, Glu230, Tyr231, Ala232, Met282, Glu236, Lys181, and Thr292 (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>). The comparison reveals that most of the active kinases (inhibition of >80% in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) share >55% identity and >75% similarity with these residues in the AKT2 binding environment while AKT1 and RPS6KB1 share >75% identity and >85% similarity, respectively. KDR is an exception to the >55% and 75% rule, i.e., 33% and 67%, respectively. Further examination of the KDR binding site reveals that two cysteines at the binding site (Cys919 and Cys1045 equivalent to the spatial positions for Ala232 and Thr292 in AKT2) adopt an orientation that favors covalent Michael addition to the α,β-unsaturated ketone moiety. It is conceivable that covalent binding dominates the binding affinities in this case and thereby rationalizes the similar KDR IC<sub>50</sub> values for the four curcumin analogues <b>3</b>, <b>4</b>, <b>5</b>, and <b>7</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). However, examination of other kinases with low activity in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> also reveals similar cysteines at the ATP binding sites (example, KIT), suggesting that the corresponding cysteines alone do not contribute the majority of the observed activity of KDR. Further work is still required to understand why KDR and NEK1 are exceptions.</div><div class="NLM_p">The inactive kinases (≤10% inhibition, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), by contrast, exhibit <35% identity and <70% similarity on average for the nine residues listed above compared to AKT2. Since these residues are critically important for the binding of <b>4</b>, we surmise that while the ATP binding site side chain constitution is not the full story, it appears to capture a major structural feature behind much of the pleiotropism of <b>4</b>, although exceptions such as KDR and NEK1 exist. Other important features of the kinases not captured by Glide docking include the plasticity of the DLG motif and the glycine-rich loop.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> These aspects are under active investigation for the kinases considered here.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/medium/jm-2013-002692_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Key residues around the ATP binding sites of various kinases. Residue type and number are according to AKT2: 1, Ala179; 2, Met229, Glu230, Tyr231, Ala232; 3, Met282; 4, Glu236; 5, Lys181; 6, Thr292. Upper panel shows >85% inhibition. Lower panel shows ≤10% inhibition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4002692&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The sequence comparisons of Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a> likewise address the predominant selectivity for Ser/Thr kinases by the monocarbonyl inhibitors. Of the ≥85% inhibition hits from <b>4</b>’s interrogation of the kinase panel, the sequence identities for the Ser/Thr kinases (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, orange color) range from 56% to 100% relative to AKT2 while the KDR (Tyr kinase) and NEK1 (dual function kinase) exceptions fall at 33%. In a similar fashion, the corresponding sequence identities for Ser/Thr kinases that were poorly blocked (≤10% inhibition, PIM1, IRAK4, CDK7, ACVR1B, CDK2, EGFR) also fall in the 22–33% range. Accordingly, kinase binding site structure trends with both the Ser/Thr selectivity and the observed pleiotropic behavior.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18014" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18014" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">By examination of 50 kinases, we have identified a family of enzymes that are inhibited by a small panel of curcumin mimics, nearly a dozen of which are blocked at micromolar or submicromolar concentrations. Two MAP kinase cascade pathways identified from the present kinase inhibition data are at the heart of tumor development (p38α-MAPKAPK2 and RAF1-MEK1-ERK2). Various oncogenic factors activate these pathways and, by this means, relay proliferative, survival, chemoresistance, and angiogenic signals essential to tumor maintenance.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> The present observations suggest that the pleiotropic nature of the curcumin analogues leads to damping of pathways without dependence on a single kinase for inhibition (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and <a class="ref internalNav" href="#notes-2" aria-label="Figure S1">Figure S1</a>).</div><div class="NLM_p">Enzyme kinetics studies reveal that kinase inhibition by compounds within series <b>2</b> operates by multiple mechanisms, with ATP competition appearing to be a major factor. Complementary molecular modeling at the ATP binding site of AKT2 provides a qualitative explanation for ligand activity. Reversible Michael addition to curcumin mimetics by cysteine residues in the kinases is compatible with the observed mixed mechanism kinetics and the flat IC<sub>50</sub> values for the KDR kinase. Sequence comparisons for residues at the kinase active sites suggest that site geometry is an important feature for both the pleiotropic character of the inhibitors and the Ser/Thr selectivity.</div><div class="NLM_p last">In a cancer context, one might expect drug resistance to be significantly diminished in cells following treatment with such inhibitors. With the rising importance of the “omes” (genome, proteome, kinome, transcriptome, etc.) and our ability to understand and map the complexities of intracellular signaling, curcumin analogues may be an example of a molecular class that is able to target multiple enzymes with a “magic shotgun”.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> This would be especially valuable for diseases like cancer that are complex, inflammation associated, and often evolve mutations in multiple genes. Not surprisingly, the class parent, curcumin, shares these properties. In spite of its minimal bioavailability and poor solubility, the compound perturbs numerous cellular proteins<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and has achieved clinical status in more than 30 different cancer trials.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The ability of a single molecule to target multiple cellular proteins and pathways represents an emerging philosophy in cancer drug discovery, one in which “promiscuous” drugs that target multiple enzymes or pathways may be superior to monotherapies selective for only one target.<a onclick="showRef(event, 'ref48 ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref48 ref49 ref50">(48-50)</a> Gleevec (imatinib), a highly successful anticancer agent attenuating, among others, the Ras/MapK pathway, has been approved by the FDA to treat 10 different cancers.<a onclick="showRef(event, 'ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref51 ref52">(51, 52)</a> It serves as a prime example of the phenomenon.<a onclick="showRef(event, 'ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref53 ref54">(53, 54)</a></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56317" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56317" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Chemicals, Reagents, and Assay Kits</h3><div class="NLM_p">Compounds <b>3</b>,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a><b>4</b>,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a><b>5</b>,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a><b>6</b>,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and <b>7</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> were prepared at Emory University, GA, as previously described. All compounds were recrystallized and judged to be >95% pure as determined by HPLC (various concentrations of MeOH in 0.1% aqueous formic acid solution; Agilent Zorbax 50 mm C<sub>18</sub> column; 1 mL/min; monitoring at 254 and 340 nm). For kinase profiling, ADP Quest (catalog no. 90-0071) and ATP Gold (catalog no. 90-0099) were obtained from DiscoveRx,<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> while the Crosstide peptide substrate (95% pure) was available from Millipore (catalog no. 12-331).<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></div><div class="NLM_p">Z′-LYTE kinase assay kits were provided by Invitrogen:<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Ser/Thr 6 (catalog no. PV3179), Ser/Thr 05 (catalog no. PV3178), Tyr 02 (catalog no. PV3191), Ser/Thr 03 (catalog no. PV3176), Tyr 01 (catalog no. PV3190), Ser/Thr 07 (catalog no. PV3180), Ser/Thr 23 (catalog no. PV4644), Ser/Thr 04 (catalog no. PV 3177), and Ser/Thr 15 (catalog no. PV3799).</div><div class="NLM_p last">Recombinant proteins came from Invitrogen:<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> AKT1 (PKBα) (catalog no. P2999), AKT2 (PKBβ) (catalog no.PV3184), IKBKB (IKKβ) (catalog no. PV3836), SRC (catalog no. PV3044), RAF1 (cRAF) Y340D Y341D (catalog no. PV3805), inactive MAP2K1 (MEK1) (catalog no. 3093), MAP2K1 (MEK1) (catalog no. P3093), inactive MAPK1 (ERK2) (catalog no. 3314), MAPK1 (ERK2) (catalog no. PV3313), IGF1R (catalog no. PV3250), RPS6KB1 (p70S6K) (catalog no. PV3815), AMPK A1/B1/G1 (catalog no. PV4672), NEK1 (catalog no. PV4202), KDR (VEGFR2) (catalog no. PV3660), p38α (MAPK14) (catalog no. PV3304), MAPKAPK2, Inactive (catalog no. PV3316), MAPKAPK2 (catalog no. PV3317).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Z′-LYTE in Vitro Kinase Assay (Invitrogen)</h3><div class="NLM_p last">In a 10 μL kinase reaction, the IKKβ transfers the γ-phosphate of ATP to a single serine/threonine residue in a specific synthetic peptide substrate (2 μM). The peptide is labeled with the two fluorophores coumarin and fluorescein, one at each end of the peptide to make up a FRET pair. In the development reaction, 5 μL of a site-specific protease recognizes and cleaves any nonphosphorylated peptides. Cleavage disrupts FRET between the coumarin and the fluorescein on the peptide. Phosphorylation of the peptide suppresses cleavage by the protease. Uncleaved, phosphorylated peptides maintain the FRET pair. An amount of 5 μL of stop reagent is added to halt the development reaction before the plate is read by an Envision 2102 plate reader from Perkin-Elmer. During detection, a ratiometric readout of the donor emission over the acceptor emission quantitates reaction progress. The ratio is low if the peptide is phosphorylated, and the ratio is high if the peptide is nonphosphorylated. Percent phosphorylation was calculated using controls, and each compound concentration was run in triplicate. Results were graphed using GraphPad Prism, and IC<sub>50</sub> values were calculated using nonlinear regression.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Fluorescence Interference</h3><div class="NLM_p last">Curcumin could not be compared in the Z′-LYTE assay because of fluorescence interference from curcumin in the readouts of the assays used. For instance, the Z′-LYTE assay uses excitation at 400 nm and measures fluorescence of the fluorophores coumarin and fluorescein at 445 and 520 nm respectively. Curcumin, depending on solvent, absorbs light from 350 to 475 nm with maximal absorption around 425 nm. It then fluoresces in the 450–700 nm range<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> using the 355 nm excitation to measure fluorescence. This would be sufficient to disrupt all aspects of the readout from absorbing the excitation light to absorbing the fluoresced light from coumarin, as well as curcumin fluorescing at wavelengths that are similar to those of fluorescein. These effects were observed when the “test compound fluorescence interference” control was run according the Z′-LYTE assay protocol. The curcumin analogues, however, did not show any fluorescence interference at concentrations up to 50 μM.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Cascade Reaction Assay</h3><div class="NLM_p">Some of the assays require a cascade reaction in which inactivated kinase is activated by an upstream kinase. Two cascades were important for our studies: the RAF1-MEK1-ERK2 cascade and the p38α (MAPK14)-MAPKAPK2 cascade. A direct assay was used for p38α (MAPK14) when generating its nine-point IC<sub>50</sub> curve.</div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> RAF1 (cRAF) Kinase Cascade</h4><div class="NLM_p last">The final 10 μL kinase mixture consists of 0.001–0.005 ng of RAF1 (cRAF), 10 ng of inactive MAP2K1 (MEK1), and 100 ng of inactive MAPK1 (ERK2).</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> MAP2K1 (MEK1) Kinase Cascade</h4><div class="NLM_p last">The final 10 μL of kinase mixture consists of 1.0–4.0 ng of MAP2K1 (MEK1) and 105 ng of inactive MAPK1 (ERK2).</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> p38α (MAPK14) Kinase Cascade</h4><div class="NLM_p last">The final 10 μL of kinase mixture consists of 0.01–0.02 ng of p38α (MAPK14) and 5 ng of inactive MAPKAPK2.</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Kinase Profile Screen</h3><div class="NLM_p last">Compound <b>4</b> was tested against a panel of kinases at 5 μM. Each data point was measured in duplicate using Z′-LYTE substrates with two control wells. One control well contains a protease control to determine if the compound interferes with the development reaction. The second well encloses a fluorescence control to ascertain if the compound interferes with the fluorescense reading of the FRET pair.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Adapta Assay</h3><div class="NLM_p last">After addition of inhibitor and all other kinase reaction components, the reaction was incubated for 1 h. During this period, the kinase reaction produces phosphorylated peptide and ADP. A detection solution of europium-labeled anti-ADP antibodies, a labeled ADP tracer, and EDTA to stop kinase reaction were added. ADP formed by the kinase reaction will displace the ADP tracer from the antibody, resulting in a TR-FRET signal decrease. When an inhibitor is used, the amount of ADP formed by the kinase reaction is reduced, and the resulting intact antibody–tracer interaction results in a high TR-FRET signal. By comparison of this to a control, the amount of inhibition can be calculated.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> ADP Quest</h3><div class="NLM_p last">Kinase assays for the enzyme kinetics were accomplished with ADP Quest assays. By use of purified recombinant AKT2 from Invitrogen (PV3184) and the Crosstide substrate from Millipore (catalog no. 12-331), kinase reactions were run from 10 to 90 min using fresh samples of varying ATP concentrations. When the Crosstide substrate molecule is phosphorylated, an ADP molecule is generated. The ADP Quest procedure measures total ADP by an enzyme coupled reaction that causes a fluorescent signal. The latter is compared with a known control.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Michaelis–Menten Analysis of Enzyme Kinetics</h3><div class="NLM_p last">Analysis of reaction velocities was performed by first determining reaction rates using the ADP quest assay. The reaction rates were measured by following ADP produced over time. The reaction velocities were graphed on a Lineweaver–Burk plot and two Michaelis–Menten plots with appropriate constraints for the type of model represented. Calculations were performed with GraphicPad Prism 5.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Molecular Modeling</h3><div id="sec4_9_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Docking</h4><div class="NLM_p last">The structures of compounds <b>3</b>, <b>4</b>, <b>5</b>, <b>6</b>, and <b>7</b> were drawn in 2D with ChemDraw and then submitted to Ligprep in Maestro 9.1 to obtain 3D structures. Protein complexes were processed by the Protein Preparation Wizard in Maestro followed by removal of the ligands. The receptor grid was generated at the ATP binding sites. Ligand-docking was accomplished with SP precision (Maestro 9.0) for flexible docking of the ligands.<a onclick="showRef(event, 'ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref60 ref61">(60, 61)</a> The side chain of Lys181 was adjusted to accommodate an H-bond interaction with C═O of the ligand after docking. The PDB codes used in the analysis were as follow: AKT2, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3E88">3E88</a>; AKT1, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MVH">3MVH</a>; IKKB, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QAD">3QAD</a>; NEK1,<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4B9D">4B9D</a>; RPS6KB1, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3A60">3A60</a>; AMPK, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3AQV">3AQV</a>; PRKCB1, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2I0E">2I0E</a>; CHEK1, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YEX">2YEX</a>; KDR, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XIR">2XIR</a>; MAPKAPK2, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3W2M">3W2M</a>; PIM1, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QF9">3QF9</a>; IRAK4, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OIC">2OIC</a>; CDK7, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UA2">1UA2</a>; KIT, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3G0E">3G0E</a>; ACVR1B, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1RW8">1RW8</a>; CDK2, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XMY">2XMY</a>; EGFR, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3BEL">3BEL</a>; PLK1, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3THB">3THB</a>; ERBB2, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PP0">3PP0</a>.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Generation of a Kinase Interaction Network</h4><div class="NLM_p last">A network of the 10 most inhibited kinases by <b>4</b> (≥85% inhibition at 5 μM, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>a) was generated using IPA with direct connections (Ingenuity Systems, Inc.).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27"><a href="/doi/suppl/10.1021/jm4002692">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54708" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54708" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Ingenuity pathway analysis interaction network for the 12 most inhibited kinases. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm4002692/suppl_file/jm4002692_si_001.pdf">jm4002692_si_001.pdf (411.22 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm4002692" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54032" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54032" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hyunsuk Shim</span> - <span class="hlFld-Affiliation affiliation">†Winship
Cancer Institute, ‡Department of Chemistry, §Emory Institute for Drug Development (EIDD), and ∥Department of
Radiology and Imaging Sciences, Emory University, Atlanta, Georgia 30322, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#bcd4cfd4d5d1fcd9d1d3cec592d9d8c99cd6cfd2c5d8d9cefcd9d1d3cec592d9d8c9"><span class="__cf_email__" data-cfemail="9ff7ecf7f6f2dffaf2f0ede6b1fafbea">[email protected]</span> <span class="__cf_email__" data-cfemail="214b524f5845445361444c4e53580f444554">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James P. Snyder</span> - <span class="hlFld-Affiliation affiliation">†Winship
Cancer Institute, ‡Department of Chemistry, §Emory Institute for Drug Development (EIDD), and ∥Department of
Radiology and Imaging Sciences, Emory University, Atlanta, Georgia 30322, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a3cbd0cbcacee3c6ceccd1da8dc6c7d683c9d0cddac7c6d1e3c6ceccd1da8dc6c7d6"><span class="__cf_email__" data-cfemail="9af2e9f2f3f7dafff7f5e8e3b4fffeef">[email protected]</span> <span class="__cf_email__" data-cfemail="2e445d40574a4b5c6e4b43415c57004b4a5b">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew Brown</span> - <span class="hlFld-Affiliation affiliation">†Winship
Cancer Institute, ‡Department of Chemistry, §Emory Institute for Drug Development (EIDD), and ∥Department of
Radiology and Imaging Sciences, Emory University, Atlanta, Georgia 30322, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qi Shi</span> - <span class="hlFld-Affiliation affiliation">†Winship
Cancer Institute, ‡Department of Chemistry, §Emory Institute for Drug Development (EIDD), and ∥Department of
Radiology and Imaging Sciences, Emory University, Atlanta, Georgia 30322, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Terry W. Moore</span> - <span class="hlFld-Affiliation affiliation">†Winship
Cancer Institute, ‡Department of Chemistry, §Emory Institute for Drug Development (EIDD), and ∥Department of
Radiology and Imaging Sciences, Emory University, Atlanta, Georgia 30322, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Younghyoun Yoon</span> - <span class="hlFld-Affiliation affiliation">†Winship
Cancer Institute, ‡Department of Chemistry, §Emory Institute for Drug Development (EIDD), and ∥Department of
Radiology and Imaging Sciences, Emory University, Atlanta, Georgia 30322, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew Prussia</span> - <span class="hlFld-Affiliation affiliation">†Winship
Cancer Institute, ‡Department of Chemistry, §Emory Institute for Drug Development (EIDD), and ∥Department of
Radiology and Imaging Sciences, Emory University, Atlanta, Georgia 30322, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Clinton Maddox</span> - <span class="hlFld-Affiliation affiliation">†Winship
Cancer Institute, ‡Department of Chemistry, §Emory Institute for Drug Development (EIDD), and ∥Department of
Radiology and Imaging Sciences, Emory University, Atlanta, Georgia 30322, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dennis C. Liotta</span> - <span class="hlFld-Affiliation affiliation">†Winship
Cancer Institute, ‡Department of Chemistry, §Emory Institute for Drug Development (EIDD), and ∥Department of
Radiology and Imaging Sciences, Emory University, Atlanta, Georgia 30322, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>A.B. and Q.S. contributed equally to the writing of this paper.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d261e1659-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00061" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00061" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We are grateful to Dr. Dale Edmundson and Erika Milczek (Department of Biochemistry, Emory University, GA) for their invaluable assistance and patience concerning analysis of data from the enzyme kinetics studies. We also thank Jessica Paulishen for editing the manuscript. This study was partially supported by NCI Grant R01 CA 165306 (H.S.).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i30" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i30"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i31" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i31"> Abbreviations Used</h2><tr><td class="NLM_term">IKKβIκB</td><td class="NLM_def"><p class="first last">kinase</p></td></tr><tr><td class="NLM_term">IκB</td><td class="NLM_def"><p class="first last">inhibitor of NF-κB</p></td></tr><tr><td class="NLM_term">AKT</td><td class="NLM_def"><p class="first last">protein kinase B</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphosphate</p></td></tr><tr><td class="NLM_term">HT-29</td><td class="NLM_def"><p class="first last">human colonic adenocarcinoma</p></td></tr><tr><td class="NLM_term">mTOR</td><td class="NLM_def"><p class="first last">mammalian target of rapamycin</p></td></tr><tr><td class="NLM_term">NF-κB</td><td class="NLM_def"><p class="first last">nuclear factor κ B</p></td></tr><tr><td class="NLM_term">RAW264.7</td><td class="NLM_def"><p class="first last">mouse macrophage-like cell line</p></td></tr><tr><td class="NLM_term">PI3K</td><td class="NLM_def"><p class="first last">phosphoinositide 3-kinase</p></td></tr><tr><td class="NLM_term">PKA</td><td class="NLM_def"><p class="first last">protein kinase A</p></td></tr><tr><td class="NLM_term">BCR</td><td class="NLM_def"><p class="first last">breakpoint cluster region</p></td></tr><tr><td class="NLM_term">ABL</td><td class="NLM_def"><p class="first last">Ableson leukemia oncogene cellular homologue</p></td></tr><tr><td class="NLM_term">Src</td><td class="NLM_def"><p class="first last">Rous sarcoma oncogene cellular homologue</p></td></tr><tr><td class="NLM_term">RAF</td><td class="NLM_def"><p class="first last">rapidly accelerated fibrosarcoma</p></td></tr><tr><td class="NLM_term">MEK</td><td class="NLM_def"><p class="first last">MAPK/Erk kinase</p></td></tr><tr><td class="NLM_term">IGFR</td><td class="NLM_def"><p class="first last">insulin-like growth factor receptor</p></td></tr><tr><td class="NLM_term">Ser/Thr</td><td class="NLM_def"><p class="first last">serine/threonine</p></td></tr><tr><td class="NLM_term">Tyr</td><td class="NLM_def"><p class="first last">tyrosine</p></td></tr><tr><td class="NLM_term">Cys</td><td class="NLM_def"><p class="first last">cysteine</p></td></tr><tr><td class="NLM_term">KDR</td><td class="NLM_def"><p class="first last">kinase domain receptor</p></td></tr><tr><td class="NLM_term">RPS6K1</td><td class="NLM_def"><p class="first last">ribosomal protein S6 kinase 1</p></td></tr><tr><td class="NLM_term">AMPK</td><td class="NLM_def"><p class="first last">adenosine monophosphate-activated protein kinase</p></td></tr><tr><td class="NLM_term">NEK1</td><td class="NLM_def"><p class="first last">never in mitosis gene A-related kinase 1</p></td></tr><tr><td class="NLM_term">VEGF</td><td class="NLM_def"><p class="first last">vascular endothelial growth factor</p></td></tr><tr><td class="NLM_term">VEGFR2</td><td class="NLM_def"><p class="first last">vascular endothelial growth factor receptor-2</p></td></tr><tr><td class="NLM_term">MAPK</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase</p></td></tr><tr><td class="NLM_term">MAPKAP</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase activated protein kinase</p></td></tr><tr><td class="NLM_term">ERK</td><td class="NLM_def"><p class="first last">extracellular signal-regulated kinase</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">PRKC</td><td class="NLM_def"><p class="first last">protein kinase C</p></td></tr><tr><td class="NLM_term">p38</td><td class="NLM_def"><p class="first last">stress-activated protein kinase</p></td></tr><tr><td class="NLM_term">COT</td><td class="NLM_def"><p class="first last">cancer osaka thyroid</p></td></tr><tr><td class="NLM_term">RSK1</td><td class="NLM_def"><p class="first last">ribosomal S6 kinase 1</p></td></tr><tr><td class="NLM_term">S6K1</td><td class="NLM_def"><p class="first last">S6 kinase 1</p></td></tr><tr><td class="NLM_term">IKBKB</td><td class="NLM_def"><p class="first last">κ B kinase β</p></td></tr><tr><td class="NLM_term">Chek1</td><td class="NLM_def"><p class="first last">checkpoint kinase</p></td></tr><tr><td class="NLM_term">Chk1</td><td class="NLM_def"><p class="first last">checkpoint kinase</p></td></tr><tr><td class="NLM_term">VDAC1</td><td class="NLM_def"><p class="first last">voltage-dependent anion-selective channel protein 1</p></td></tr><tr><td class="NLM_term">FRET</td><td class="NLM_def"><p class="first last">fluorescence resonance energy transfer</p></td></tr><tr><td class="NLM_term">PDB</td><td class="NLM_def"><p class="first last">Protein Data Bank</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01026" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01026" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 61 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Jurenka, J. S.</span><span> </span><span class="NLM_article-title">Anti-inflammatory properties of curcumin, a major constituent of <i>Curcuma longa</i>: a review of preclinical and clinical research</span> <span class="citation_source-journal">Altern. Med. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm4002692&amp;key=19594223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A280%3ADC%252BD1MrmslOmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=141&author=J.+S.+Jurenka&title=Anti-inflammatory+properties+of+curcumin%2C+a+major+constituent+of+Curcuma+longa%3A+a+review+of+preclinical+and+clinical+research"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research</span></div><div class="casAuthors">Jurenka Julie S</div><div class="citationInfo"><span class="NLM_cas:title">Alternative medicine review : a journal of clinical therapeutic</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">141-53</span>
        ISSN:<span class="NLM_cas:issn">1089-5159</span>.
    </div><div class="casAbstract">Curcuma longa (turmeric) has a long history of use in Ayurvedic medicine as a treatment for inflammatory conditions.  Turmeric constituents include the three curcuminoids: curcumin (diferuloylmethane; the primary constituent and the one responsible for its vibrant yellow color), demethoxycurcumin, and bisdemethoxycurcumin, as well as volatile oils (tumerone, atlantone, and zingiberone), sugars, proteins, and resins.  While numerous pharmacological activities, including antioxidant and antimicrobial properties, have been attributed to curcumin, this article focuses on curcumin's anti-inflammatory properties and its use for inflammatory conditions.  Curcumin's effect on cancer (from an anti-inflammatory perspective) will also be discussed; however, an exhaustive review of its many anticancer mechanisms is outside the scope of this article.  Research has shown curcumin to be a highly pleiotropic molecule capable of interacting with numerous molecular targets involved in inflammation.  Based on early cell culture and animal research, clinical trials indicate curcumin may have potential as a therapeutic agent in diseases such as inflammatory bowel disease, pancreatitis, arthritis, and chronic anterior uveitis, as well as certain types of cancer.  Because of curcumin's rapid plasma clearance and conjugation, its therapeutic usefulness has been somewhat limited, leading researchers to investigate the benefits of complexing curcumin with other substances to increase systemic bioavailability.  Numerous in-progress clinical trials should provide an even deeper understanding of the mechanisms and therapeutic potential of curcumin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRt6mmQFWtMvtLIORRPd5lbfW6udTcc2eau2wQLc7-3ALntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MrmslOmtQ%253D%253D&md5=b5a792205ec07f7043faa96c4f01276f</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJurenka%26aufirst%3DJ.%2BS.%26atitle%3DAnti-inflammatory%2520properties%2520of%2520curcumin%252C%2520a%2520major%2520constituent%2520of%2520Curcuma%2520longa%253A%2520a%2520review%2520of%2520preclinical%2520and%2520clinical%2520research%26jtitle%3DAltern.%2520Med.%2520Rev.%26date%3D2009%26volume%3D14%26spage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Perry, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demeule, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moumdjian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beliveau, R.</span><span> </span><span class="NLM_article-title">Curcumin inhibits tumor growth and angiogenesis in glioblastoma xenografts</span> <span class="citation_source-journal">Mol. Nutr. Food Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm4002692&amp;key=20087857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvVyqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=1192&author=M.+C.+Perryauthor=M.+Demeuleauthor=A.+Reginaauthor=R.+Moumdjianauthor=R.+Beliveau&title=Curcumin+inhibits+tumor+growth+and+angiogenesis+in+glioblastoma+xenografts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Curcumin inhibits tumor growth and angiogenesis in glioblastoma xenografts</span></div><div class="casAuthors">Perry, Marie-Claude; Demeule, Michel; Regina, Anthony; Moumdjian, Robert; Beliveau, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Nutrition & Food Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1192-1201</span>CODEN:
                <span class="NLM_cas:coden">MNFRCV</span>;
        ISSN:<span class="NLM_cas:issn">1613-4125</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Among the natural products shown to possess chemopreventive and anticancer properties, curcumin is one of the most potent.  In the current study, we investigated the effects of this natural product on the growth of human glioma U-87 cells xenografted into athymic mice.  We show here that curcumin administration exerted significant anti-tumor effects on s.c. and intracerebral gliomas as demonstrated by the slower tumor growth rate and the increase of animal survival time.  While investigating the mechanism of its action in vivo, we obsd. that curcumin decreased the gelatinolytic activities of matrix metalloproteinase-9.  Furthermore, treatment with curcumin inhibited glioma-induced angiogenesis as indicated by the decrease of endothelial cell marker from newly formed vessels and by the diminution of the concn. of Hb in curcumin-treaded tumors.  We also demonstrate, using an in vitro model of blood-brain barrier, that curcumin can cross the blood-brain barrier to a high level.  These are the first results showing that curcumin suppresses tumor growth of gliomas in xenograft models.  The mechanisms of the anti-tumor effects of curcumin were related, at least partly, to the inhibition of glioma-induced angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzthyuuPffW7Vg90H21EOLACvtfcHk0lgOdt7_DczAHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvVyqtLs%253D&md5=fbc9d28f6ae7f40390504fd32c8ba89e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerry%26aufirst%3DM.%2BC.%26aulast%3DDemeule%26aufirst%3DM.%26aulast%3DRegina%26aufirst%3DA.%26aulast%3DMoumdjian%26aufirst%3DR.%26aulast%3DBeliveau%26aufirst%3DR.%26atitle%3DCurcumin%2520inhibits%2520tumor%2520growth%2520and%2520angiogenesis%2520in%2520glioblastoma%2520xenografts%26jtitle%3DMol.%2520Nutr.%2520Food%2520Res.%26date%3D2010%26volume%3D54%26spage%3D1192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Lee, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, O. J.</span><span> </span><span class="NLM_article-title">Regulatory effect of the AMPK-COX-2 signaling pathway in curcumin-induced apoptosis in HT-29 colon cancer cells</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1171</span><span class="NLM_x">, </span> <span class="NLM_fpage">489</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1171&publication_year=2009&pages=489&author=Y.+K.+Leeauthor=S.+Y.+Parkauthor=Y.+M.+Kimauthor=O.+J.+Park&title=Regulatory+effect+of+the+AMPK-COX-2+signaling+pathway+in+curcumin-induced+apoptosis+in+HT-29+colon+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DY.%2BK.%26aulast%3DPark%26aufirst%3DS.%2BY.%26aulast%3DKim%26aufirst%3DY.%2BM.%26aulast%3DPark%26aufirst%3DO.%2BJ.%26atitle%3DRegulatory%2520effect%2520of%2520the%2520AMPK-COX-2%2520signaling%2520pathway%2520in%2520curcumin-induced%2520apoptosis%2520in%2520HT-29%2520colon%2520cancer%2520cells%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2009%26volume%3D1171%26spage%3D489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Yang, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Y. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span> </span><span class="NLM_article-title">Curcumin blocks small cell lung cancer cells migration, invasion, angiogenesis, cell cycle and neoplasia through Janus kinase-STAT3 signalling pathway</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e37960</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e37960&author=C.+L.+Yangauthor=Y.+Y.+Liuauthor=Y.+G.+Maauthor=Y.+X.+Xueauthor=D.+G.+Liuauthor=Y.+Renauthor=X.+B.+Liuauthor=Y.+Liauthor=Z.+Li&title=Curcumin+blocks+small+cell+lung+cancer+cells+migration%2C+invasion%2C+angiogenesis%2C+cell+cycle+and+neoplasia+through+Janus+kinase-STAT3+signalling+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DC.%2BL.%26aulast%3DLiu%26aufirst%3DY.%2BY.%26aulast%3DMa%26aufirst%3DY.%2BG.%26aulast%3DXue%26aufirst%3DY.%2BX.%26aulast%3DLiu%26aufirst%3DD.%2BG.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DX.%2BB.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26atitle%3DCurcumin%2520blocks%2520small%2520cell%2520lung%2520cancer%2520cells%2520migration%252C%2520invasion%252C%2520angiogenesis%252C%2520cell%2520cycle%2520and%2520neoplasia%2520through%2520Janus%2520kinase-STAT3%2520signalling%2520pathway%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De37960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Aggarwal, B. B.; Surh, Y.-J.; Shishodia, S.</span> <span class="citation_source-book">The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease</span>; <span class="NLM_publisher-name">Springer Science+Business Media, LLC</span>: <span class="NLM_publisher-loc">New York, U.S.</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.1007%2F978-0-387-46401-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=B.+B.+Aggarwal&author=Y.-J.+Surh&author=S.+Shishodia&title=The+Molecular+Targets+and+Therapeutic+Uses+of+Curcumin+in+Health+and+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2F978-0-387-46401-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-0-387-46401-5%26sid%3Dliteratum%253Aachs%26aulast%3DAggarwal%26aufirst%3DB.%2BB.%26btitle%3DThe%2520Molecular%2520Targets%2520and%2520Therapeutic%2520Uses%2520of%2520Curcumin%2520in%2520Health%2520and%2520Disease%26pub%3DSpringer%2520Science%252BBusiness%2520Media%252C%2520LLC%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beevers, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.</span><span> </span><span class="NLM_article-title">The targets of curcumin</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">332</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.2174%2F138945011794815356" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=332&author=H.+Zhouauthor=C.+S.+Beeversauthor=S.+Huang&title=The+targets+of+curcumin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F138945011794815356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138945011794815356%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DBeevers%26aufirst%3DC.%2BS.%26aulast%3DHuang%26aufirst%3DS.%26atitle%3DThe%2520targets%2520of%2520curcumin%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2010%26volume%3D12%26spage%3D332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Sharma, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steward, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gescher, A. J.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and pharmacodynamics of curcumin</span> <span class="citation_source-journal">Adv. Exp. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">595</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.1007%2F978-0-387-46401-5_20" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm4002692&amp;key=17569224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A280%3ADC%252BD2szlslGnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=595&publication_year=2007&pages=453&author=R.+A.+Sharmaauthor=W.+P.+Stewardauthor=A.+J.+Gescher&title=Pharmacokinetics+and+pharmacodynamics+of+curcumin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and pharmacodynamics of curcumin</span></div><div class="casAuthors">Sharma Ricky A; Steward William P; Gescher Andreas J</div><div class="citationInfo"><span class="NLM_cas:title">Advances in experimental medicine and biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">595</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">453-70</span>
        ISSN:<span class="NLM_cas:issn">0065-2598</span>.
    </div><div class="casAbstract">Curcuma spp. contain turmerin, essential oils, and curcuminoids, including curcumin.  Curcumin [1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione] is regarded as the most biologically active constituent of the spice turmeric and it comprises 2-8% of most turmeric preparations.  Preclinical data from animal models and phase I clinical studies performed with human volunteers and patients with cancer have demonstrated low systemic bioavailability following oral dosing.  Efficient first-pass metabolism and some degree of intestinal metabolism, particularly glucuronidation and sulfation of curcumin, might explain its poor systemic availability when administered via the oral route.  A daily oral dose of 3.6 g of curcumin is compatible with detectable levels of the parent compound in colorectal tissue from patients with cancer.  The levels demonstrated might be sufficient to exert pharmacological activity.  There appears to be negligible distribution of the parent drug to hepatic tissue or other tissues beyond the gastrointestinal tract.  Curcumin possesses wide-ranging anti-inflammatory and anticancer properties.  Many of these biological activities can be attributed to its potent antioxidant capacity at neutral and acidic pH, its inhibition of cell signaling pathways at multiple levels, its diverse effects on cellular enzymes, and its effects on cell adhesion and angiogenesis.  In particular, curcumin's ability to alter gene transcription and induce apoptosis in preclinical models advocates its potential utility in cancer chemoprevention and chemotherapy.  With regard to considerable public and scientific interest in the use of phytochemicals derived from dietary components to combat or prevent human diseases, curcumin is currently a leading agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTNHoLsb061FisZ1x6zOs0vfW6udTcc2eb4ytee-bMBAbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2szlslGnuw%253D%253D&md5=0538b10f53ceca35fedfd9ec76428b10</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2F978-0-387-46401-5_20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-0-387-46401-5_20%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DR.%2BA.%26aulast%3DSteward%26aufirst%3DW.%2BP.%26aulast%3DGescher%26aufirst%3DA.%2BJ.%26atitle%3DPharmacokinetics%2520and%2520pharmacodynamics%2520of%2520curcumin%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D2007%26volume%3D595%26spage%3D453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Ji, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H. L.</span><span> </span><span class="NLM_article-title">Curcumin and its formulations: potential anti-cancer agents</span> <span class="citation_source-journal">Anti-Cancer Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">210</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=210&author=J.+L.+Jiauthor=X.+F.+Huangauthor=H.+L.+Zhu&title=Curcumin+and+its+formulations%3A+potential+anti-cancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DJ.%2BL.%26aulast%3DHuang%26aufirst%3DX.%2BF.%26aulast%3DZhu%26aufirst%3DH.%2BL.%26atitle%3DCurcumin%2520and%2520its%2520formulations%253A%2520potential%2520anti-cancer%2520agents%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2011%26volume%3D12%26spage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Sun, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J. K.</span><span> </span><span class="NLM_article-title">Cycle arrest and apoptosis in MDA-MB-231/Her2 cells induced by curcumin</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">690</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.1016%2Fj.ejphar.2012.05.036" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=690&publication_year=2010&pages=22-30&author=S.+H.+Sunauthor=H.+C.+Huangauthor=C.+Huangauthor=J.+K.+Lin&title=Cycle+arrest+and+apoptosis+in+MDA-MB-231%2FHer2+cells+induced+by+curcumin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2012.05.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2012.05.036%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%2BH.%26aulast%3DHuang%26aufirst%3DH.%2BC.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DJ.%2BK.%26atitle%3DCycle%2520arrest%2520and%2520apoptosis%2520in%2520MDA-MB-231%252FHer2%2520cells%2520induced%2520by%2520curcumin%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D690%26spage%3D22%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Epelbaum, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vizel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badmaev, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Sela, G.</span><span> </span><span class="NLM_article-title">Curcumin and gemcitabine in patients with advanced pancreatic cancer</span> <span class="citation_source-journal">Nutr. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1137</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.1080%2F01635581.2010.513802" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm4002692&amp;key=21058202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlyku7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=1137&author=R.+Epelbaumauthor=M.+Schafferauthor=B.+Vizelauthor=V.+Badmaevauthor=G.+Bar-Sela&title=Curcumin+and+gemcitabine+in+patients+with+advanced+pancreatic+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer</span></div><div class="casAuthors">Epelbaum, Ron; Schaffer, Moshe; Vizel, Bella; Badmaev, Vladimir; Bar-Sela, Gil</div><div class="citationInfo"><span class="NLM_cas:title">Nutrition and Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1137-1141</span>CODEN:
                <span class="NLM_cas:coden">NUCADQ</span>;
        ISSN:<span class="NLM_cas:issn">0163-5581</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Curcumin has a potent antiproliferative activity and can also potentiate the antitumor effect of gemcitabine.  This study was undertaken to evaluate the activity and feasibility of gemcitabine in combination with curcumin in patients with advanced pancreatic cancer.  Seventeen patients were enrolled in the study and received 8,000 mg of curcumin by mouth daily, concurrently with gemcitabine 1,000 mg/m2 IV weekly × 3 of 4 wk; 5 patients (29%) discontinued curcumin after a few days to 2 wk due to intractable abdominal fullness or pain, and the dose of curcumin was reduced to 4,000 mg/day because of abdominal complaints in 2 other patients.  One of 11 evaluable patients (9%) had partial response, 4 (36%) had stable disease, and 6 (55%) had tumor progression.  Time to tumor progression was 1-12 mo (median 21/2), and overall survival was 1-24 mo (median 5).  Low compliance for curcumin at a dose of 8,000 mg/day, when taken together with systemic gemcitabine, may prevent the use of high doses of oral curcumin needed to achieve systemic effect.  Further studies should be conducted to evaluate the ability of other formulations of curcumin to enhance the effect of chemotherapy in cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOd34cVcMfrbVg90H21EOLACvtfcHk0ljKbkh7cAeIgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlyku7vE&md5=5f41cd5ceb8bb015a2a313e94701afc0</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1080%2F01635581.2010.513802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F01635581.2010.513802%26sid%3Dliteratum%253Aachs%26aulast%3DEpelbaum%26aufirst%3DR.%26aulast%3DSchaffer%26aufirst%3DM.%26aulast%3DVizel%26aufirst%3DB.%26aulast%3DBadmaev%26aufirst%3DV.%26aulast%3DBar-Sela%26aufirst%3DG.%26atitle%3DCurcumin%2520and%2520gemcitabine%2520in%2520patients%2520with%2520advanced%2520pancreatic%2520cancer%26jtitle%3DNutr.%2520Cancer%26date%3D2010%26volume%3D62%26spage%3D1137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Bayet-Robert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwiatkowski, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leheurteur, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gachon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Planchat, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrial, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouret-Reynier, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durando, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barthomeuf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chollet, P.</span><span> </span><span class="NLM_article-title">Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer</span> <span class="citation_source-journal">Cancer Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.4161%2Fcbt.9.1.10392" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm4002692&amp;key=19901561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1Wjtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=8&author=M.+Bayet-Robertauthor=F.+Kwiatkowskiauthor=M.+Leheurteurauthor=F.+Gachonauthor=E.+Planchatauthor=C.+Abrialauthor=M.+A.+Mouret-Reynierauthor=X.+Durandoauthor=C.+Barthomeufauthor=P.+Chollet&title=Phase+I+dose+escalation+trial+of+docetaxel+plus+curcumin+in+patients+with+advanced+and+metastatic+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer</span></div><div class="casAuthors">Bayet-Robert, Mathilde; Kwiatkowski, Fabrice; Leheurteur, Marianne; Gachon, Francoise; Planchat, Eloise; Abrial, Catherine; Mouret-Reynier, Marie-Ange; Durando, Xavier; Barthomeuf, Chantal; Chollet, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8-14</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Background: Since the improvement of chemotherapy with safe mols. is needed for a better efficacy without supplementary toxicity, we investigated the feasibility and tolerability of the combination of docetaxel and curcumin, a polyphenolic deriv. extd. from Curcuma longa root.  Results: Fourteen patients were accrued in this open-label phase I trial.  At the last dose level of curcumin, three dose-limiting toxicities were obsd. and two out of three patients at this dose level refused to continue treatment, leading us to define the maximal tolerated dose of curcumin at 8,000 mg/d.  Eight patients out of 14 had measurable lesions according to RECIST criteria, with five PR and three SD.  Some improvements as biol. and clin. responses were obsd. in most patients.  Patients and Methods: Patients with advanced or metastatic breast cancer were eligible.  Docetaxel (100 mg/m2) was administered as a 1 h i.v. infusion every 3 w on d 1 for six cycles.  Curcumin was orally given from 500 mg/d for seven consecutive d by cycle (from d-4 to d+2) and escalated until a dose-limiting toxicity should occur.  The primary endpoint of this study was to det. the maximal tolerated dose of the combination of dose-escalating curcumin and std. dose of docetaxel chemotherapy in advanced and metastatic breast cancer patients.  Secondary objectives included toxicity, safety, vascular endothelial growth factor and tumor markers measurements and assessment of objective and clin. responses to the combination therapy.  Conclusion: The recommended dose of curcumin is 6,000 mg/d for seven consecutive d every 3 w in combination with a std. dose of docetaxel.  From the encouraging efficacy results, a comparative Phase II trial of this regimen plus docetaxel vs. docetaxel alone is ongoing in advanced and metastatic breast cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3p0dnfRr3ALVg90H21EOLACvtfcHk0lgYgZ5xaNkAWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1Wjtrc%253D&md5=95710a301381b5dc60aa5ad970fe893a</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.4161%2Fcbt.9.1.10392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.9.1.10392%26sid%3Dliteratum%253Aachs%26aulast%3DBayet-Robert%26aufirst%3DM.%26aulast%3DKwiatkowski%26aufirst%3DF.%26aulast%3DLeheurteur%26aufirst%3DM.%26aulast%3DGachon%26aufirst%3DF.%26aulast%3DPlanchat%26aufirst%3DE.%26aulast%3DAbrial%26aufirst%3DC.%26aulast%3DMouret-Reynier%26aufirst%3DM.%2BA.%26aulast%3DDurando%26aufirst%3DX.%26aulast%3DBarthomeuf%26aufirst%3DC.%26aulast%3DChollet%26aufirst%3DP.%26atitle%3DPhase%2520I%2520dose%2520escalation%2520trial%2520of%2520docetaxel%2520plus%2520curcumin%2520in%2520patients%2520with%2520advanced%2520and%2520metastatic%2520breast%2520cancer%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2010%26volume%3D9%26spage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Taylor, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, M. C.</span><span> </span><span class="NLM_article-title">Curcumin for inflammatory bowel disease: a review of human studies</span> <span class="citation_source-journal">Altern. Med. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm4002692&amp;key=21649456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A280%3ADC%252BC3MrotlemsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=152&author=R.+A.+Taylorauthor=M.+C.+Leonard&title=Curcumin+for+inflammatory+bowel+disease%3A+a+review+of+human+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Curcumin for inflammatory bowel disease: a review of human studies</span></div><div class="casAuthors">Taylor Rebecca A; Leonard Mandy C</div><div class="citationInfo"><span class="NLM_cas:title">Alternative medicine review : a journal of clinical therapeutic</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">152-6</span>
        ISSN:<span class="NLM_cas:issn">1089-5159</span>.
    </div><div class="casAbstract">OBJECTIVE:  To evaluate the use of curcumin in inflammatory bowel disease.  DATA SOURCES:  ALTMEDEX, Comprehensive Database of Natural Medicines, MEDLINE/PubMed were searched from January 1980 through May 2009 using the terms curcumin, turmeric, ulcerative colitis, Crohn's disease, Curcuma longa, Curcuma domestica, Indian saffron, inflammatory bowel disease.  Data was limited to human trials.  References of identified articles were reviewed.  DATA SYNTHESIS:  Data evaluating the use of curcumin in inflammatory bowel disease (including ulcerative colitis and Crohn's disease) is limited to two studies comprising data for only 99 patients.  Curcumin in conjunction with mainstream therapy, consisting of sulfasalazine (SZ) or mesalamine (5-aminosalicylic acid [5-ASA] derivatives) or corticosteroids was shown to improve patient symptoms and allow for a decrease in the dosage of corticosteroids or 5-ASA derivatives.  In one small study of 10 patients, some patients even stopped taking corticosteroids or 5-ASA.  CONCLUSIONS:  Although two small studies have shown promising results, all authors conclude that larger-scale, double-blind trials need to be conducted to establish a role for curcumin in the treatment of ulcerative colitis.  In addition to improving results when used in conjunction with conventional medications for UC, curcumin may pose a less-expensive alternative.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTKiSytaz4fsUcLvDNbOD4DfW6udTcc2ea63e57yDaty7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MrotlemsA%253D%253D&md5=31869a0c484718eb37bc0a9c0fff858e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DR.%2BA.%26aulast%3DLeonard%26aufirst%3DM.%2BC.%26atitle%3DCurcumin%2520for%2520inflammatory%2520bowel%2520disease%253A%2520a%2520review%2520of%2520human%2520studies%26jtitle%3DAltern.%2520Med.%2520Rev.%26date%3D2011%26volume%3D16%26spage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Gupta, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patchva, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aggarwal, B. B.</span><span> </span><span class="NLM_article-title">Therapeutic roles of curcumin: lessons learned from clinical trials</span> <span class="citation_source-journal">Am. Assoc. Pharm. Sci. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">218</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=195-218&author=S.+C.+Guptaauthor=S.+Patchvaauthor=B.+B.+Aggarwal&title=Therapeutic+roles+of+curcumin%3A+lessons+learned+from+clinical+trials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DS.%2BC.%26aulast%3DPatchva%26aufirst%3DS.%26aulast%3DAggarwal%26aufirst%3DB.%2BB.%26atitle%3DTherapeutic%2520roles%2520of%2520curcumin%253A%2520lessons%2520learned%2520from%2520clinical%2520trials%26jtitle%3DAm.%2520Assoc.%2520Pharm.%2520Sci.%2520J.%26date%3D2013%26volume%3D15%26spage%3D195%26epage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span>National Institutes of Health. <a href="http://www.clinicaltrials.gov/ct2/results?term=curcumin&amp;Search=Search" class="extLink">http://www.clinicaltrials.gov/ct2/results?term=curcumin&Search=Search</a> (last accessed Feb 10,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=National+Institutes+of+Health.+http%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fresults%3Fterm%3Dcurcumin%26Search%3DSearch+%28last+accessed+Feb+10%2C+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Adams, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferstl, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herold, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurtkaya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camalier, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollingshead, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sausville, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rickles, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoji, M.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">3871</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.1016%2Fj.bmc.2004.05.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm4002692&amp;key=15210154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltVKisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=3871&author=B.+K.+Adamsauthor=E.+M.+Ferstlauthor=M.+C.+Davisauthor=M.+Heroldauthor=S.+Kurtkayaauthor=R.+F.+Camalierauthor=M.+G.+Hollingsheadauthor=G.+Kaurauthor=E.+A.+Sausvilleauthor=F.+R.+Ricklesauthor=J.+P.+Snyderauthor=D.+C.+Liottaauthor=M.+Shoji&title=Synthesis+and+biological+evaluation+of+novel+curcumin+analogs+as+anti-cancer+and+anti-angiogenesis+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents</span></div><div class="casAuthors">Adams, Brian K.; Ferstl, Eva M.; Davis, Matthew C.; Herold, Marike; Kurtkaya, Serdar; Camalier, Richard F.; Hollingshead, Melinda G.; Kaur, Gurmeet; Sausville, Edward A.; Rickles, Frederick R.; Snyder, James P.; Liotta, Dennis C.; Shoji, Mamoru</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3871-3883</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of novel curcumin analogs were synthesized and screened for anti-cancer and anti-angiogenesis activities at Emory University and at the National Cancer Institute (NCI).  These compds. are sym. α,β-unsatd. and satd. ketones.  The majority of the analogs demonstrated a moderate degree of anti-cancer activity.  Three Compds. exhibited a high degree of cytotoxicity in the NCI in vitro anti-cancer cell line screen.  In addn., this screen revealed that these compds. inhibit tumor cell growth with a higher potency than the commonly used chemotherapeutic drug, cisplatin.  In independent in vitro screens conducted at Emory, 5 compds. exhibited a high degree of cytotoxicity to tumor cells.  Analogs that were effective in the anti-cancer screens were also effective in in vitro anti-angiogenesis assays.  In the assays conducted by the NCI, I was almost as potent as the anti-angiogenic drug TNP-470, which has undergone clin. trials.  Based on the favorable in vitro anti-cancer and anti-angiogenesis results with I, further in vivo tests were conducted.  This compd. effectively reduced the size of human breast tumors grown in female athymic nude mice and showed little toxicity.  This data, coupled with the remarkable in vitro data, suggests that I may potentially be an effective chemotherapeutic agent.  As a follow-up, a 3D quant. structure relation based on I has been developed.  It shows a cross-validated r2(q2)=0.83 and a predictive r2(p2)=0.71.  COMPARE anal. suggests the compd. to be a possible RNA/DNA antimetabolite, but also implies that the compd.'s cytotoxicity may arise from a presently unknown mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwmpU3h4OlGrVg90H21EOLACvtfcHk0ljP2YOlxJHlTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltVKisr8%253D&md5=94f8cdb257139ec0dcd3a742a90b9252</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2004.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2004.05.006%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DB.%2BK.%26aulast%3DFerstl%26aufirst%3DE.%2BM.%26aulast%3DDavis%26aufirst%3DM.%2BC.%26aulast%3DHerold%26aufirst%3DM.%26aulast%3DKurtkaya%26aufirst%3DS.%26aulast%3DCamalier%26aufirst%3DR.%2BF.%26aulast%3DHollingshead%26aufirst%3DM.%2BG.%26aulast%3DKaur%26aufirst%3DG.%26aulast%3DSausville%26aufirst%3DE.%2BA.%26aulast%3DRickles%26aufirst%3DF.%2BR.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DShoji%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520curcumin%2520analogs%2520as%2520anti-cancer%2520and%2520anti-angiogenesis%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D3871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Sun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoji, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span> </span><span class="NLM_article-title">Curcumin analog cytotoxicity against breast cancer cells: exploitation of a redox-dependent mechanism</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6627</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=6627&author=A.+Sunauthor=Y.+J.+Luauthor=H.+Huauthor=M.+Shojiauthor=D.+C.+Liottaauthor=J.+P.+Snyder&title=Curcumin+analog+cytotoxicity+against+breast+cancer+cells%3A+exploitation+of+a+redox-dependent+mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DA.%26aulast%3DLu%26aufirst%3DY.%2BJ.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DShoji%26aufirst%3DM.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26atitle%3DCurcumin%2520analog%2520cytotoxicity%2520against%2520breast%2520cancer%2520cells%253A%2520exploitation%2520of%2520a%2520redox-dependent%2520mechanism%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D6627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Avonto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taglialatela-Scafati, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollastro, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minassi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marzo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Petrocellis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appendino, G.</span><span> </span><span class="NLM_article-title">An NMR spectroscopic method to identify and classify thiol-trapping agents: revival of michael acceptors for drug discovery?</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">467</span><span class="NLM_x">–</span> <span class="NLM_lpage">471</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=467-471&author=C.+Avontoauthor=O.+Taglialatela-Scafatiauthor=F.+Pollastroauthor=A.+Minassiauthor=V.+Di+Marzoauthor=L.+De+Petrocellisauthor=G.+Appendino&title=An+NMR+spectroscopic+method+to+identify+and+classify+thiol-trapping+agents%3A+revival+of+michael+acceptors+for+drug+discovery%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAvonto%26aufirst%3DC.%26aulast%3DTaglialatela-Scafati%26aufirst%3DO.%26aulast%3DPollastro%26aufirst%3DF.%26aulast%3DMinassi%26aufirst%3DA.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DDe%2BPetrocellis%26aufirst%3DL.%26aulast%3DAppendino%26aufirst%3DG.%26atitle%3DAn%2520NMR%2520spectroscopic%2520method%2520to%2520identify%2520and%2520classify%2520thiol-trapping%2520agents%253A%2520revival%2520of%2520michael%2520acceptors%2520for%2520drug%2520discovery%253F%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2011%26volume%3D50%26spage%3D467%26epage%3D471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Usta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wortelboer, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vervoort, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boersma, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rietjens, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Bladeren, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cnubben, N. H.</span><span> </span><span class="NLM_article-title">Human glutathione <i>S</i>-transferase-mediated glutathione conjugation of curcumin and efflux of these conjugates in Caco-2 cells</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1895</span><span class="NLM_x">–</span> <span class="NLM_lpage">1902</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx7002245" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2007&pages=1895-1902&author=M.+Ustaauthor=H.+M.+Wortelboerauthor=J.+Vervoortauthor=M.+G.+Boersmaauthor=I.+M.+Rietjensauthor=P.+J.+van+Bladerenauthor=N.+H.+Cnubben&title=Human+glutathione+S-transferase-mediated+glutathione+conjugation+of+curcumin+and+efflux+of+these+conjugates+in+Caco-2+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Ftx7002245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx7002245%26sid%3Dliteratum%253Aachs%26aulast%3DUsta%26aufirst%3DM.%26aulast%3DWortelboer%26aufirst%3DH.%2BM.%26aulast%3DVervoort%26aufirst%3DJ.%26aulast%3DBoersma%26aufirst%3DM.%2BG.%26aulast%3DRietjens%26aufirst%3DI.%2BM.%26aulast%3Dvan%2BBladeren%26aufirst%3DP.%2BJ.%26aulast%3DCnubben%26aufirst%3DN.%2BH.%26atitle%3DHuman%2520glutathione%2520S-transferase-mediated%2520glutathione%2520conjugation%2520of%2520curcumin%2520and%2520efflux%2520of%2520these%2520conjugates%2520in%2520Caco-2%2520cells%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2007%26volume%3D20%26spage%3D1895%26epage%3D1902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Wortelboer, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Velde, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boersma, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spenkelink, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Zanden, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rietjens, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Bladeren, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cnubben, N. H.</span><span> </span><span class="NLM_article-title">Interplay between MRP inhibition and metabolism of MRP inhibitors: the case of curcumin</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1642</span><span class="NLM_x">–</span> <span class="NLM_lpage">1651</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx034101x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2003&pages=1642-1651&author=H.+M.+Wortelboerauthor=M.+Ustaauthor=A.+E.+van+der+Veldeauthor=M.+G.+Boersmaauthor=B.+Spenkelinkauthor=J.+J.+van+Zandenauthor=I.+M.+Rietjensauthor=P.+J.+van+Bladerenauthor=N.+H.+Cnubben&title=Interplay+between+MRP+inhibition+and+metabolism+of+MRP+inhibitors%3A+the+case+of+curcumin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Ftx034101x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx034101x%26sid%3Dliteratum%253Aachs%26aulast%3DWortelboer%26aufirst%3DH.%2BM.%26aulast%3DUsta%26aufirst%3DM.%26aulast%3Dvan%2Bder%2BVelde%26aufirst%3DA.%2BE.%26aulast%3DBoersma%26aufirst%3DM.%2BG.%26aulast%3DSpenkelink%26aufirst%3DB.%26aulast%3Dvan%2BZanden%26aufirst%3DJ.%2BJ.%26aulast%3DRietjens%26aufirst%3DI.%2BM.%26aulast%3Dvan%2BBladeren%26aufirst%3DP.%2BJ.%26aulast%3DCnubben%26aufirst%3DN.%2BH.%26atitle%3DInterplay%2520between%2520MRP%2520inhibition%2520and%2520metabolism%2520of%2520MRP%2520inhibitors%253A%2520the%2520case%2520of%2520curcumin%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2003%26volume%3D16%26spage%3D1642%26epage%3D1651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Awasthi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandya, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singhal, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiviyanathan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seifert, W. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awasthi, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ansari, G. A.</span><span> </span><span class="NLM_article-title">Curcumin–glutathione interactions and the role of human glutathione <i>S</i>-transferase P1-1</span> <span class="citation_source-journal">Chem.-Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.1016%2FS0009-2797%2800%2900185-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm4002692&amp;key=10996298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtlOlsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2000&pages=19&author=S.+Awasthiauthor=U.+Pandyaauthor=S.+S.+Singhalauthor=J.+T.+Linauthor=V.+Thiviyanathanauthor=W.+E.+Seifertauthor=Y.+C.+Awasthiauthor=G.+A.+Ansari&title=Curcumin%E2%80%93glutathione+interactions+and+the+role+of+human+glutathione+S-transferase+P1-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Curcumin-glutathione interactions and the role of human glutathione S-transferase P1-1</span></div><div class="casAuthors">Awasthi, S.; Pandya, U.; Singhal, S. S.; Lin, J. T.; Thiviyanathan, V.; Seifert, W. E.; Awasthi, Y. C.; Ansari, G. A. S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-38</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">Curcumin (diferuloylmethane), a yellow pigment of turmeric with antioxidant properties has been shown to be a cancer preventative in animal studies.  It contains two electrophilic α, β-unsatd. carbonyl groups, which can react with nucleophilic compds. such as glutathione (GSH), but formation of the GSH-curcumin conjugates has not previously been demonstrated.  In the present studies, we investigated the reactions of curcumin with GSH and the effect of recombinant human glutathione S-transferase(GST)P1-1 on reaction kinetics.  Glutathionylated products of curcumin identified by FAB-MS and MALDI-MS included mono- and di-glutathionyl-adducts of curcumin as well as cyclic rearrangement products of GSH adducts of feruloylmethylketone (FMK) and feruloylaldehyde (FAL).  The presence of GSTP1-1 significantly accelerated the initial rate of GSH-mediated consumption of curcumin in 10 mM potassium phosphate, pH 7.0, and 1 mM GSH.  GSTP1-1 kinetics detd. using HPLC indicated substrate inhibition (apparent Km for curcumin of 25±11 μM, and apparent Ki for curcumin of 8±3 μM).  GSTP1-1 was also shown to catalyze the reverse reaction leading to the formation of curcumin from GSH adducts of FMK and FAL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeKW1kajK1EbVg90H21EOLACvtfcHk0lidHH-fm61Swg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtlOlsL4%253D&md5=749797f39e599cefdd3282b4016b71f4</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS0009-2797%2800%2900185-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0009-2797%252800%252900185-X%26sid%3Dliteratum%253Aachs%26aulast%3DAwasthi%26aufirst%3DS.%26aulast%3DPandya%26aufirst%3DU.%26aulast%3DSinghal%26aufirst%3DS.%2BS.%26aulast%3DLin%26aufirst%3DJ.%2BT.%26aulast%3DThiviyanathan%26aufirst%3DV.%26aulast%3DSeifert%26aufirst%3DW.%2BE.%26aulast%3DAwasthi%26aufirst%3DY.%2BC.%26aulast%3DAnsari%26aufirst%3DG.%2BA.%26atitle%3DCurcumin%25E2%2580%2593glutathione%2520interactions%2520and%2520the%2520role%2520of%2520human%2520glutathione%2520S-transferase%2520P1-1%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2000%26volume%3D128%26spage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Targeting cancer with small molecule kinase inhibitors</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.1038%2Fnrc2559" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm4002692&amp;key=19104514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1yg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=28-39&author=J.+Zhangauthor=P.+L.+Yangauthor=N.+S.+Gray&title=Targeting+cancer+with+small+molecule+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cancer with small molecule kinase inhibitors</span></div><div class="casAuthors">Zhang, Jianming; Yang, Priscilla L.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-39</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Deregulation of kinase activity has emerged as a major mechanism by which cancer cells evade normal physiol. constraints on growth and survival.  To date, 11 kinase inhibitors have received US Food and Drug Administration approval as cancer treatments, and there are considerable efforts to develop selective small mol. inhibitors for a host of other kinases that are implicated in cancer and other diseases.  Herein we discuss the current challenges in the field, such as designing selective inhibitors and developing strategies to overcome resistance mutations.  This Review provides a broad overview of some of the approaches currently used to discover and characterize new kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriSM3BN_uEz7Vg90H21EOLACvtfcHk0lidHH-fm61Swg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1yg&md5=35bc38f414cd21eef5e61ce181b580fb</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnrc2559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2559%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DP.%2BL.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DTargeting%2520cancer%2520with%2520small%2520molecule%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26spage%3D28%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Kothari, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shanker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalyana-Sundaram, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vats, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasso, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simeone, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnaiyan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar-Sinha, C.</span><span> </span><span class="NLM_article-title">Outlier kinase expression by RNA sequencing as targets for precision therapy</span> <span class="citation_source-journal">Cancer Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=1-14&author=V.+Kothariauthor=I.+Weiauthor=S.+Shankerauthor=S.+Kalyana-Sundaramauthor=L.+Wangauthor=L.+W.+Maauthor=P.+Vatsauthor=C.+S.+Grassoauthor=D.+R.+Robinsonauthor=Y.+M.+Wuauthor=X.+Caoauthor=D.+M.+Simeoneauthor=A.+M.+Chinnaiyanauthor=C.+Kumar-Sinha&title=Outlier+kinase+expression+by+RNA+sequencing+as+targets+for+precision+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKothari%26aufirst%3DV.%26aulast%3DWei%26aufirst%3DI.%26aulast%3DShanker%26aufirst%3DS.%26aulast%3DKalyana-Sundaram%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DMa%26aufirst%3DL.%2BW.%26aulast%3DVats%26aufirst%3DP.%26aulast%3DGrasso%26aufirst%3DC.%2BS.%26aulast%3DRobinson%26aufirst%3DD.%2BR.%26aulast%3DWu%26aufirst%3DY.%2BM.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DSimeone%26aufirst%3DD.%2BM.%26aulast%3DChinnaiyan%26aufirst%3DA.%2BM.%26aulast%3DKumar-Sinha%26aufirst%3DC.%26atitle%3DOutlier%2520kinase%2520expression%2520by%2520RNA%2520sequencing%2520as%2520targets%2520for%2520precision%2520therapy%26jtitle%3DCancer%2520Discovery%26date%3D2013%26volume%3D3%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Adams, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herold, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoji, M.</span><span> </span><span class="NLM_article-title">EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redox-dependent mechanism</span> <span class="citation_source-journal">Anti-Cancer Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=263&author=B.+K.+Adamsauthor=J.+Caiauthor=J.+Armstrongauthor=M.+Heroldauthor=Y.+J.+Luauthor=A.+Sunauthor=J.+P.+Snyderauthor=D.+C.+Liottaauthor=D.+P.+Jonesauthor=M.+Shoji&title=EF24%2C+a+novel+synthetic+curcumin+analog%2C+induces+apoptosis+in+cancer+cells+via+a+redox-dependent+mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DB.%2BK.%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DArmstrong%26aufirst%3DJ.%26aulast%3DHerold%26aufirst%3DM.%26aulast%3DLu%26aufirst%3DY.%2BJ.%26aulast%3DSun%26aufirst%3DA.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DJones%26aufirst%3DD.%2BP.%26aulast%3DShoji%26aufirst%3DM.%26atitle%3DEF24%252C%2520a%2520novel%2520synthetic%2520curcumin%2520analog%252C%2520induces%2520apoptosis%2520in%2520cancer%2520cells%2520via%2520a%2520redox-dependent%2520mechanism%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D2005%26volume%3D16%26spage%3D263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Kasinski, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khuri, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoji, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, H.</span><span> </span><span class="NLM_article-title">Inhibition of IkappaB kinase-nuclear factor-kappaB signaling pathway by 3,5-bis(2-flurobenzylidene)piperidin-4-one (EF24), a novel monoketone analog of curcumin</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">654</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2008&pages=654&author=A.+L.+Kasinskiauthor=Y.+Duauthor=S.+L.+Thomasauthor=J.+Zhaoauthor=S.+Y.+Sunauthor=F.+R.+Khuriauthor=C.+Y.+Wangauthor=M.+Shojiauthor=A.+Sunauthor=J.+P.+Snyderauthor=D.+Liottaauthor=H.+Fu&title=Inhibition+of+IkappaB+kinase-nuclear+factor-kappaB+signaling+pathway+by+3%2C5-bis%282-flurobenzylidene%29piperidin-4-one+%28EF24%29%2C+a+novel+monoketone+analog+of+curcumin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKasinski%26aufirst%3DA.%2BL.%26aulast%3DDu%26aufirst%3DY.%26aulast%3DThomas%26aufirst%3DS.%2BL.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DS.%2BY.%26aulast%3DKhuri%26aufirst%3DF.%2BR.%26aulast%3DWang%26aufirst%3DC.%2BY.%26aulast%3DShoji%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DA.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DLiotta%26aufirst%3DD.%26aulast%3DFu%26aufirst%3DH.%26atitle%3DInhibition%2520of%2520IkappaB%2520kinase-nuclear%2520factor-kappaB%2520signaling%2520pathway%2520by%25203%252C5-bis%25282-flurobenzylidene%2529piperidin-4-one%2520%2528EF24%2529%252C%2520a%2520novel%2520monoketone%2520analog%2520of%2520curcumin%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D74%26spage%3D654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Thomas, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purcell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khuri, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, H.</span><span> </span><span class="NLM_article-title">Activation of the p38 pathway by a novel monoketone curcumin analog, EF24, suggests a potential combination strategy</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">1309</span><span class="NLM_x">–</span> <span class="NLM_lpage">1316</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2010&pages=1309-1316&author=S.+L.+Thomasauthor=J.+Zhaoauthor=Z.+Liauthor=B.+Louauthor=Y.+Duauthor=J.+Purcellauthor=J.+P.+Snyderauthor=F.+R.+Khuriauthor=D.+Liottaauthor=H.+Fu&title=Activation+of+the+p38+pathway+by+a+novel+monoketone+curcumin+analog%2C+EF24%2C+suggests+a+potential+combination+strategy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DS.%2BL.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLou%26aufirst%3DB.%26aulast%3DDu%26aufirst%3DY.%26aulast%3DPurcell%26aufirst%3DJ.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DKhuri%26aufirst%3DF.%2BR.%26aulast%3DLiotta%26aufirst%3DD.%26aulast%3DFu%26aufirst%3DH.%26atitle%3DActivation%2520of%2520the%2520p38%2520pathway%2520by%2520a%2520novel%2520monoketone%2520curcumin%2520analog%252C%2520EF24%252C%2520suggests%2520a%2520potential%2520combination%2520strategy%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2010%26volume%3D80%26spage%3D1309%26epage%3D1316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Olivera, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shim, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcus, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pace, T. W.</span><span> </span><span class="NLM_article-title">Inhibition of the NF-kappaB signaling pathway by the curcumin analog, 3,5-bis(2-pyridinylmethylidene)-4-piperidone (EF31): anti-inflammatory and anti-cancer properties</span> <span class="citation_source-journal">Int. Immunopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">368</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.1016%2Fj.intimp.2011.12.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm4002692&amp;key=22197802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A528%3ADC%252BC38XitVWkt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=368&author=A.+Oliveraauthor=T.+W.+Mooreauthor=F.+Huauthor=A.+P.+Brownauthor=A.+Sunauthor=D.+C.+Liottaauthor=J.+P.+Snyderauthor=Y.+Yoonauthor=H.+Shimauthor=A.+I.+Marcusauthor=A.+H.+Millerauthor=T.+W.+Pace&title=Inhibition+of+the+NF-kappaB+signaling+pathway+by+the+curcumin+analog%2C+3%2C5-bis%282-pyridinylmethylidene%29-4-piperidone+%28EF31%29%3A+anti-inflammatory+and+anti-cancer+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the NF-κB signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): Anti-inflammatory and anti-cancer properties</span></div><div class="casAuthors">Olivera, Anlys; Moore, Terry W.; Hu, Fang; Brown, Andrew P.; Sun, Aiming; Liotta, Dennis C.; Snyder, James P.; Yoon, Younghyoun; Shim, Hyunsuk; Marcus, Adam I.; Miller, Andrew H.; Pace, Thaddeus W. W.</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">368-377</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nuclear factor kappa B (NF-κB) is a key signaling mol. in the elaboration of the inflammatory response.  Data indicate that curcumin, a natural ingredient of the curry spice turmeric, acts as a NF-κB inhibitor and exhibits both anti-inflammatory and anti-cancer properties.  Curcumin analogs with enhanced activity on NF-κB and other inflammatory signaling pathways were developed including the synthetic monoketone compd. 3,5-Bis(2-fluorobenzylidene)-4-piperidone (EF24).  3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31) is a structurally-related curcumin analog whose potency for NF-κB inhibition has yet to be detd.  To examine the activity of EF31 compared to EF24 and curcumin, mouse RAW264.7 macrophages were treated with EF31, EF24, curcumin (1-100 μM), or vehicle (DMSO 1%) for 1 h.  NF-κB pathway activity was assessed following treatment with lipopolysaccharide (LPS) (1 μg/mL).  EF31 (IC50 ∼ 5 μM) exhibited significantly more potent inhibition of LPS-induced NF-κB DNA binding compared to both EF24 (IC50 ∼ 35 μM) and curcumin (IC50 > 50 μM).  In addn., EF31 exhibited greater inhibition of NF-κB nuclear translocation as well as the induction of downstream inflammatory mediators including pro-inflammatory cytokine mRNA and protein (tumor necrosis factor-α, interleukin-1β, and interleukin-6).  Regarding the mechanism of these effects on NF-κB, EF31 (IC50 ∼ 1.92 μM) exhibited significantly greater inhibition of IκB kinase β compared to EF24 (IC50 ∼ 131 μM).  Finally, EF31 demonstrated potent toxicity in NF-κB-dependent cancer cell lines while having minimal and reversible toxicity in RAW264.7 macrophages.  These data indicate that EF31 is a more potent inhibitor of NF-κB activity than either EF24 or curcumin while exhibiting both anti-inflammatory and anticancer activities.  Thus, EF31 represents a promising curcumin analog for further therapeutic development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2ep39PwkqobVg90H21EOLACvtfcHk0lgRrqiDs9O60w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitVWkt7c%253D&md5=9c422de1325e9b1d376098f3f9e2d3fe</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2011.12.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2011.12.009%26sid%3Dliteratum%253Aachs%26aulast%3DOlivera%26aufirst%3DA.%26aulast%3DMoore%26aufirst%3DT.%2BW.%26aulast%3DHu%26aufirst%3DF.%26aulast%3DBrown%26aufirst%3DA.%2BP.%26aulast%3DSun%26aufirst%3DA.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DYoon%26aufirst%3DY.%26aulast%3DShim%26aufirst%3DH.%26aulast%3DMarcus%26aufirst%3DA.%2BI.%26aulast%3DMiller%26aufirst%3DA.%2BH.%26aulast%3DPace%26aufirst%3DT.%2BW.%26atitle%3DInhibition%2520of%2520the%2520NF-kappaB%2520signaling%2520pathway%2520by%2520the%2520curcumin%2520analog%252C%25203%252C5-bis%25282-pyridinylmethylidene%2529-4-piperidone%2520%2528EF31%2529%253A%2520anti-inflammatory%2520and%2520anti-cancer%2520properties%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2012%26volume%3D12%26spage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Yamaguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoji, M.</span><span> </span><span class="NLM_article-title">Novel curcumin analogue UBS 109 potently stimulates osteoblastogenesis and suppresses osteoclastogenesis: involvement in Smad activation and NF-κB inhibition</span> <span class="citation_source-journal">Integr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">905</span><span class="NLM_x">–</span> <span class="NLM_lpage">913</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.1039%2Fc2ib20045g" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWntLzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=905-913&author=M.+Yamaguchiauthor=T.+W.+Mooreauthor=A.+Sunauthor=J.+P.+Snyderauthor=M.+Shoji&title=Novel+curcumin+analogue+UBS+109+potently+stimulates+osteoblastogenesis+and+suppresses+osteoclastogenesis%3A+involvement+in+Smad+activation+and+NF-%CE%BAB+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Novel curcumin analogue UBS109 potently stimulates osteoblastogenesis and suppresses osteoclastogenesis: involvement in Smad activation and NF-κB inhibition</span></div><div class="casAuthors">Yamaguchi, Masayoshi; Moore, Terry W.; Sun, Aiming; Snyder, James P.; Shoji, Mamoru</div><div class="citationInfo"><span class="NLM_cas:title">Integrative Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">905-913</span>CODEN:
                <span class="NLM_cas:coden">IBNIFL</span>;
        ISSN:<span class="NLM_cas:issn">1757-9694</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Bone homeostasis is maintained through a balance between osteoblastic bone formation and osteoclastic bone resorption.  Bone loss is induced due to decreased osteoblastic bone formation and increased osteoclastic bone resorption with various pathol. states.  Osteoporosis with its accompanying decrease in bone mass is widely recognized as a major public health problem.  Pharmacol. and functional food factors may play a role in the prevention of bone loss with aging.  This study was undertaken to det. the effect of curcumin analogs (curcumin, EF31, ECMN909, and UBS109), which were newly synthesized, on osteoblastogenesis and osteoclastogenesis in vitro.  Among these compds., UBS109 had a unique stimulatory effect on osteoblastic differentiation and mineralization.  UBS109 stimulated both basal and bone morphogenic protein-2 (BMP2)-increased Smad-luciferase activity, the Smad signaling of which is related to osteoblastogenesis.  Such an effect was not seen with other compds.  Moreover, UBS109 potently suppressed tumor necrosis factor-α (TNF-α)-increased osteoblastic nuclear factor kappa B (NF-κB)-luciferase activity.  In addn., EF31, ECMN909, and UBS109 had a suppressive effect on osteoclastogenesis as compared with that of curcumin.  ECMN909 and UBS109 potently inhibited the receptor activator of NF-κB (RANK) ligand (RANKL)-increased preosteoclastic NF-κB-luciferase activity, in which NF-κB signaling plays a pivotal role in osteoclastogenesis.  In the present study, curcumin analog UBS109 was found to have a stimulating effect on osteoblastogenesis and a suppressive effect on osteoclastogenesis in vitro, suggesting an anabolic effect of the compd. on bone mass.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrq_TFEfPM6ebVg90H21EOLACvtfcHk0liSL2Ce6od7hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWntLzN&md5=67d9d431ae9e41e99bf8237f8dde3eb8</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1039%2Fc2ib20045g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2ib20045g%26sid%3Dliteratum%253Aachs%26aulast%3DYamaguchi%26aufirst%3DM.%26aulast%3DMoore%26aufirst%3DT.%2BW.%26aulast%3DSun%26aufirst%3DA.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DShoji%26aufirst%3DM.%26atitle%3DNovel%2520curcumin%2520analogue%2520UBS%2520109%2520potently%2520stimulates%2520osteoblastogenesis%2520and%2520suppresses%2520osteoclastogenesis%253A%2520involvement%2520in%2520Smad%2520activation%2520and%2520NF-%25CE%25BAB%2520inhibition%26jtitle%3DIntegr.%2520Biol.%26date%3D2012%26volume%3D4%26spage%3D905%26epage%3D913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Landis, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarroll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiddingh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turker, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoatlin, M. E.</span><span> </span><span class="NLM_article-title">Monoketone analogs of curcumin, a new class of potent Fanconi anemia pathway inhibitors</span> <span class="citation_source-journal">Mol. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">133</span><span class="NLM_x">) </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm4002692&amp;key=19128456" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=1-13&issue=133&author=I.+Landisauthor=M.+McCarrollauthor=C.+Yangauthor=A.+Sunauthor=S.+Hiddinghauthor=M.+S.+Turkerauthor=J.+P.+Snyderauthor=M.+E.+Hoatlin&title=Monoketone+analogs+of+curcumin%2C+a+new+class+of+potent+Fanconi+anemia+pathway+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLandis%26aufirst%3DI.%26aulast%3DMcCarroll%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DA.%26aulast%3DHiddingh%26aufirst%3DS.%26aulast%3DTurker%26aufirst%3DM.%2BS.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DHoatlin%26aufirst%3DM.%2BE.%26atitle%3DMonoketone%2520analogs%2520of%2520curcumin%252C%2520a%2520new%2520class%2520of%2520potent%2520Fanconi%2520anemia%2520pathway%2520inhibitors%26jtitle%3DMol.%2520Cancer%26date%3D2009%26volume%3D8%26issue%3D133%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Thomas, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malik, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannakakou, P.</span><span> </span><span class="NLM_article-title">EF24, a novel curcumin analog, disrupts the microtubule cytoskeleton and inhibits HIF-1</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2409</span><span class="NLM_x">–</span> <span class="NLM_lpage">2417</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=2409-2417&author=S.+L.+Thomasauthor=D.+Zhongauthor=W.+Zhouauthor=S.+Malikauthor=D.+Liottaauthor=J.+P.+Snyderauthor=E.+Hamelauthor=P.+Giannakakou&title=EF24%2C+a+novel+curcumin+analog%2C+disrupts+the+microtubule+cytoskeleton+and+inhibits+HIF-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DS.%2BL.%26aulast%3DZhong%26aufirst%3DD.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DMalik%26aufirst%3DS.%26aulast%3DLiotta%26aufirst%3DD.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DGiannakakou%26aufirst%3DP.%26atitle%3DEF24%252C%2520a%2520novel%2520curcumin%2520analog%252C%2520disrupts%2520the%2520microtubule%2520cytoskeleton%2520and%2520inhibits%2520HIF-1%26jtitle%3DCell%2520Cycle%26date%3D2008%26volume%3D7%26spage%3D2409%26epage%3D2417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Zhu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morii, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culver, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrendale, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sica, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khuri, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoji, M.</span><span> </span><span class="NLM_article-title">Synthetic curcumin analog EF31 inhibits the growth of head and neck squamous cell carcinoma xenografts</span> <span class="citation_source-journal">Integr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">633</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.1039%2Fc2ib20007d" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvVOqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=633&author=S.+Zhuauthor=T.+W.+Mooreauthor=X.+Linauthor=N.+Moriiauthor=A.+Manciniauthor=R.+B.+Howardauthor=D.+Culverauthor=R.+F.+Arrendaleauthor=P.+Reddyauthor=T.+J.+Eversauthor=H.+Zhangauthor=G.+Sicaauthor=Z.+G.+Chenauthor=A.+Sunauthor=H.+Fuauthor=F.+R.+Khuriauthor=D.+M.+Shinauthor=J.+P.+Snyderauthor=M.+Shoji&title=Synthetic+curcumin+analog+EF31+inhibits+the+growth+of+head+and+neck+squamous+cell+carcinoma+xenografts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic curcumin analog EF31 inhibits the growth of head and neck squamous cell carcinoma xenografts</span></div><div class="casAuthors">Zhu, Shijun; Moore, Terry W.; Lin, Xiaoqian; Morii, Nao; Mancini, Alessandra; Howard, Randy B.; Culver, Deborah; Arrendale, Richard F.; Reddy, Prabhakar; Evers, Taylor J.; Zhang, Hongzheng; Sica, Gabriel; Chen, Zhuo G.; Sun, Aiming; Fu, Haian; Khuri, Fadlo R.; Shin, Dong M.; Snyder, James P.; Shoji, Mamoru</div><div class="citationInfo"><span class="NLM_cas:title">Integrative Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">633-640</span>CODEN:
                <span class="NLM_cas:coden">IBNIFL</span>;
        ISSN:<span class="NLM_cas:issn">1757-9694</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Objectives are to examine the efficacy, pharmacokinetics, and toxicol. of a synthetic curcumin analog EF31 in head and neck squamous cell carcinoma.  The synthesis of EF31 was described for the first time.  Soly. of EF24 and EF31 was compared using nephelometric anal.  Human head and neck squamous cell carcinoma Tu212 xenograft tumors were established in athymic nude mice and treated with EF31 i.p. once daily five days a week for about 5-6 wk.  The long term effect of EF31 on the NF-κB signaling system in the tumors was examd. by Western blot anal.  EF31 at 25 mg kg-1, i.p. inhibited tumor growth almost completely.  Solubilities of EF24 and EF31 are <10 and 13 μg mL-1 or <32 and 47 μM, resp.  The serum chem. profiles of treated mice were within the limits of normal, they revealed a linear increase of Cmax.  EF31 decreased the level of phosphorylation of NF-κB p65.  In conclusion, the novel synthetic curcumin analog EF31 is efficacious in inhibiting the growth of Tu212 xenograft tumors and may be useful for treating head and neck squamous cell carcinoma.  The long term EF31 treatment inhibited NF-κB p65 phosphorylation in xenografts, implicating downregulation of cancer promoting transcription factors such as angiogenesis and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhDK76kX4njLVg90H21EOLACvtfcHk0liSL2Ce6od7hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvVOqt70%253D&md5=8930c4c94e3baa169179eb876c33e368</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1039%2Fc2ib20007d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2ib20007d%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DMoore%26aufirst%3DT.%2BW.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DMorii%26aufirst%3DN.%26aulast%3DMancini%26aufirst%3DA.%26aulast%3DHoward%26aufirst%3DR.%2BB.%26aulast%3DCulver%26aufirst%3DD.%26aulast%3DArrendale%26aufirst%3DR.%2BF.%26aulast%3DReddy%26aufirst%3DP.%26aulast%3DEvers%26aufirst%3DT.%2BJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DSica%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DZ.%2BG.%26aulast%3DSun%26aufirst%3DA.%26aulast%3DFu%26aufirst%3DH.%26aulast%3DKhuri%26aufirst%3DF.%2BR.%26aulast%3DShin%26aufirst%3DD.%2BM.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DShoji%26aufirst%3DM.%26atitle%3DSynthetic%2520curcumin%2520analog%2520EF31%2520inhibits%2520the%2520growth%2520of%2520head%2520and%2520neck%2520squamous%2520cell%2520carcinoma%2520xenografts%26jtitle%3DIntegr.%2520Biol.%26date%3D2012%26volume%3D4%26spage%3D633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Zhu, S.; Moore, T. W.; Snyder, J. P.; Shoji, M.</span> Manuscript in preparation.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Zhu%2C+S.%3B+Moore%2C+T.+W.%3B+Snyder%2C+J.+P.%3B+Shoji%2C+M.+Manuscript+in+preparation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DS." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span>IPA, Ingenuity Systems, Inc. (1700 Seaport Blvd, 3rd Floor, Redwood City, CA 94063). <a href="http://www.ingenuity.com/" class="extLink">http://www.ingenuity.com/</a> (accessed Sep 20,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=IPA%2C+Ingenuity+Systems%2C+Inc.+%281700+Seaport+Blvd%2C+3rd+Floor%2C+Redwood+City%2C+CA+94063%29.+http%3A%2F%2Fwww.ingenuity.com%2F+%28accessed+Sep+20%2C+2012%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Zhu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morii, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culver, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrendale, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sica, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khuri, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoji, M.</span><span> </span><span class="NLM_article-title">Synthetic curcumin analog EF31 inhibits the growth of head and neck squamous cell carcinoma xenografts</span> <span class="citation_source-journal">Integr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">633</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.1039%2Fc2ib20007d" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvVOqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=633&author=S.+Zhuauthor=T.+W.+Mooreauthor=X.+Linauthor=N.+Moriiauthor=A.+Manciniauthor=R.+B.+Howardauthor=D.+Culverauthor=R.+F.+Arrendaleauthor=P.+Reddyauthor=T.+J.+Eversauthor=H.+Zhangauthor=G.+Sicaauthor=Z.+G.+Chenauthor=A.+Sunauthor=H.+Fuauthor=F.+R.+Khuriauthor=D.+M.+Shinauthor=J.+P.+Snyderauthor=M.+Shoji&title=Synthetic+curcumin+analog+EF31+inhibits+the+growth+of+head+and+neck+squamous+cell+carcinoma+xenografts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic curcumin analog EF31 inhibits the growth of head and neck squamous cell carcinoma xenografts</span></div><div class="casAuthors">Zhu, Shijun; Moore, Terry W.; Lin, Xiaoqian; Morii, Nao; Mancini, Alessandra; Howard, Randy B.; Culver, Deborah; Arrendale, Richard F.; Reddy, Prabhakar; Evers, Taylor J.; Zhang, Hongzheng; Sica, Gabriel; Chen, Zhuo G.; Sun, Aiming; Fu, Haian; Khuri, Fadlo R.; Shin, Dong M.; Snyder, James P.; Shoji, Mamoru</div><div class="citationInfo"><span class="NLM_cas:title">Integrative Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">633-640</span>CODEN:
                <span class="NLM_cas:coden">IBNIFL</span>;
        ISSN:<span class="NLM_cas:issn">1757-9694</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Objectives are to examine the efficacy, pharmacokinetics, and toxicol. of a synthetic curcumin analog EF31 in head and neck squamous cell carcinoma.  The synthesis of EF31 was described for the first time.  Soly. of EF24 and EF31 was compared using nephelometric anal.  Human head and neck squamous cell carcinoma Tu212 xenograft tumors were established in athymic nude mice and treated with EF31 i.p. once daily five days a week for about 5-6 wk.  The long term effect of EF31 on the NF-κB signaling system in the tumors was examd. by Western blot anal.  EF31 at 25 mg kg-1, i.p. inhibited tumor growth almost completely.  Solubilities of EF24 and EF31 are <10 and 13 μg mL-1 or <32 and 47 μM, resp.  The serum chem. profiles of treated mice were within the limits of normal, they revealed a linear increase of Cmax.  EF31 decreased the level of phosphorylation of NF-κB p65.  In conclusion, the novel synthetic curcumin analog EF31 is efficacious in inhibiting the growth of Tu212 xenograft tumors and may be useful for treating head and neck squamous cell carcinoma.  The long term EF31 treatment inhibited NF-κB p65 phosphorylation in xenografts, implicating downregulation of cancer promoting transcription factors such as angiogenesis and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhDK76kX4njLVg90H21EOLACvtfcHk0lj_KidrLeK2Jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvVOqt70%253D&md5=8930c4c94e3baa169179eb876c33e368</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1039%2Fc2ib20007d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2ib20007d%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DMoore%26aufirst%3DT.%2BW.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DMorii%26aufirst%3DN.%26aulast%3DMancini%26aufirst%3DA.%26aulast%3DHoward%26aufirst%3DR.%2BB.%26aulast%3DCulver%26aufirst%3DD.%26aulast%3DArrendale%26aufirst%3DR.%2BF.%26aulast%3DReddy%26aufirst%3DP.%26aulast%3DEvers%26aufirst%3DT.%2BJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DSica%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DZ.%2BG.%26aulast%3DSun%26aufirst%3DA.%26aulast%3DFu%26aufirst%3DH.%26aulast%3DKhuri%26aufirst%3DF.%2BR.%26aulast%3DShin%26aufirst%3DD.%2BM.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DShoji%26aufirst%3DM.%26atitle%3DSynthetic%2520curcumin%2520analog%2520EF31%2520inhibits%2520the%2520growth%2520of%2520head%2520and%2520neck%2520squamous%2520cell%2520carcinoma%2520xenografts%26jtitle%3DIntegr.%2520Biol.%26date%3D2012%26volume%3D4%26spage%3D633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craigen, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, D. J.</span><span> </span><span class="NLM_article-title">Nek1 regulates cell death and mitochondrial membrane permeability through phosphorylation of VDAC1</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=257&author=Y.+Chenauthor=W.+J.+Craigenauthor=D.+J.+Riley&title=Nek1+regulates+cell+death+and+mitochondrial+membrane+permeability+through+phosphorylation+of+VDAC1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DCraigen%26aufirst%3DW.%2BJ.%26aulast%3DRiley%26aufirst%3DD.%2BJ.%26atitle%3DNek1%2520regulates%2520cell%2520death%2520and%2520mitochondrial%2520membrane%2520permeability%2520through%2520phosphorylation%2520of%2520VDAC1%26jtitle%3DCell%2520Cycle%26date%3D2009%26volume%3D8%26spage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Sa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, T.</span><span> </span><span class="NLM_article-title">Anti cancer effects of curcumin: cycle of life and death</span> <span class="citation_source-journal">Cell Div.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">14</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.1186%2F1747-1028-3-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm4002692&amp;key=18834508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A280%3ADC%252BD1cnot1KntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=14&author=G.+Saauthor=T.+Das&title=Anti+cancer+effects+of+curcumin%3A+cycle+of+life+and+death"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Anti cancer effects of curcumin: cycle of life and death</span></div><div class="casAuthors">Sa Gaurisankar; Das Tanya</div><div class="citationInfo"><span class="NLM_cas:title">Cell division</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">14</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract"> Increasing knowledge on the cell cycle deregulations in cancers has promoted the introduction of phytochemicals, which can either modulate signaling pathways leading to cell cycle regulation or directly alter cell cycle regulatory molecules, in cancer therapy.  Most human malignancies are driven by chromosomal translocations or other genetic alterations that directly affect the function of critical cell cycle proteins such as cyclins as well as tumor suppressors, e.g., p53.  In this respect, cell cycle regulation and its modulation by curcumin are gaining widespread attention in recent years.  Extensive research has addressed the chemotherapeutic potential of curcumin (diferuloylmethane), a relatively non-toxic plant derived polyphenol.  The mechanisms implicated are diverse and appear to involve a combination of cell signaling pathways at multiple levels.  In the present review we discuss how alterations in the cell cycle control contribute to the malignant transformation and provide an overview of how curcumin targets cell cycle regulatory molecules to assert anti-proliferative and/or apoptotic effects in cancer cells.  The purpose of the current article is to present an appraisal of the current level of knowledge regarding the potential of curcumin as an agent for the chemoprevention of cancer via an understanding of its mechanism of action at the level of cell cycle regulation.  Taken together, this review seeks to summarize the unique properties of curcumin that may be exploited for successful clinical cancer prevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRvj4eQtgbgB9NTrvPZP1IpfW6udTcc2eYdwzo5N8BGDbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cnot1KntQ%253D%253D&md5=550176cb9633822d465928f653b994ad</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1186%2F1747-1028-3-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1747-1028-3-14%26sid%3Dliteratum%253Aachs%26aulast%3DSa%26aufirst%3DG.%26aulast%3DDas%26aufirst%3DT.%26atitle%3DAnti%2520cancer%2520effects%2520of%2520curcumin%253A%2520cycle%2520of%2520life%2520and%2520death%26jtitle%3DCell%2520Div.%26date%3D2008%26volume%3D3%26spage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span>GraphPad Software, Inc., 2236 Avenida de la Playa, La Jolla, CA 92037, U.S.; <a href="http://www.graphpad.com/" class="extLink">http://www.graphpad.com/</a> (accessed Sep 20,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=GraphPad+Software%2C+Inc.%2C+2236+Avenida+de+la+Playa%2C+La+Jolla%2C+CA+92037%2C+U.S.%3B+http%3A%2F%2Fwww.graphpad.com%2F+%28accessed+Sep+20%2C+2012%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="note"><p class="first last">Global analysis is a nonlinear regression treatment for multiple curves corresponding to different inhibitor concentrations. The <i>K</i><sub>m</sub>, <i>V</i><sub>max</sub>, and <i>K</i><sub>i</sub> parameters for each curve are adjusted for the best global fit of the data using GraphicPad<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> but constrained to the same value for each curve. Thus, for example, the resulting <i>V</i><sub>max</sub> in a competitive model is forced to be shared across all curves.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="note"><p class="first last">The parameter α derived from the global analysis of the data in GraphPad Prism<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> differs from the similarly named variables α and α′ in the classic Michaelis–Menten equations.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><div class="note"><p class="first last">Compound <b>3</b> has also been shown to exhibit reversibility by the NMR method of Appendino et al.:<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></p></div><span class="NLM_contrib-group">Moore, T.; Snyder, J. P.</span> Unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Compound+3+has+also+been+shown+to+exhibit+reversibility+by+the+NMR+method+of+Appendino+et+al.%3A%2817%29Moore%2C+T.%3B+Snyder%2C+J.+P.+Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DT." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niwa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirata, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noyori, R.</span><span> </span><span class="NLM_article-title">Chemical implications for antitumor and antiviral prostaglandins: reaction of Δ7-prostaglandin A1 and prostaglandin A1 methyl esters with thiols</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">2376</span><span class="NLM_x">–</span> <span class="NLM_lpage">2385</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja9628359" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1997&pages=2376-2385&author=M.+Suzukiauthor=M.+Moriauthor=T.+Niwaauthor=R.+Hirataauthor=K.+Furutaauthor=T.+Ishikawaauthor=R.+Noyori&title=Chemical+implications+for+antitumor+and+antiviral+prostaglandins%3A+reaction+of+%CE%947-prostaglandin+A1+and+prostaglandin+A1+methyl+esters+with+thiols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fja9628359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9628359%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DMori%26aufirst%3DM.%26aulast%3DNiwa%26aufirst%3DT.%26aulast%3DHirata%26aufirst%3DR.%26aulast%3DFuruta%26aufirst%3DK.%26aulast%3DIshikawa%26aufirst%3DT.%26aulast%3DNoyori%26aufirst%3DR.%26atitle%3DChemical%2520implications%2520for%2520antitumor%2520and%2520antiviral%2520prostaglandins%253A%2520reaction%2520of%2520%25CE%25947-prostaglandin%2520A1%2520and%2520prostaglandin%2520A1%2520methyl%2520esters%2520with%2520thiols%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1997%26volume%3D119%26spage%3D2376%26epage%3D2385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Yamakoshi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanoh, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muroi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satake, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohori, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishioka, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oshima, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiba, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwabuchi, Y.</span><span> </span><span class="NLM_article-title">KSRP/FUBP2 is a binding protein of GO-Y086, a cytotoxic curcumin analogue</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">–</span> <span class="NLM_lpage">276</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml1000454" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=273-276&author=H.+Yamakoshiauthor=N.+Kanohauthor=C.+Kudoauthor=A.+Satoauthor=K.+Uedaauthor=M.+Muroiauthor=S.+Konauthor=M.+Satakeauthor=H.+Ohoriauthor=C.+Ishiokaauthor=Y.+Oshimaauthor=H.+Osadaauthor=N.+Chibaauthor=H.+Shibataauthor=Y.+Iwabuchi&title=KSRP%2FFUBP2+is+a+binding+protein+of+GO-Y086%2C+a+cytotoxic+curcumin+analogue"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fml1000454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml1000454%26sid%3Dliteratum%253Aachs%26aulast%3DYamakoshi%26aufirst%3DH.%26aulast%3DKanoh%26aufirst%3DN.%26aulast%3DKudo%26aufirst%3DC.%26aulast%3DSato%26aufirst%3DA.%26aulast%3DUeda%26aufirst%3DK.%26aulast%3DMuroi%26aufirst%3DM.%26aulast%3DKon%26aufirst%3DS.%26aulast%3DSatake%26aufirst%3DM.%26aulast%3DOhori%26aufirst%3DH.%26aulast%3DIshioka%26aufirst%3DC.%26aulast%3DOshima%26aufirst%3DY.%26aulast%3DOsada%26aufirst%3DH.%26aulast%3DChiba%26aufirst%3DN.%26aulast%3DShibata%26aufirst%3DH.%26aulast%3DIwabuchi%26aufirst%3DY.%26atitle%3DKSRP%252FFUBP2%2520is%2520a%2520binding%2520protein%2520of%2520GO-Y086%252C%2520a%2520cytotoxic%2520curcumin%2520analogue%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D273%26epage%3D276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Serafimova, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pufall, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maglathlin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFarland, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frodin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taunton, J.</span><span> </span><span class="NLM_article-title">Reversible targeting of noncatalytic cysteines with chemically tuned electrophiles</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">471</span><span class="NLM_x">–</span> <span class="NLM_lpage">476</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.1038%2Fnchembio.925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm4002692&amp;key=22466421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvVKitrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=471-476&author=I.+M.+Serafimovaauthor=M.+A.+Pufallauthor=S.+Krishnanauthor=K.+Dudaauthor=M.+S.+Cohenauthor=R.+L.+Maglathlinauthor=J.+M.+McFarlandauthor=R.+M.+Millerauthor=M.+Frodinauthor=J.+Taunton&title=Reversible+targeting+of+noncatalytic+cysteines+with+chemically+tuned+electrophiles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Reversible targeting of noncatalytic cysteines with chemically tuned electrophiles</span></div><div class="casAuthors">Serafimova, Iana M.; Pufall, Miles A.; Krishnan, Shyam; Duda, Katarzyna; Cohen, Michael S.; Maglathlin, Rebecca L.; McFarland, Jesse M.; Miller, Rand M.; Froedin, Morten; Taunton, Jack</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">471-476</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Targeting noncatalytic cysteine residues with irreversible acrylamide-based inhibitors is a powerful approach for enhancing pharmacol. potency and selectivity.  Nevertheless, concerns about off-target modification motivate the development of reversible cysteine-targeting strategies.  Here we show that electron-deficient olefins, including acrylamides, can be tuned to react with cysteine thiols in a rapidly reversible manner.  Installation of a nitrile group increased the olefins' intrinsic reactivity, but, paradoxically, eliminated the formation of irreversible adducts.  Incorporation of these electrophiles into a noncovalent kinase-recognition scaffold produced slowly dissocg., covalent inhibitors of the p90 ribosomal protein S6 kinase RSK2.  A cocrystal structure revealed specific noncovalent interactions that stabilize the complex by positioning the electrophilic carbon near the targeted cysteine.  Disruption of these interactions by protein unfolding or proteolysis promoted instantaneous cleavage of the covalent bond.  Our results establish a chem.-based framework for engineering sustained covalent inhibition without accumulating permanently modified proteins and peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlcv3GjPOB6rVg90H21EOLACvtfcHk0lggeJRtalg7bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvVKitrw%253D&md5=6455a9a029714beb317286f71ac1326b</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.925%26sid%3Dliteratum%253Aachs%26aulast%3DSerafimova%26aufirst%3DI.%2BM.%26aulast%3DPufall%26aufirst%3DM.%2BA.%26aulast%3DKrishnan%26aufirst%3DS.%26aulast%3DDuda%26aufirst%3DK.%26aulast%3DCohen%26aufirst%3DM.%2BS.%26aulast%3DMaglathlin%26aufirst%3DR.%2BL.%26aulast%3DMcFarland%26aufirst%3DJ.%2BM.%26aulast%3DMiller%26aufirst%3DR.%2BM.%26aulast%3DFrodin%26aufirst%3DM.%26aulast%3DTaunton%26aufirst%3DJ.%26atitle%3DReversible%2520targeting%2520of%2520noncatalytic%2520cysteines%2520with%2520chemically%2520tuned%2520electrophiles%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2012%26volume%3D8%26spage%3D471%26epage%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Lee, C.-U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossmann, T. N.</span><span> </span><span class="NLM_article-title">Reversible covalent inhibition of a protein target</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">8699</span><span class="NLM_x">–</span> <span class="NLM_lpage">8700</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.1002%2Fanie.201203341" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVehtLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=8699-8700&author=C.-U.+Leeauthor=T.+N.+Grossmann&title=Reversible+covalent+inhibition+of+a+protein+target"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Reversible covalent inhibition of a protein target</span></div><div class="casAuthors">Lee, Chang-Uk; Grossmann, Tom N.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">8699-8700</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Electron-deficient Michael acceptors can be used in reversible addn./elimination reactions with thiols.  These electrophiles have been used by J. Taunton and colleagues [M. S. Cohen et al. (2005)] to convert a known irreversible protein kinase inhibitor into a covalent reversible inhibitor.  Such an approach might provide high-affinity binders with increased selectivity without the toxicol. risks assocd. with irreversible protein modifications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8c9MUbShnWLVg90H21EOLACvtfcHk0lggeJRtalg7bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVehtLrM&md5=af55c6ca399146709faaaf23532b784a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fanie.201203341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201203341%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DC.-U.%26aulast%3DGrossmann%26aufirst%3DT.%2BN.%26atitle%3DReversible%2520covalent%2520inhibition%2520of%2520a%2520protein%2520target%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26spage%3D8699%26epage%3D8700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Targeting cancer with small molecule kinase inhibitors</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.1038%2Fnrc2559" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm4002692&amp;key=19104514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1yg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=28-39&author=J.+Zhangauthor=P.+L.+Yangauthor=N.+S.+Gray&title=Targeting+cancer+with+small+molecule+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cancer with small molecule kinase inhibitors</span></div><div class="casAuthors">Zhang, Jianming; Yang, Priscilla L.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-39</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Deregulation of kinase activity has emerged as a major mechanism by which cancer cells evade normal physiol. constraints on growth and survival.  To date, 11 kinase inhibitors have received US Food and Drug Administration approval as cancer treatments, and there are considerable efforts to develop selective small mol. inhibitors for a host of other kinases that are implicated in cancer and other diseases.  Herein we discuss the current challenges in the field, such as designing selective inhibitors and developing strategies to overcome resistance mutations.  This Review provides a broad overview of some of the approaches currently used to discover and characterize new kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriSM3BN_uEz7Vg90H21EOLACvtfcHk0lhTX6i3V-tRgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1yg&md5=35bc38f414cd21eef5e61ce181b580fb</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fnrc2559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2559%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DP.%2BL.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DTargeting%2520cancer%2520with%2520small%2520molecule%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26spage%3D28%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Hu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span> </span><span class="NLM_article-title">Models for predicting IKKA and IKKB blockade</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">310</span><span class="NLM_x">–</span> <span class="NLM_lpage">3199</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=310-3199&author=H.+Huauthor=J.+P.+Snyder&title=Models+for+predicting+IKKA+and+IKKB+blockade"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DH.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26atitle%3DModels%2520for%2520predicting%2520IKKA%2520and%2520IKKB%2520blockade%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2012%26volume%3D52%26spage%3D310%26epage%3D3199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Yang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.-D.</span><span> </span><span class="NLM_article-title">Targeting the BMK1 MAP kinase pathway in cancer therapy</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3527</span><span class="NLM_x">–</span> <span class="NLM_lpage">3532</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.1158%2F1078-0432.CCR-10-2504" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm4002692&amp;key=21385929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvFCqtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=3527-3532&author=Q.+Yangauthor=J.-D.+Lee&title=Targeting+the+BMK1+MAP+kinase+pathway+in+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the BMK1 MAP Kinase Pathway in Cancer Therapy</span></div><div class="casAuthors">Yang, Qingkai; Lee, Jiing-Dwan</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3527-3532</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  The big mitogen activated protein kinase 1 (BMK1) pathway is the most recently discovered and least-studied mammalian mitogen-activated protein (MAP) kinase cascade, ubiquitously expressed in all types of cancer cells tested so far.  Mitogens and oncogenic signals strongly activate this cellular MAP kinase pathway, thereby passing down proliferative, survival, chemoresistance, invasive, and angiogenic signals in tumor cells.  Recently, several pharmacol. small mol. inhibitors of this pathway have been developed.  Among them, the BMK1 inhibitor XMD8-92 blocks cellular BMK1 activation and significantly suppresses tumor growth in lung and cervical tumor models and is well tolerated in animals.  On the other hand, MEK5 inhibitors, BIX02188, BIX02189, and compd. 6, suppress cellular MEK5 activity, but no data exist to date on their effectiveness in animals.  Clin Cancer Res; 17(11); 3527-32.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWXXWpsDjbRbVg90H21EOLACvtfcHk0lhTX6i3V-tRgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvFCqtbY%253D&md5=33b8e8f71e4406a50a4ebc216e008989</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-10-2504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-10-2504%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DLee%26aufirst%3DJ.-D.%26atitle%3DTargeting%2520the%2520BMK1%2520MAP%2520kinase%2520pathway%2520in%2520cancer%2520therapy%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2011%26volume%3D17%26spage%3D3527%26epage%3D3532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheffler, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroeze, W. K.</span><span> </span><span class="NLM_article-title">Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.1038%2Fnrd1346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm4002692&amp;key=15060530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A528%3ADC%252BD2cXis1Gkt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=353&author=B.+L.+Rothauthor=D.+J.+Shefflerauthor=W.+K.+Kroeze&title=Magic+shotguns+versus+magic+bullets%3A+selectively+non-selective+drugs+for+mood+disorders+and+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia</span></div><div class="casAuthors">Roth, Bryan L.; Sheffler, Douglas J.; Kroeze, Wesley K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">353-359</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Most common central nervous system disorders - such as depression, bipolar disorder, and schizophrenia - seem to be polygenic in origin, and the most effective medications have exceedingly complex pharmacologies.  Attempts to develop more effective treatments for diseases such as schizophrenia and depression by discovering drugs selective for single mol. targets (i.e., 'magic bullets') have, not surprisingly, been largely unsuccessful.  Here the authors propose that designing selectively non-selective drugs (i.e., 'magic shotguns') that interact with several mol. targets will lead to new and more effective medications for a variety of central nervous system disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnSsuUXzmbirVg90H21EOLACvtfcHk0lhTX6i3V-tRgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXis1Gkt78%253D&md5=77196583acccca65457fec7a67218463</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2Fnrd1346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1346%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DSheffler%26aufirst%3DD.%2BJ.%26aulast%3DKroeze%26aufirst%3DW.%2BK.%26atitle%3DMagic%2520shotguns%2520versus%2520magic%2520bullets%253A%2520selectively%2520non-selective%2520drugs%2520for%2520mood%2520disorders%2520and%2520schizophrenia%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Fojo, T.</span><span> </span><span class="NLM_article-title">Commentary: Novel therapies for cancer: why dirty might be better</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=277&author=T.+Fojo&title=Commentary%3A+Novel+therapies+for+cancer%3A+why+dirty+might+be+better"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFojo%26aufirst%3DT.%26atitle%3DCommentary%253A%2520Novel%2520therapies%2520for%2520cancer%253A%2520why%2520dirty%2520might%2520be%2520better%26jtitle%3DOncologist%26date%3D2008%26volume%3D13%26spage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span> </span><span class="NLM_article-title">Drug discovery: predicting promiscuity</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">462</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.1038%2F462167a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm4002692&amp;key=19907483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVSjsrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=462&publication_year=2009&pages=167&author=A.+L.+Hopkins&title=Drug+discovery%3A+predicting+promiscuity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Drug discovery: Predicting promiscuity</span></div><div class="casAuthors">Hopkins, Andrew L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">462</span>
        (<span class="NLM_cas:issue">7270</span>),
    <span class="NLM_cas:pages">167-168</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Computational methods that reliably predict the biol. activities of compds. have long been sought.  The validation of one such method suggests that in silico predictions for drug discovery have come of age.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQeKOdE7MUxLVg90H21EOLACvtfcHk0ljgwkWUPcC1tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVSjsrnI&md5=d7a2f49900632ba698ed3790f3b3c4d5</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1038%2F462167a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F462167a%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26atitle%3DDrug%2520discovery%253A%2520predicting%2520promiscuity%26jtitle%3DNature%26date%3D2009%26volume%3D462%26spage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">von Eichborn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murgueitio, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunkel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koerner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourne, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preissner, R.</span><span> </span><span class="NLM_article-title">PROMISCUOUS: a database for network-based drug-repositioning</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">D1060</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=D1060&author=J.+von+Eichbornauthor=M.+S.+Murgueitioauthor=M.+Dunkelauthor=S.+Koernerauthor=P.+E.+Bourneauthor=R.+Preissner&title=PROMISCUOUS%3A+a+database+for+network-based+drug-repositioning"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvon%2BEichborn%26aufirst%3DJ.%26aulast%3DMurgueitio%26aufirst%3DM.%2BS.%26aulast%3DDunkel%26aufirst%3DM.%26aulast%3DKoerner%26aufirst%3DS.%26aulast%3DBourne%26aufirst%3DP.%2BE.%26aulast%3DPreissner%26aufirst%3DR.%26atitle%3DPROMISCUOUS%253A%2520a%2520database%2520for%2520network-based%2520drug-repositioning%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2011%26volume%3D39%26spage%3DD1060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Lee, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. Y. J.</span><span> </span><span class="NLM_article-title">Exploiting the promiscuity of imatinib</span> <span class="citation_source-journal">J. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">30.1</span><span class="NLM_x">–</span> <span class="NLM_lpage">30.4</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=30.1-30.4&author=S.+J.+Leeauthor=J.+Y.+J.+Wang&title=Exploiting+the+promiscuity+of+imatinib"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DWang%26aufirst%3DJ.%2BY.%2BJ.%26atitle%3DExploiting%2520the%2520promiscuity%2520of%2520imatinib%26jtitle%3DJ.%2520Biol.%26date%3D2009%26volume%3D8%26spage%3D30.1%26epage%3D30.4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><a href="http://en.wikipedia.org/wiki/Imatinib" class="extLink">http://en.wikipedia.org/wiki/Imatinib</a> (accessed Sep 21,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fen.wikipedia.org%2Fwiki%2FImatinib+%28accessed+Sep+21%2C+2012%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overington, J. P.</span><span> </span><span class="NLM_article-title">Can we rationally design promiscuous drugs?</span> <span class="citation_source-journal">Curr. Opin. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.1016%2Fj.sbi.2006.01.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm4002692&amp;key=16442279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFOjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=127-136&author=A.+L.+Hopkinsauthor=J.+S.+Masonauthor=J.+P.+Overington&title=Can+we+rationally+design+promiscuous+drugs%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Can we rationally design promiscuous drugs?</span></div><div class="casAuthors">Hopkins, Andrew L.; Mason, Jonathan S.; Overington, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Structural Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-136</span>CODEN:
                <span class="NLM_cas:coden">COSBEF</span>;
        ISSN:<span class="NLM_cas:issn">0959-440X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Structure-based drug design is now used widely in modern medicinal chem.  The application of structural biol. to medicinal chem. has heralded the 'rational drug design' vision of discovering exquisitely selective ligands.  However, recent advances in post-genomic biol. are indicating that polypharmacol. may be a necessary trait for the efficacy of many drugs, therefore questioning the 'one drug, one target' assumption of current rational drug design.  By combining advances in chemoinformatics and structural biol., it might be possible to rationally design the next generation of promiscuous drugs with polypharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQWdh60x9AHrVg90H21EOLACvtfcHk0ljgwkWUPcC1tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFOjsrc%253D&md5=8f9e95a41976b8e3ac790f2fff2c406f</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.sbi.2006.01.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.sbi.2006.01.013%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DMason%26aufirst%3DJ.%2BS.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26atitle%3DCan%2520we%2520rationally%2520design%2520promiscuous%2520drugs%253F%26jtitle%3DCurr.%2520Opin.%2520Struct.%2520Biol.%26date%3D2006%26volume%3D16%26spage%3D127%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Besnard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruda, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setola, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abecassis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguiz, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norval1, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sassano, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simeons, F. R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stojanovski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidah, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Constam, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bickerton, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetsel, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, I. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, A. L.</span><span> </span><span class="NLM_article-title">Automated design of ligands to polypharmacological profiles</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">492</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">222</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.1038%2Fnature11691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm4002692&amp;key=23235874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVamurfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=492&publication_year=2012&pages=215-222&author=J.+Besnardauthor=G.+F.+Rudaauthor=V.+Setolaauthor=K.+Abecassisauthor=R.+M.+Rodriguizauthor=X.-P.+Huangauthor=S.+Norval1author=M.+F.+Sassanoauthor=A.+I.+Shinauthor=L.+A.+Websterauthor=F.+R.+C.+Simeonsauthor=L.+Stojanovskiauthor=A.+Pratauthor=N.+G.+Seidahauthor=D.+B.+Constamauthor=G.+R.+Bickertonauthor=K.+D.+Readauthor=W.+C.+Wetselauthor=I.+H.+Gilbertauthor=B.+L.+Rothauthor=A.+L.+Hopkins&title=Automated+design+of+ligands+to+polypharmacological+profiles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Automated design of ligands to polypharmacological profiles</span></div><div class="casAuthors">Besnard, Jeremy; Ruda, Gian Filippo; Setola, Vincent; Abecassis, Keren; Rodriguiz, Ramona M.; Huang, Xi-Ping; Norval, Suzanne; Sassano, Maria F.; Shin, Antony I.; Webster, Lauren A.; Simeons, Frederick R. C.; Stojanovski, Laste; Prat, Annik; Seidah, Nabil G.; Constam, Daniel B.; Bickerton, G. Richard; Read, Kevin D.; Wetsel, William C.; Gilbert, Ian H.; Roth, Bryan L.; Hopkins, Andrew L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">492</span>
        (<span class="NLM_cas:issue">7428</span>),
    <span class="NLM_cas:pages">215-220</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The clin. efficacy and safety of a drug is detd. by its activity profile across many proteins in the proteome.  However, designing drugs with a specific multi-target profile is both complex and difficult.  Therefore methods to design drugs rationally a priori against profiles of several proteins would have immense value in drug discovery.  Here is described a new approach for the automated design of ligands against profiles of multiple drug targets.  The method is demonstrated by the evolution of an approved acetylcholinesterase inhibitor drug donepezil (I) into brain-penetrable ligands with either specific polypharmacol. or exquisite selectivity profiles for G-protein-coupled receptors.  Overall, 800 ligand-target predictions of prospectively designed ligands were tested exptl., of which 75% were confirmed to be correct.  Target engagement in vivo is also demonstrated.  The approach can be a useful source of drug leads when multi-target profiles are required to achieve either selectivity over other drug targets or a desired polypharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNu5bwrBD3tbVg90H21EOLACvtfcHk0liINx6tKTgvWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVamurfN&md5=ace6cced250cf968d327b482a5bf1798</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1038%2Fnature11691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11691%26sid%3Dliteratum%253Aachs%26aulast%3DBesnard%26aufirst%3DJ.%26aulast%3DRuda%26aufirst%3DG.%2BF.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DAbecassis%26aufirst%3DK.%26aulast%3DRodriguiz%26aufirst%3DR.%2BM.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DNorval1%26aufirst%3DS.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DShin%26aufirst%3DA.%2BI.%26aulast%3DWebster%26aufirst%3DL.%2BA.%26aulast%3DSimeons%26aufirst%3DF.%2BR.%2BC.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DPrat%26aufirst%3DA.%26aulast%3DSeidah%26aufirst%3DN.%2BG.%26aulast%3DConstam%26aufirst%3DD.%2BB.%26aulast%3DBickerton%26aufirst%3DG.%2BR.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DWetsel%26aufirst%3DW.%2BC.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26atitle%3DAutomated%2520design%2520of%2520ligands%2520to%2520polypharmacological%2520profiles%26jtitle%3DNature%26date%3D2012%26volume%3D492%26spage%3D215%26epage%3D222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><a href="http://www.discoverx.com/kinases/adp-quest_adp-quest-hs.php" class="extLink">http://www.discoverx.com/kinases/adp-quest_adp-quest-hs.php</a> (accessed Sep 21,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.discoverx.com%2Fkinases%2Fadp-quest_adp-quest-hs.php+%28accessed+Sep+21%2C+2012%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><a href="http://www.millipore.com/catalogue/item/12-331" class="extLink">http://www.millipore.com/catalogue/item/12-331</a> (accessed Sep 21,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.millipore.com%2Fcatalogue%2Fitem%2F12-331+%28accessed+Sep+21%2C+2012%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><a href="http://www.invitrogen.com/site/us/en/home/Products-and-Services/Applications/Drug-Discovery/Target-and-Lead-Identification-and-Validation/KinaseBiology/Kinase-Activity-Assays/Z-LYTE.html?CID=fl-zlyte" class="extLink">http://www.invitrogen.com/site/us/en/home/Products-and-Services/Applications/Drug-Discovery/Target-and-Lead-Identification-and-Validation/KinaseBiology/Kinase-Activity-Assays/Z-LYTE.html?CID=fl-zlyte</a> (accessed Sep 21,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.invitrogen.com%2Fsite%2Fus%2Fen%2Fhome%2FProducts-and-Services%2FApplications%2FDrug-Discovery%2FTarget-and-Lead-Identification-and-Validation%2FKinaseBiology%2FKinase-Activity-Assays%2FZ-LYTE.html%3FCID%3Dfl-zlyte+%28accessed+Sep+21%2C+2012%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><a href="http://www.invitrogen.com/site/us/en/home/Products-and-Services/Services/custom-services/Screening-and-Profiling-Services/SelectScreen-Profiling-Service/SelectScreen-Kinase-Profiling-Service.html" class="extLink">http://www.invitrogen.com/site/us/en/home/Products-and-Services/Services/custom-services/Screening-and-Profiling-Services/SelectScreen-Profiling-Service/SelectScreen-Kinase-Profiling-Service.html</a> (accessed Sep 21,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.invitrogen.com%2Fsite%2Fus%2Fen%2Fhome%2FProducts-and-Services%2FServices%2Fcustom-services%2FScreening-and-Profiling-Services%2FSelectScreen-Profiling-Service%2FSelectScreen-Kinase-Profiling-Service.html+%28accessed+Sep+21%2C+2012%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Khopde, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priyadarsini, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palit, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukherjee, T.</span><span> </span><span class="NLM_article-title">Effect of solvent on the excited-state photophysical properties of curcumin</span> <span class="citation_source-journal">Photochem. Photobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">625</span><span class="NLM_x">–</span> <span class="NLM_lpage">631</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2000&pages=625-631&author=S.+M.+Khopdeauthor=K.+I.+Priyadarsiniauthor=D.+K.+Palitauthor=T.+Mukherjee&title=Effect+of+solvent+on+the+excited-state+photophysical+properties+of+curcumin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKhopde%26aufirst%3DS.%2BM.%26aulast%3DPriyadarsini%26aufirst%3DK.%2BI.%26aulast%3DPalit%26aufirst%3DD.%2BK.%26aulast%3DMukherjee%26aufirst%3DT.%26atitle%3DEffect%2520of%2520solvent%2520on%2520the%2520excited-state%2520photophysical%2520properties%2520of%2520curcumin%26jtitle%3DPhotochem.%2520Photobiol.%26date%3D2000%26volume%3D72%26spage%3D625%26epage%3D631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span> <span class="citation_source-book">Maestro</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span><a href="http://www.schrodinger.com/products/14/12/" class="extLink">http://www.schrodinger.com/products/14/12/</a> (accessed Sep 20,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Maestro%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2009%3B+http%3A%2F%2Fwww.schrodinger.com%2Fproducts%2F14%2F12%2F+%28accessed+Sep+20%2C+2012%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMaestro%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2009%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61a"><span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halgren, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klicic, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainz, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repasky, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knoll, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenkin, P. S.</span><span> </span><span class="NLM_article-title">Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1739</span><span class="NLM_x">–</span> <span class="NLM_lpage">1749</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0306430" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61a&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1739-1749&author=R.+A.+Friesnerauthor=J.+L.+Banksauthor=R.+B.+Murphyauthor=T.+A.+Halgrenauthor=J.+J.+Klicicauthor=D.+T.+Mainzauthor=M.+P.+Repaskyauthor=E.+H.+Knollauthor=D.+E.+Shawauthor=M.+Shelleyauthor=J.+K.+Perryauthor=P.+Francisauthor=P.+S.+Shenkin&title=Glide%3A+a+new+approach+for+rapid%2C+accurate+docking+and+scoring.+1.+Method+and+assessment+of+docking+accuracy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61aR"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy</span></div><div class="casAuthors">Friesner, Richard A.; Banks, Jay L.; Murphy, Robert B.; Halgren, Thomas A.; Klicic, Jasna J.; Mainz, Daniel T.; Repasky, Matthew P.; Knoll, Eric H.; Shelley, Mee; Perry, Jason K.; Shaw, David E.; Francis, Perry; Shenkin, Peter S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1739-1749</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Unlike other methods for docking ligands to the rigid 3D structure of a known protein receptor, Glide approximates a complete systematic search of the conformational, orientational, and positional space of the docked ligand.  In this search, an initial rough positioning and scoring phase that dramatically narrows the search space is followed by torsionally flexible energy optimization on an OPLS-AA nonbonded potential grid for a few hundred surviving candidate poses.  The very best candidates are further refined via a Monte Carlo sampling of pose conformation; in some cases, this is crucial to obtaining an accurate docked pose.  Selection of the best docked pose uses a model energy function that combines empirical and force-field-based terms.  Docking accuracy is assessed by redocking ligands from 282 cocrystd. PDB complexes starting from conformationally optimized ligand geometries that bear no memory of the correctly docked pose.  Errors in geometry for the top-ranked pose are less than 1 Å in nearly half of the cases and are greater than 2 Å in only about one-third of them.  Comparisons to published data on rms deviations show that Glide is nearly twice as accurate as GOLD and more than twice as accurate as FlexX for ligands having up to 20 rotatable bonds.  Glide is also found to be more accurate than the recently described Surflex method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPuigu31qMMLVg90H21EOLACvtfcHk0liINx6tKTgvWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D&md5=8cc2f0022318b12dd972e9c493375bf9</span></div><a href="/servlet/linkout?suffix=cit61a&amp;dbid=16384&amp;doi=10.1021%2Fjm0306430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0306430%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DKlicic%26aufirst%3DJ.%2BJ.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DKnoll%26aufirst%3DE.%2BH.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DShelley%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DFrancis%26aufirst%3DP.%26aulast%3DShenkin%26aufirst%3DP.%2BS.%26atitle%3DGlide%253A%2520a%2520new%2520approach%2520for%2520rapid%252C%2520accurate%2520docking%2520and%2520scoring.%25201.%2520Method%2520and%2520assessment%2520of%2520docking%2520accuracy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1739%26epage%3D1749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit61b"><span>Schrödinger, LLC, New York, NY: <a href="http://www.schrodinger.com/products/14/5/" class="extLink">http://www.schrodinger.com/products/14/5/</a> (accessed Sep 20,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Schr%C3%B6dinger%2C+LLC%2C+New+York%2C+NY%3A+http%3A%2F%2Fwww.schrodinger.com%2Fproducts%2F14%2F5%2F+%28accessed+Sep+20%2C+2012%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':[],'ref38':[],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61a','cit61b']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 31 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Ai</span>, <span class="hlFld-ContribAuthor ">Bin  Zhu</span>, <span class="hlFld-ContribAuthor ">Caiping  Ren</span>, <span class="hlFld-ContribAuthor ">Fenghua  Kang</span>, <span class="hlFld-ContribAuthor ">Jinlong  Li</span>, <span class="hlFld-ContribAuthor ">Zhangjian  Huang</span>, <span class="hlFld-ContribAuthor ">Yisheng  Lai</span>, <span class="hlFld-ContribAuthor ">Sixun  Peng</span>, <span class="hlFld-ContribAuthor ">Ke  Ding</span>, <span class="hlFld-ContribAuthor ">Jide  Tian</span>, and <span class="hlFld-ContribAuthor ">Yihua  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of New Monocarbonyl Ligustrazine–Curcumin Hybrids for Intervention of Drug-Sensitive and Drug-Resistant Lung Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (5)
                                     , 1747-1760. <a href="https://doi.org/10.1021/acs.jmedchem.5b01203" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01203</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01203%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNew%252BMonocarbonyl%252BLigustrazine%2525E2%252580%252593Curcumin%252BHybrids%252Bfor%252BIntervention%252Bof%252BDrug-Sensitive%252Band%252BDrug-Resistant%252BLung%252BCancer%26aulast%3DAi%26aufirst%3DYong%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D30072015%26date%3D26022016%26date%3D10032016%26date%3D18022016%26volume%3D59%26issue%3D5%26spage%3D1747%26epage%3D1760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kheng-Lin  Tan</span>, <span class="hlFld-ContribAuthor ">Azhar  Ali</span>, <span class="hlFld-ContribAuthor ">Yuhong  Du</span>, <span class="hlFld-ContribAuthor ">Haian  Fu</span>, <span class="hlFld-ContribAuthor ">Hai-Xiao  Jin</span>, <span class="hlFld-ContribAuthor ">Tan-Min  Chin</span>, <span class="hlFld-ContribAuthor ">Matiullah  Khan</span>, and <span class="hlFld-ContribAuthor ">Mei-Lin  Go</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Evaluation of Bisbenzylidenedioxotetrahydrothiopranones as Activators of Endoplasmic Reticulum (ER) Stress Signaling Pathways and Apoptotic Cell Death in Acute Promyelocytic Leukemic Cells. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (14)
                                     , 5904-5918. <a href="https://doi.org/10.1021/jm401352a" title="DOI URL">https://doi.org/10.1021/jm401352a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401352a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401352a%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BEvaluation%252Bof%252BBisbenzylidenedioxotetrahydrothiopranones%252Bas%252BActivators%252Bof%252BEndoplasmic%252BReticulum%252B%252528ER%252529%252BStress%252BSignaling%252BPathways%252Band%252BApoptotic%252BCell%252BDeath%252Bin%252BAcute%252BPromyelocytic%252BLeukemic%252BCells%26aulast%3DTan%26aufirst%3DKheng-Lin%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D03092013%26date%3D11072014%26date%3D24072014%26date%3D24062014%26volume%3D57%26issue%3D14%26spage%3D5904%26epage%3D5918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Syed Nasir Abbas  Bukhari</span>, <span class="hlFld-ContribAuthor ">Ibrahim  Jantan</span>, <span class="hlFld-ContribAuthor ">Oya  Unsal Tan</span>, <span class="hlFld-ContribAuthor ">Muhammad  Sher</span>, <span class="hlFld-ContribAuthor ">M.  Naeem-ul-Hassan</span>, and <span class="hlFld-ContribAuthor ">Hua-Li  Qin</span>  . </span><span class="cited-content_cbyCitation_article-title">Biological Activity and Molecular Docking Studies of Curcumin-Related α,β-Unsaturated Carbonyl-Based Synthetic Compounds as Anticancer Agents and Mushroom Tyrosinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Agricultural and Food Chemistry</span><span> <strong>2014,</strong> <em>62 </em>
                                    (24)
                                     , 5538-5547. <a href="https://doi.org/10.1021/jf501145b" title="DOI URL">https://doi.org/10.1021/jf501145b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jf501145b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjf501145b%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Agricultural%2520and%2520Food%2520Chemistry%26atitle%3DBiological%252BActivity%252Band%252BMolecular%252BDocking%252BStudies%252Bof%252BCurcumin-Related%252B%2525CE%2525B1%25252C%2525CE%2525B2-Unsaturated%252BCarbonyl-Based%252BSynthetic%252BCompounds%252Bas%252BAnticancer%252BAgents%252Band%252BMushroom%252BTyrosinase%252BInhibitors%26aulast%3DBukhari%26aufirst%3DSyed%2BNasir%2BAbbas%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D05022014%26date%3D05062014%26date%3D27052014%26date%3D10062014%26date%3D18062014%26date%3D05062014%26volume%3D62%26issue%3D24%26spage%3D5538%26epage%3D5547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Terry W.  Moore</span>, <span class="hlFld-ContribAuthor ">Shijun  Zhu</span>, <span class="hlFld-ContribAuthor ">Ryan  Randolph</span>, <span class="hlFld-ContribAuthor ">Mamoru  Shoji</span>, and <span class="hlFld-ContribAuthor ">James P.  Snyder</span>  . </span><span class="cited-content_cbyCitation_article-title">Liver S9 Fraction-Derived Metabolites of Curcumin Analogue UBS109. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>5 </em>
                                    (4)
                                     , 288-292. <a href="https://doi.org/10.1021/ml4002453" title="DOI URL">https://doi.org/10.1021/ml4002453</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml4002453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml4002453%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DLiver%252BS9%252BFraction-Derived%252BMetabolites%252Bof%252BCurcumin%252BAnalogue%252BUBS109%26aulast%3DMoore%26aufirst%3DTerry%2BW.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D28062013%26date%3D10012014%26date%3D16012014%26date%3D10042014%26date%3D10012014%26volume%3D5%26issue%3D4%26spage%3D288%26epage%3D292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adeoluwa  Adeluola</span>, <span class="hlFld-ContribAuthor ">Abu Hasanat Md  Zulfiker</span>, <span class="hlFld-ContribAuthor ">Daniel  Brazeau</span>, <span class="hlFld-ContribAuthor ">A.R.M. Ruhul  Amin</span>. </span><span class="cited-content_cbyCitation_article-title">Perspectives for synthetic curcumins in chemoprevention and treatment of cancer: An update with promising analogues. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2021,</strong> <em>906 </em>, 174266. <a href="https://doi.org/10.1016/j.ejphar.2021.174266" title="DOI URL">https://doi.org/10.1016/j.ejphar.2021.174266</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2021.174266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2021.174266%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DPerspectives%252Bfor%252Bsynthetic%252Bcurcumins%252Bin%252Bchemoprevention%252Band%252Btreatment%252Bof%252Bcancer%25253A%252BAn%252Bupdate%252Bwith%252Bpromising%252Banalogues%26aulast%3DAdeluola%26aufirst%3DAdeoluwa%26date%3D2021%26volume%3D906%26spage%3D174266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui  Shen</span>, <span class="hlFld-ContribAuthor ">Jianfen  Shen</span>, <span class="hlFld-ContribAuthor ">Huan  Pan</span>, <span class="hlFld-ContribAuthor ">Longsheng  Xu</span>, <span class="hlFld-ContribAuthor ">Han  Sheng</span>, <span class="hlFld-ContribAuthor ">Beibei  Liu</span>, <span class="hlFld-ContribAuthor ">Ming  Yao</span>. </span><span class="cited-content_cbyCitation_article-title">Curcumin analog B14 has high bioavailability and enhances the effect of anti‐breast cancer cells in vitro and in vivo. </span><span class="cited-content_cbyCitation_journal-name">Cancer Science</span><span> <strong>2021,</strong> <em>112 </em>
                                    (2)
                                     , 815-827. <a href="https://doi.org/10.1111/cas.14770" title="DOI URL">https://doi.org/10.1111/cas.14770</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cas.14770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcas.14770%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Science%26atitle%3DCurcumin%252Banalog%252BB14%252Bhas%252Bhigh%252Bbioavailability%252Band%252Benhances%252Bthe%252Beffect%252Bof%252Banti%2525E2%252580%252590breast%252Bcancer%252Bcells%252Bin%252Bvitro%252Band%252Bin%252Bvivo%26aulast%3DShen%26aufirst%3DHui%26date%3D2021%26date%3D2020%26volume%3D112%26issue%3D2%26spage%3D815%26epage%3D827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ayah  Abdeldayem</span>, <span class="hlFld-ContribAuthor ">Yasir S.  Raouf</span>, <span class="hlFld-ContribAuthor ">Stefan N.  Constantinescu</span>, <span class="hlFld-ContribAuthor ">Richard  Moriggl</span>, <span class="hlFld-ContribAuthor ">Patrick T.  Gunning</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in covalent kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2020,</strong> <em>49 </em>
                                    (9)
                                     , 2617-2687. <a href="https://doi.org/10.1039/C9CS00720B" title="DOI URL">https://doi.org/10.1039/C9CS00720B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9CS00720B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9CS00720B%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DAdvances%252Bin%252Bcovalent%252Bkinase%252Binhibitors%26aulast%3DAbdeldayem%26aufirst%3DAyah%26date%3D2020%26date%3D2020%26volume%3D49%26issue%3D9%26spage%3D2617%26epage%3D2687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">V.  Porchezhiyan</span>, <span class="hlFld-ContribAuthor ">D.  Kalaivani</span>, <span class="hlFld-ContribAuthor ">J.  Shobana</span>, <span class="hlFld-ContribAuthor ">S.E.  Noorjahan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, docking and in vitro evaluation of  -proline derived 1,3-diketones possessing anti-cancer and anti-inflammatory activities. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2020,</strong> <em>1206 </em>, 127754. <a href="https://doi.org/10.1016/j.molstruc.2020.127754" title="DOI URL">https://doi.org/10.1016/j.molstruc.2020.127754</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2020.127754&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2020.127754%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DSynthesis%25252C%252Bdocking%252Band%252Bin%2525C2%2525A0vitro%252Bevaluation%252Bof%252B-proline%252Bderived%252B1%25252C3-diketones%252Bpossessing%252Banti-cancer%252Band%252Banti-inflammatory%252Bactivities%26aulast%3DPorchezhiyan%26aufirst%3DV.%26date%3D2020%26volume%3D1206%26spage%3D127754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Wang</span>, <span class="hlFld-ContribAuthor ">Wenda  Zhang</span>, <span class="hlFld-ContribAuthor ">Junqiang  Dong</span>, <span class="hlFld-ContribAuthor ">Jianbo  Gao</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and bioactivity evaluation of coumarin-chalcone hybrids as potential anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>95 </em>, 103530. <a href="https://doi.org/10.1016/j.bioorg.2019.103530" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103530</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103530%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbioactivity%252Bevaluation%252Bof%252Bcoumarin-chalcone%252Bhybrids%252Bas%252Bpotential%252Banticancer%252Bagents%26aulast%3DWang%26aufirst%3DYu%26date%3D2020%26volume%3D95%26spage%3D103530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eirini  Chainoglou</span>, <span class="hlFld-ContribAuthor ">Dimitra  Hadjipavlou-Litina</span>. </span><span class="cited-content_cbyCitation_article-title">Curcumin analogues and derivatives with anti-proliferative and anti-inflammatory activity: Structural characteristics and molecular targets. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2019,</strong> <em>14 </em>
                                    (8)
                                     , 821-842. <a href="https://doi.org/10.1080/17460441.2019.1614560" title="DOI URL">https://doi.org/10.1080/17460441.2019.1614560</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2019.1614560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2019.1614560%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DCurcumin%252Banalogues%252Band%252Bderivatives%252Bwith%252Banti-proliferative%252Band%252Banti-inflammatory%252Bactivity%25253A%252BStructural%252Bcharacteristics%252Band%252Bmolecular%252Btargets%26aulast%3DChainoglou%26aufirst%3DEirini%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D8%26spage%3D821%26epage%3D842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaodong  Ma</span>, <span class="hlFld-ContribAuthor ">Mengqi  Hu</span>, <span class="hlFld-ContribAuthor ">Hao  Wang</span>, <span class="hlFld-ContribAuthor ">Jiaming  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of traditional Chinese medicine monomers and their synthetic intermediates, analogs or derivatives for battling P-gp-mediated multi-drug resistance. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>159 </em>, 381-392. <a href="https://doi.org/10.1016/j.ejmech.2018.09.061" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.09.061</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.09.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.09.061%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Btraditional%252BChinese%252Bmedicine%252Bmonomers%252Band%252Btheir%2525C2%2525A0synthetic%252Bintermediates%25252C%252Banalogs%252Bor%252Bderivatives%252Bfor%252Bbattling%252BP-gp-mediated%252Bmulti-drug%252Bresistance%26aulast%3DMa%26aufirst%3DXiaodong%26date%3D2018%26volume%3D159%26spage%3D381%26epage%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Felipe  Lima</span>, <span class="hlFld-ContribAuthor ">Viviane  Seba</span>, <span class="hlFld-ContribAuthor ">Gabriel  Silva</span>, <span class="hlFld-ContribAuthor ">Guilherme  Torrezan</span>, <span class="hlFld-ContribAuthor ">Carlos  Polaquini</span>, <span class="hlFld-ContribAuthor ">Vitor  Pinhanelli</span>, <span class="hlFld-ContribAuthor ">Seung  Baek</span>, <span class="hlFld-ContribAuthor ">Ana  Fachin</span>, <span class="hlFld-ContribAuthor ">Luis  Regasini</span>, <span class="hlFld-ContribAuthor ">Mozart  Marins</span>. </span><span class="cited-content_cbyCitation_article-title">The Curcumin Analog CH-5 Exerts Anticancer Effects in Human Osteosarcoma Cells via Modulation of Transcription Factors p53/Sp1. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2018,</strong> <em>19 </em>
                                    (7)
                                     , 1909. <a href="https://doi.org/10.3390/ijms19071909" title="DOI URL">https://doi.org/10.3390/ijms19071909</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms19071909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms19071909%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DThe%252BCurcumin%252BAnalog%252BCH-5%252BExerts%252BAnticancer%252BEffects%252Bin%252BHuman%252BOsteosarcoma%252BCells%252Bvia%252BModulation%252Bof%252BTranscription%252BFactors%252Bp53%25252FSp1%26aulast%3DLima%26aufirst%3DFelipe%26date%3D2018%26date%3D2018%26volume%3D19%26issue%3D7%26spage%3D1909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Florian  Schmitt</span>, <span class="hlFld-ContribAuthor ">Dharmalingam  Subramaniam</span>, <span class="hlFld-ContribAuthor ">Shrikant  Anant</span>, <span class="hlFld-ContribAuthor ">Subhash  Padhye</span>, <span class="hlFld-ContribAuthor ">Gerrit  Begemann</span>, <span class="hlFld-ContribAuthor ">Rainer  Schobert</span>, <span class="hlFld-ContribAuthor ">Bernhard  Biersack</span>. </span><span class="cited-content_cbyCitation_article-title">Halogenated Bis(methoxybenzylidene)-4-piperidone Curcuminoids with Improved Anticancer Activity. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2018,</strong> <em>13 </em>
                                    (11)
                                     , 1115-1123. <a href="https://doi.org/10.1002/cmdc.201800135" title="DOI URL">https://doi.org/10.1002/cmdc.201800135</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800135%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DHalogenated%252BBis%252528methoxybenzylidene%252529-4-piperidone%252BCurcuminoids%252Bwith%252BImproved%252BAnticancer%252BActivity%26aulast%3DSchmitt%26aufirst%3DFlorian%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D11%26spage%3D1115%26epage%3D1123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rong  Jin</span>, <span class="hlFld-ContribAuthor ">Qiuxiang  Chen</span>, <span class="hlFld-ContribAuthor ">Song  Yao</span>, <span class="hlFld-ContribAuthor ">Encheng  Bai</span>, <span class="hlFld-ContribAuthor ">Weitao  Fu</span>, <span class="hlFld-ContribAuthor ">Ledan  Wang</span>, <span class="hlFld-ContribAuthor ">Jiabing  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaojing  Du</span>, <span class="hlFld-ContribAuthor ">Tao  Wei</span>, <span class="hlFld-ContribAuthor ">Haineng  Xu</span>, <span class="hlFld-ContribAuthor ">Chengxi  Jiang</span>, <span class="hlFld-ContribAuthor ">Peihong  Qiu</span>, <span class="hlFld-ContribAuthor ">Jianzhang  Wu</span>, <span class="hlFld-ContribAuthor ">Wulan  Li</span>, <span class="hlFld-ContribAuthor ">Guang  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and anti-tumor activity of EF24 analogues as IKKβ inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>144 </em>, 218-228. <a href="https://doi.org/10.1016/j.ejmech.2017.11.077" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.11.077</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.11.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.11.077%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Banti-tumor%252Bactivity%252Bof%252BEF24%252Banalogues%252Bas%252BIKK%2525CE%2525B2%252Binhibitors%26aulast%3DJin%26aufirst%3DRong%26date%3D2018%26volume%3D144%26spage%3D218%26epage%3D228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peihong  Qiu</span>, <span class="hlFld-ContribAuthor ">Shanshan  Zhang</span>, <span class="hlFld-ContribAuthor ">Yangyang  Zhou</span>, <span class="hlFld-ContribAuthor ">Min  Zhu</span>, <span class="hlFld-ContribAuthor ">Yanting  Kang</span>, <span class="hlFld-ContribAuthor ">Dahui  Chen</span>, <span class="hlFld-ContribAuthor ">Jiabing  Wang</span>, <span class="hlFld-ContribAuthor ">Peng  Zhou</span>, <span class="hlFld-ContribAuthor ">Wulan  Li</span>, <span class="hlFld-ContribAuthor ">Qing  Xu</span>, <span class="hlFld-ContribAuthor ">Rong  Jin</span>, <span class="hlFld-ContribAuthor ">Jianzhang  Wu</span>, <span class="hlFld-ContribAuthor ">Guang  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of asymmetric curcuminoid analogs as potential anticancer agents that downregulate NF-κB activation and enhance the sensitivity of gastric cancer cell lines to irinotecan chemotherapy. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>139 </em>, 917-925. <a href="https://doi.org/10.1016/j.ejmech.2017.08.022" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.08.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.08.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.08.022%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Basymmetric%252Bcurcuminoid%252Banalogs%252Bas%252Bpotential%252Banticancer%252Bagents%252Bthat%252Bdownregulate%252BNF-%2525CE%2525BAB%252Bactivation%252Band%252Benhance%252Bthe%252Bsensitivity%252Bof%252Bgastric%252Bcancer%252Bcell%252Blines%252Bto%252Birinotecan%252Bchemotherapy%26aulast%3DQiu%26aufirst%3DPeihong%26date%3D2017%26volume%3D139%26spage%3D917%26epage%3D925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Florian  Schmitt</span>, <span class="hlFld-ContribAuthor ">Madeleine  Gold</span>, <span class="hlFld-ContribAuthor ">Gerrit  Begemann</span>, <span class="hlFld-ContribAuthor ">Ion  Andronache</span>, <span class="hlFld-ContribAuthor ">Bernhard  Biersack</span>, <span class="hlFld-ContribAuthor ">Rainer  Schobert</span>. </span><span class="cited-content_cbyCitation_article-title">Fluoro and pentafluorothio analogs of the antitumoral curcuminoid EF24 with superior antiangiogenic and vascular-disruptive effects. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (17)
                                     , 4894-4903. <a href="https://doi.org/10.1016/j.bmc.2017.07.039" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.07.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.07.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.07.039%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DFluoro%252Band%252Bpentafluorothio%252Banalogs%252Bof%252Bthe%252Bantitumoral%252Bcurcuminoid%252BEF24%252Bwith%252Bsuperior%252Bantiangiogenic%252Band%252Bvascular-disruptive%252Beffects%26aulast%3DSchmitt%26aufirst%3DFlorian%26date%3D2017%26volume%3D25%26issue%3D17%26spage%3D4894%26epage%3D4903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rita Maria Concetta  Di Martino</span>, <span class="hlFld-ContribAuthor ">Alessandra  Bisi</span>, <span class="hlFld-ContribAuthor ">Angela  Rampa</span>, <span class="hlFld-ContribAuthor ">Silvia  Gobbi</span>, <span class="hlFld-ContribAuthor ">Federica  Belluti</span>. </span><span class="cited-content_cbyCitation_article-title">Recent progress on curcumin-based therapeutics: a patent review (2012-2016). Part II: curcumin derivatives in cancer and neurodegeneration. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2017,</strong> <em>27 </em>
                                    (8)
                                     , 953-965. <a href="https://doi.org/10.1080/13543776.2017.1339793" title="DOI URL">https://doi.org/10.1080/13543776.2017.1339793</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2017.1339793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2017.1339793%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DRecent%252Bprogress%252Bon%252Bcurcumin-based%252Btherapeutics%25253A%252Ba%252Bpatent%252Breview%252B%2525282012-2016%252529.%252BPart%252BII%25253A%252Bcurcumin%252Bderivatives%252Bin%252Bcancer%252Band%252Bneurodegeneration%26aulast%3DDi%2BMartino%26aufirst%3DRita%2BMaria%2BConcetta%26date%3D2017%26date%3D2017%26volume%3D27%26issue%3D8%26spage%3D953%26epage%3D965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Baoxia  Liang</span>, <span class="hlFld-ContribAuthor ">Ziyi  Liu</span>, <span class="hlFld-ContribAuthor ">Yingnan  Cao</span>, <span class="hlFld-ContribAuthor ">Cuige  Zhu</span>, <span class="hlFld-ContribAuthor ">Yinglin  Zuo</span>, <span class="hlFld-ContribAuthor ">Lei  Huang</span>, <span class="hlFld-ContribAuthor ">Gesi  Wen</span>, <span class="hlFld-ContribAuthor ">Nana  Shang</span>, <span class="hlFld-ContribAuthor ">Yu  Chen</span>, <span class="hlFld-ContribAuthor ">Xin  Yue</span>, <span class="hlFld-ContribAuthor ">Jun  Du</span>, <span class="hlFld-ContribAuthor ">Baojian  Li</span>, <span class="hlFld-ContribAuthor ">Binhua  Zhou</span>, <span class="hlFld-ContribAuthor ">Xianzhang  Bu</span>. </span><span class="cited-content_cbyCitation_article-title">MC37, a new mono-carbonyl curcumin analog, induces G2/M cell cycle arrest and mitochondria-mediated apoptosis in human colorectal cancer cells. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2017,</strong> <em>796 </em>, 139-148. <a href="https://doi.org/10.1016/j.ejphar.2016.12.030" title="DOI URL">https://doi.org/10.1016/j.ejphar.2016.12.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2016.12.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2016.12.030%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DMC37%25252C%252Ba%252Bnew%252Bmono-carbonyl%252Bcurcumin%252Banalog%25252C%252Binduces%252BG2%25252FM%252Bcell%252Bcycle%252Barrest%252Band%252Bmitochondria-mediated%252Bapoptosis%252Bin%252Bhuman%252Bcolorectal%252Bcancer%252Bcells%26aulast%3DLiang%26aufirst%3DBaoxia%26date%3D2017%26volume%3D796%26spage%3D139%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianzhang  Wu</span>, <span class="hlFld-ContribAuthor ">Shoubiao  Wu</span>, <span class="hlFld-ContribAuthor ">Lingyi  Shi</span>, <span class="hlFld-ContribAuthor ">Shanshan  Zhang</span>, <span class="hlFld-ContribAuthor ">Jiye  Ren</span>, <span class="hlFld-ContribAuthor ">Song  Yao</span>, <span class="hlFld-ContribAuthor ">Di  Yun</span>, <span class="hlFld-ContribAuthor ">Lili  Huang</span>, <span class="hlFld-ContribAuthor ">Jiabing  Wang</span>, <span class="hlFld-ContribAuthor ">Wulan  Li</span>, <span class="hlFld-ContribAuthor ">Xiaoping  Wu</span>, <span class="hlFld-ContribAuthor ">Peihong  Qiu</span>, <span class="hlFld-ContribAuthor ">Guang  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and evaluation of asymmetric EF24 analogues as potential anti-cancer agents for lung cancer. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>125 </em>, 1321-1331. <a href="https://doi.org/10.1016/j.ejmech.2016.10.027" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.10.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.10.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.10.027%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bevaluation%252Bof%252Basymmetric%252BEF24%252Banalogues%252Bas%252Bpotential%252Banti-cancer%252Bagents%252Bfor%252Blung%252Bcancer%26aulast%3DWu%26aufirst%3DJianzhang%26date%3D2017%26volume%3D125%26spage%3D1321%26epage%3D1331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohd Fadhlizil Fasihi  Mohd Aluwi</span>, <span class="hlFld-ContribAuthor ">Kamal  Rullah</span>, <span class="hlFld-ContribAuthor ">Bohari M.  Yamin</span>, <span class="hlFld-ContribAuthor ">Sze Wei  Leong</span>, <span class="hlFld-ContribAuthor ">Mohd Nazri  Abdul Bahari</span>, <span class="hlFld-ContribAuthor ">Sock Jin  Lim</span>, <span class="hlFld-ContribAuthor ">Siti Munirah  Mohd Faudzi</span>, <span class="hlFld-ContribAuthor ">Juriyati  Jalil</span>, <span class="hlFld-ContribAuthor ">Faridah  Abas</span>, <span class="hlFld-ContribAuthor ">Norsyahida  Mohd Fauzi</span>, <span class="hlFld-ContribAuthor ">Nor Hadiani  Ismail</span>, <span class="hlFld-ContribAuthor ">Ibrahim  Jantan</span>, <span class="hlFld-ContribAuthor ">Kok Wai  Lam</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of unsymmetrical monocarbonyl curcumin analogues with potent inhibition on prostaglandin E2 production in LPS-induced murine and human macrophages cell lines. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (10)
                                     , 2531-2538. <a href="https://doi.org/10.1016/j.bmcl.2016.03.092" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.03.092</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.03.092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.03.092%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Bof%252Bunsymmetrical%252Bmonocarbonyl%252Bcurcumin%252Banalogues%252Bwith%252Bpotent%252Binhibition%252Bon%252Bprostaglandin%252BE2%252Bproduction%252Bin%252BLPS-induced%252Bmurine%252Band%252Bhuman%252Bmacrophages%252Bcell%252Blines%26aulast%3DMohd%2BAluwi%26aufirst%3DMohd%2BFadhlizil%2BFasihi%26date%3D2016%26volume%3D26%26issue%3D10%26spage%3D2531%26epage%3D2538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryan  Lillico</span>, <span class="hlFld-ContribAuthor ">Nicholas  Stesco</span>, <span class="hlFld-ContribAuthor ">Tina  Khorshid Amhad</span>, <span class="hlFld-ContribAuthor ">Claudia  Cortes</span>, <span class="hlFld-ContribAuthor ">Mike P  Namaka</span>, <span class="hlFld-ContribAuthor ">Ted M  Lakowski</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors of enzymes catalyzing modifications to histone lysine residues: structure, function and activity. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2016,</strong> <em>8 </em>
                                    (8)
                                     , 879-897. <a href="https://doi.org/10.4155/fmc-2016-0021" title="DOI URL">https://doi.org/10.4155/fmc-2016-0021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2016-0021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2016-0021%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DInhibitors%252Bof%252Benzymes%252Bcatalyzing%252Bmodifications%252Bto%252Bhistone%252Blysine%252Bresidues%25253A%252Bstructure%25252C%252Bfunction%252Band%252Bactivity%26aulast%3DLillico%26aufirst%3DRyan%26date%3D2016%26volume%3D8%26issue%3D8%26spage%3D879%26epage%3D897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luyang  Ding</span>, <span class="hlFld-ContribAuthor ">Shuli  Ma</span>, <span class="hlFld-ContribAuthor ">Hongxiang  Lou</span>, <span class="hlFld-ContribAuthor ">Longru  Sun</span>, <span class="hlFld-ContribAuthor ">Mei  Ji</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Curcumin Derivatives with Water-Soluble Groups as Potential Antitumor Agents: An in Vitro Investigation Using Tumor Cell Lines. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2015,</strong> <em>20 </em>
                                    (12)
                                     , 21501-21514. <a href="https://doi.org/10.3390/molecules201219772" title="DOI URL">https://doi.org/10.3390/molecules201219772</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules201219772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules201219772%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BCurcumin%252BDerivatives%252Bwith%252BWater-Soluble%252BGroups%252Bas%252BPotential%252BAntitumor%252BAgents%25253A%252BAn%252Bin%252BVitro%252BInvestigation%252BUsing%252BTumor%252BCell%252BLines%26aulast%3DDing%26aufirst%3DLuyang%26date%3D2015%26date%3D2015%26volume%3D20%26issue%3D12%26spage%3D21501%26epage%3D21514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kashif  Mahmood</span>, <span class="hlFld-ContribAuthor ">Khalid Mahmood  Zia</span>, <span class="hlFld-ContribAuthor ">Mohammad  Zuber</span>, <span class="hlFld-ContribAuthor ">Mahwish  Salman</span>, <span class="hlFld-ContribAuthor ">Muhammad Naveed  Anjum</span>. </span><span class="cited-content_cbyCitation_article-title">Recent developments in curcumin and curcumin based polymeric materials for biomedical applications: A review. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Biological Macromolecules</span><span> <strong>2015,</strong> <em>81 </em>, 877-890. <a href="https://doi.org/10.1016/j.ijbiomac.2015.09.026" title="DOI URL">https://doi.org/10.1016/j.ijbiomac.2015.09.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijbiomac.2015.09.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijbiomac.2015.09.026%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Biological%2520Macromolecules%26atitle%3DRecent%252Bdevelopments%252Bin%252Bcurcumin%252Band%252Bcurcumin%252Bbased%252Bpolymeric%252Bmaterials%252Bfor%252Bbiomedical%252Bapplications%25253A%252BA%252Breview%26aulast%3DMahmood%26aufirst%3DKashif%26date%3D2015%26volume%3D81%26spage%3D877%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sanjeev K.  Gupta</span>, <span class="hlFld-ContribAuthor ">Haiying  He</span>, <span class="hlFld-ContribAuthor ">Chunhui  Liu</span>, <span class="hlFld-ContribAuthor ">Ranu  Dutta</span>, <span class="hlFld-ContribAuthor ">Ravindra  Pandey</span>. </span><span class="cited-content_cbyCitation_article-title">Interaction of metallic clusters with biologically active curcumin molecules. </span><span class="cited-content_cbyCitation_journal-name">Chemical Physics Letters</span><span> <strong>2015,</strong> <em>636 </em>, 163-166. <a href="https://doi.org/10.1016/j.cplett.2015.07.040" title="DOI URL">https://doi.org/10.1016/j.cplett.2015.07.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cplett.2015.07.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cplett.2015.07.040%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Physics%2520Letters%26atitle%3DInteraction%252Bof%252Bmetallic%252Bclusters%252Bwith%252Bbiologically%252Bactive%252Bcurcumin%252Bmolecules%26aulast%3DGupta%26aufirst%3DSanjeev%2BK.%26date%3D2015%26volume%3D636%26spage%3D163%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian  Adams</span>, <span class="hlFld-ContribAuthor ">Marike  Herold</span>, <span class="hlFld-ContribAuthor ">Eva  Ferstl</span>, <span class="hlFld-ContribAuthor ">Jungwhan  Choi</span>, <span class="hlFld-ContribAuthor ">Shijun  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Anticancer effects of monocarbonyl analogs of curcumin: oxidative stress, nuclear translocation and modulation of AP-1 and NF-κB. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Cancer Therapy and Oncology</span><span> <strong>2015,</strong> <em>3 </em>
                                    (2)
                                     , 3219. <a href="https://doi.org/10.14319/ijcto.32.19" title="DOI URL">https://doi.org/10.14319/ijcto.32.19</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.14319/ijcto.32.19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.14319%2Fijcto.32.19%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Cancer%2520Therapy%2520and%2520Oncology%26atitle%3DAnticancer%252Beffects%252Bof%252Bmonocarbonyl%252Banalogs%252Bof%252Bcurcumin%25253A%252Boxidative%252Bstress%25252C%252Bnuclear%252Btranslocation%252Band%252Bmodulation%252Bof%252BAP-1%252Band%252BNF-%2525CE%2525BAB%26aulast%3DAdams%26aufirst%3DBrian%26date%3D2015%26date%3D2015%26volume%3D3%26issue%3D2%26spage%3D3219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kadir Ozden  Yerdelen</span>, <span class="hlFld-ContribAuthor ">Halise Inci  Gul</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Sakagami</span>, <span class="hlFld-ContribAuthor ">Naoki  Umemura</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of 1,5-bis(4-hydroxy-3-methoxyphenyl)penta-1,4-dien-3-one and its aminomethyl derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2015,</strong> <em>30 </em>
                                    (3)
                                     , 383-388. <a href="https://doi.org/10.3109/14756366.2014.940934" title="DOI URL">https://doi.org/10.3109/14756366.2014.940934</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/14756366.2014.940934&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F14756366.2014.940934%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B1%25252C5-bis%2525284-hydroxy-3-methoxyphenyl%252529penta-1%25252C4-dien-3-one%252Band%252Bits%252Baminomethyl%252Bderivatives%26aulast%3DYerdelen%26aufirst%3DKadir%2BOzden%26date%3D2015%26date%3D2014%26volume%3D30%26issue%3D3%26spage%3D383%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Patrick R.  Baldwin</span>, <span class="hlFld-ContribAuthor ">Analise Z.  Reeves</span>, <span class="hlFld-ContribAuthor ">Kimberly R.  Powell</span>, <span class="hlFld-ContribAuthor ">Ruth J.  Napier</span>, <span class="hlFld-ContribAuthor ">Alyson I.  Swimm</span>, <span class="hlFld-ContribAuthor ">Aiming  Sun</span>, <span class="hlFld-ContribAuthor ">Kyle  Giesler</span>, <span class="hlFld-ContribAuthor ">Bettina  Bommarius</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Shinnick</span>, <span class="hlFld-ContribAuthor ">James P.  Snyder</span>, <span class="hlFld-ContribAuthor ">Dennis C.  Liotta</span>, <span class="hlFld-ContribAuthor ">Daniel  Kalman</span>. </span><span class="cited-content_cbyCitation_article-title">Monocarbonyl analogs of curcumin inhibit growth of antibiotic sensitive and resistant strains of Mycobacterium tuberculosis. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>92 </em>, 693-699. <a href="https://doi.org/10.1016/j.ejmech.2015.01.020" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.01.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.01.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.01.020%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMonocarbonyl%252Banalogs%252Bof%252Bcurcumin%252Binhibit%252Bgrowth%252Bof%252Bantibiotic%252Bsensitive%252Band%252Bresistant%252Bstrains%252Bof%252BMycobacterium%252Btuberculosis%26aulast%3DBaldwin%26aufirst%3DPatrick%2BR.%26date%3D2015%26volume%3D92%26spage%3D693%26epage%3D699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dinesh  Shetty</span>, <span class="hlFld-ContribAuthor ">Yong  Kim</span>, <span class="hlFld-ContribAuthor ">Hyunsuk  Shim</span>, <span class="hlFld-ContribAuthor ">James  Snyder</span>. </span><span class="cited-content_cbyCitation_article-title">Eliminating the Heart from the Curcumin Molecule: Monocarbonyl Curcumin Mimics (MACs). </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2015,</strong> <em>20 </em>
                                    (1)
                                     , 249-292. <a href="https://doi.org/10.3390/molecules20010249" title="DOI URL">https://doi.org/10.3390/molecules20010249</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules20010249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules20010249%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DEliminating%252Bthe%252BHeart%252Bfrom%252Bthe%252BCurcumin%252BMolecule%25253A%252BMonocarbonyl%252BCurcumin%252BMimics%252B%252528MACs%252529%26aulast%3DShetty%26aufirst%3DDinesh%26date%3D2015%26date%3D2014%26volume%3D20%26issue%3D1%26spage%3D249%26epage%3D292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nawal K.  Paul</span>, <span class="hlFld-ContribAuthor ">Mamta  Jha</span>, <span class="hlFld-ContribAuthor ">Khushwant S.  Bhullar</span>, <span class="hlFld-ContribAuthor ">H.P. Vasantha  Rupasinghe</span>, <span class="hlFld-ContribAuthor ">Jan  Balzarini</span>, <span class="hlFld-ContribAuthor ">Amitabh  Jha</span>. </span><span class="cited-content_cbyCitation_article-title">All trans 1-(3-arylacryloyl)-3,5-bis(pyridin-4-ylmethylene)piperidin-4-ones as curcumin-inspired antineoplastics. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>87 </em>, 461-470. <a href="https://doi.org/10.1016/j.ejmech.2014.09.090" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.09.090</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.09.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.09.090%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAll%252Btrans%252B1-%2525283-arylacryloyl%252529-3%25252C5-bis%252528pyridin-4-ylmethylene%252529piperidin-4-ones%252Bas%252Bcurcumin-inspired%252Bantineoplastics%26aulast%3DPaul%26aufirst%3DNawal%2BK.%26date%3D2014%26volume%3D87%26spage%3D461%26epage%3D470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chao  Ding</span>, <span class="hlFld-ContribAuthor ">Cunlong  Zhang</span>, <span class="hlFld-ContribAuthor ">Mingli  Zhang</span>, <span class="hlFld-ContribAuthor ">Yu Zong  Chen</span>, <span class="hlFld-ContribAuthor ">Chunyan  Tan</span>, <span class="hlFld-ContribAuthor ">Ying  Tan</span>, <span class="hlFld-ContribAuthor ">Yuyang  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Multitarget inhibitors derived from crosstalk mechanism involving VEGFR2. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2014,</strong> <em>6 </em>
                                    (16)
                                     , 1771-1789. <a href="https://doi.org/10.4155/fmc.14.112" title="DOI URL">https://doi.org/10.4155/fmc.14.112</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.14.112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.14.112%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DMultitarget%252Binhibitors%252Bderived%252Bfrom%252Bcrosstalk%252Bmechanism%252Binvolving%252BVEGFR2%26aulast%3DDing%26aufirst%3DChao%26date%3D2014%26volume%3D6%26issue%3D16%26spage%3D1771%26epage%3D1789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nawras  Samaan</span>, <span class="hlFld-ContribAuthor ">Qiu  Zhong</span>, <span class="hlFld-ContribAuthor ">Jayjoel  Fernandez</span>, <span class="hlFld-ContribAuthor ">Guanglin  Chen</span>, <span class="hlFld-ContribAuthor ">Ali M.  Hussain</span>, <span class="hlFld-ContribAuthor ">Shilong  Zheng</span>, <span class="hlFld-ContribAuthor ">Guangdi  Wang</span>, <span class="hlFld-ContribAuthor ">Qiao-Hong  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and evaluation of novel heteroaromatic analogs of curcumin as anti-cancer agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>75 </em>, 123-131. <a href="https://doi.org/10.1016/j.ejmech.2014.01.041" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.01.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.01.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.01.041%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bevaluation%252Bof%252Bnovel%252Bheteroaromatic%252Banalogs%252Bof%2525C2%2525A0curcumin%252Bas%252Banti-cancer%252Bagents%26aulast%3DSamaan%26aufirst%3DNawras%26date%3D2014%26volume%3D75%26spage%3D123%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/medium/jm-2013-002692_0013.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4002692&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/medium/jm-2013-002692_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Curcumin <b>1</b> modifications to generate a series of curcumin analogues <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4002692&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/medium/jm-2013-002692_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Screening of a 50-kinase panel by curcumin analogue <b>4</b> (EF31) by the Z′-LYTE in vitro kinase assay. (a) <b>4</b> was screened against the panel in duplicate at 5 μM with ATP concentrations at <i>K</i><sub>mapp</sub> for each individual kinase. Because of experimental error, values above 100% and below 0% are regarded as maximal or no inhibition, respectively: (∗) Adapta and (∗∗) kinase cascade assays. See <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. (b) Types of kinases among the 50 in both number and % of total. (c) Activity ranges: hits (>80% inhibition), modest activity 40–80% inhibition), and low activity (less than 40% inhibition).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4002692&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/medium/jm-2013-002692_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. IC<sub>50</sub> values for inhibited kinases. (a) The analogues were tested at nine different concentrations using serial dilutions: (red triangle) <b>3</b> (EF24), (purple triangle) <b>4</b> (EF31), (gray diamond) <b>5</b> (UBS109), (yellow triangle) <b>6</b>, (green circle) <b>7</b>. Assays for RAF1 and MEK used the kinase cascade method diagrammed in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and discussed in <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4002692&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/medium/jm-2013-002692_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Phosphorylation and other interactions of transcription factors and enzymes leading to cell proliferation, differentiation, and survival. Kinases highlighted in blue have been studied in this work (Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Alternative kinase names are as follows: ERK2 = MAPK1 = MAPK2; p38 = MAPK14; MEK1 = MAP2K; COT = MAP3KB; RSK1 = RPS6KA1; AMPK = PRKAA1; IKKb = IKBKB; KDR = VEGFR-2; RPS6KB1 = S6K1; Chek1 = Chk1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4002692&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/medium/jm-2013-002692_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Diagram of kinase cascade used in the Z′-LYTE kinase assay. The RAF1 assay is a three-tiered cascade initiated with RAF1, which subsequently phosphorylates and activates MEK1 and ERK2, leading to peptide substrate phosphorylation employed to measure reaction progress (see Z′-LYTE in vitro kinase assay in <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4002692&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/medium/jm-2013-002692_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Analysis of enzyme kinetics data for <b>4</b> and AKT2: (a) Michaelis–Menten graph of kinetic data using a competitive model of inhibition; (b) Michaelis–Menten plot using a mixed model of inhibition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4002692&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/medium/jm-2013-002692_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Top predicted curcumin analogue poses from Glide docking of ligands on AKT2: (a) <b>4</b> (EF31); (b) <b>3</b> (EF24); (c) <b>5</b> (UBS109).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4002692&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/medium/jm-2013-002692_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Top predicted curcumin analogue poses for enantiomers of <b>6</b>: (a) <b>6</b><i><b>R</b></i>; (b) <b>6</b><i><b>S</b></i>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4002692&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/medium/jm-2013-002692_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Top predicted pose for <b>7</b> (SEF31) on AKT2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4002692&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/medium/jm-2013-002692_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Cys311 in the cleft where the substrate binds on AKT2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4002692&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/medium/jm-2013-002692_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Key residues around the ATP binding sites of various kinases. Residue type and number are according to AKT2: 1, Ala179; 2, Met229, Glu230, Tyr231, Ala232; 3, Met282; 4, Glu236; 5, Lys181; 6, Thr292. Upper panel shows >85% inhibition. Lower panel shows ≤10% inhibition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm4002692/production/images/large/jm-2013-002692_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4002692&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i32">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88701" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88701" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 61 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Jurenka, J. S.</span><span> </span><span class="NLM_article-title">Anti-inflammatory properties of curcumin, a major constituent of <i>Curcuma longa</i>: a review of preclinical and clinical research</span> <span class="citation_source-journal">Altern. Med. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm4002692&amp;key=19594223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A280%3ADC%252BD1MrmslOmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=141&author=J.+S.+Jurenka&title=Anti-inflammatory+properties+of+curcumin%2C+a+major+constituent+of+Curcuma+longa%3A+a+review+of+preclinical+and+clinical+research"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research</span></div><div class="casAuthors">Jurenka Julie S</div><div class="citationInfo"><span class="NLM_cas:title">Alternative medicine review : a journal of clinical therapeutic</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">141-53</span>
        ISSN:<span class="NLM_cas:issn">1089-5159</span>.
    </div><div class="casAbstract">Curcuma longa (turmeric) has a long history of use in Ayurvedic medicine as a treatment for inflammatory conditions.  Turmeric constituents include the three curcuminoids: curcumin (diferuloylmethane; the primary constituent and the one responsible for its vibrant yellow color), demethoxycurcumin, and bisdemethoxycurcumin, as well as volatile oils (tumerone, atlantone, and zingiberone), sugars, proteins, and resins.  While numerous pharmacological activities, including antioxidant and antimicrobial properties, have been attributed to curcumin, this article focuses on curcumin's anti-inflammatory properties and its use for inflammatory conditions.  Curcumin's effect on cancer (from an anti-inflammatory perspective) will also be discussed; however, an exhaustive review of its many anticancer mechanisms is outside the scope of this article.  Research has shown curcumin to be a highly pleiotropic molecule capable of interacting with numerous molecular targets involved in inflammation.  Based on early cell culture and animal research, clinical trials indicate curcumin may have potential as a therapeutic agent in diseases such as inflammatory bowel disease, pancreatitis, arthritis, and chronic anterior uveitis, as well as certain types of cancer.  Because of curcumin's rapid plasma clearance and conjugation, its therapeutic usefulness has been somewhat limited, leading researchers to investigate the benefits of complexing curcumin with other substances to increase systemic bioavailability.  Numerous in-progress clinical trials should provide an even deeper understanding of the mechanisms and therapeutic potential of curcumin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRt6mmQFWtMvtLIORRPd5lbfW6udTcc2ebwWm8pwRkf8Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MrmslOmtQ%253D%253D&md5=b5a792205ec07f7043faa96c4f01276f</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJurenka%26aufirst%3DJ.%2BS.%26atitle%3DAnti-inflammatory%2520properties%2520of%2520curcumin%252C%2520a%2520major%2520constituent%2520of%2520Curcuma%2520longa%253A%2520a%2520review%2520of%2520preclinical%2520and%2520clinical%2520research%26jtitle%3DAltern.%2520Med.%2520Rev.%26date%3D2009%26volume%3D14%26spage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Perry, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demeule, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moumdjian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beliveau, R.</span><span> </span><span class="NLM_article-title">Curcumin inhibits tumor growth and angiogenesis in glioblastoma xenografts</span> <span class="citation_source-journal">Mol. Nutr. Food Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm4002692&amp;key=20087857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvVyqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=1192&author=M.+C.+Perryauthor=M.+Demeuleauthor=A.+Reginaauthor=R.+Moumdjianauthor=R.+Beliveau&title=Curcumin+inhibits+tumor+growth+and+angiogenesis+in+glioblastoma+xenografts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Curcumin inhibits tumor growth and angiogenesis in glioblastoma xenografts</span></div><div class="casAuthors">Perry, Marie-Claude; Demeule, Michel; Regina, Anthony; Moumdjian, Robert; Beliveau, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Nutrition & Food Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1192-1201</span>CODEN:
                <span class="NLM_cas:coden">MNFRCV</span>;
        ISSN:<span class="NLM_cas:issn">1613-4125</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Among the natural products shown to possess chemopreventive and anticancer properties, curcumin is one of the most potent.  In the current study, we investigated the effects of this natural product on the growth of human glioma U-87 cells xenografted into athymic mice.  We show here that curcumin administration exerted significant anti-tumor effects on s.c. and intracerebral gliomas as demonstrated by the slower tumor growth rate and the increase of animal survival time.  While investigating the mechanism of its action in vivo, we obsd. that curcumin decreased the gelatinolytic activities of matrix metalloproteinase-9.  Furthermore, treatment with curcumin inhibited glioma-induced angiogenesis as indicated by the decrease of endothelial cell marker from newly formed vessels and by the diminution of the concn. of Hb in curcumin-treaded tumors.  We also demonstrate, using an in vitro model of blood-brain barrier, that curcumin can cross the blood-brain barrier to a high level.  These are the first results showing that curcumin suppresses tumor growth of gliomas in xenograft models.  The mechanisms of the anti-tumor effects of curcumin were related, at least partly, to the inhibition of glioma-induced angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzthyuuPffW7Vg90H21EOLACvtfcHk0likwrl9oNBwoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvVyqtLs%253D&md5=fbc9d28f6ae7f40390504fd32c8ba89e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerry%26aufirst%3DM.%2BC.%26aulast%3DDemeule%26aufirst%3DM.%26aulast%3DRegina%26aufirst%3DA.%26aulast%3DMoumdjian%26aufirst%3DR.%26aulast%3DBeliveau%26aufirst%3DR.%26atitle%3DCurcumin%2520inhibits%2520tumor%2520growth%2520and%2520angiogenesis%2520in%2520glioblastoma%2520xenografts%26jtitle%3DMol.%2520Nutr.%2520Food%2520Res.%26date%3D2010%26volume%3D54%26spage%3D1192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Lee, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, O. J.</span><span> </span><span class="NLM_article-title">Regulatory effect of the AMPK-COX-2 signaling pathway in curcumin-induced apoptosis in HT-29 colon cancer cells</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1171</span><span class="NLM_x">, </span> <span class="NLM_fpage">489</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1171&publication_year=2009&pages=489&author=Y.+K.+Leeauthor=S.+Y.+Parkauthor=Y.+M.+Kimauthor=O.+J.+Park&title=Regulatory+effect+of+the+AMPK-COX-2+signaling+pathway+in+curcumin-induced+apoptosis+in+HT-29+colon+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DY.%2BK.%26aulast%3DPark%26aufirst%3DS.%2BY.%26aulast%3DKim%26aufirst%3DY.%2BM.%26aulast%3DPark%26aufirst%3DO.%2BJ.%26atitle%3DRegulatory%2520effect%2520of%2520the%2520AMPK-COX-2%2520signaling%2520pathway%2520in%2520curcumin-induced%2520apoptosis%2520in%2520HT-29%2520colon%2520cancer%2520cells%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2009%26volume%3D1171%26spage%3D489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Yang, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Y. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span> </span><span class="NLM_article-title">Curcumin blocks small cell lung cancer cells migration, invasion, angiogenesis, cell cycle and neoplasia through Janus kinase-STAT3 signalling pathway</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e37960</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e37960&author=C.+L.+Yangauthor=Y.+Y.+Liuauthor=Y.+G.+Maauthor=Y.+X.+Xueauthor=D.+G.+Liuauthor=Y.+Renauthor=X.+B.+Liuauthor=Y.+Liauthor=Z.+Li&title=Curcumin+blocks+small+cell+lung+cancer+cells+migration%2C+invasion%2C+angiogenesis%2C+cell+cycle+and+neoplasia+through+Janus+kinase-STAT3+signalling+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DC.%2BL.%26aulast%3DLiu%26aufirst%3DY.%2BY.%26aulast%3DMa%26aufirst%3DY.%2BG.%26aulast%3DXue%26aufirst%3DY.%2BX.%26aulast%3DLiu%26aufirst%3DD.%2BG.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DX.%2BB.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26atitle%3DCurcumin%2520blocks%2520small%2520cell%2520lung%2520cancer%2520cells%2520migration%252C%2520invasion%252C%2520angiogenesis%252C%2520cell%2520cycle%2520and%2520neoplasia%2520through%2520Janus%2520kinase-STAT3%2520signalling%2520pathway%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De37960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Aggarwal, B. B.; Surh, Y.-J.; Shishodia, S.</span> <span class="citation_source-book">The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease</span>; <span class="NLM_publisher-name">Springer Science+Business Media, LLC</span>: <span class="NLM_publisher-loc">New York, U.S.</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.1007%2F978-0-387-46401-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=B.+B.+Aggarwal&author=Y.-J.+Surh&author=S.+Shishodia&title=The+Molecular+Targets+and+Therapeutic+Uses+of+Curcumin+in+Health+and+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2F978-0-387-46401-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-0-387-46401-5%26sid%3Dliteratum%253Aachs%26aulast%3DAggarwal%26aufirst%3DB.%2BB.%26btitle%3DThe%2520Molecular%2520Targets%2520and%2520Therapeutic%2520Uses%2520of%2520Curcumin%2520in%2520Health%2520and%2520Disease%26pub%3DSpringer%2520Science%252BBusiness%2520Media%252C%2520LLC%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beevers, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.</span><span> </span><span class="NLM_article-title">The targets of curcumin</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">332</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.2174%2F138945011794815356" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=332&author=H.+Zhouauthor=C.+S.+Beeversauthor=S.+Huang&title=The+targets+of+curcumin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F138945011794815356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138945011794815356%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DBeevers%26aufirst%3DC.%2BS.%26aulast%3DHuang%26aufirst%3DS.%26atitle%3DThe%2520targets%2520of%2520curcumin%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2010%26volume%3D12%26spage%3D332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Sharma, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steward, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gescher, A. J.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and pharmacodynamics of curcumin</span> <span class="citation_source-journal">Adv. Exp. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">595</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.1007%2F978-0-387-46401-5_20" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm4002692&amp;key=17569224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A280%3ADC%252BD2szlslGnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=595&publication_year=2007&pages=453&author=R.+A.+Sharmaauthor=W.+P.+Stewardauthor=A.+J.+Gescher&title=Pharmacokinetics+and+pharmacodynamics+of+curcumin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and pharmacodynamics of curcumin</span></div><div class="casAuthors">Sharma Ricky A; Steward William P; Gescher Andreas J</div><div class="citationInfo"><span class="NLM_cas:title">Advances in experimental medicine and biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">595</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">453-70</span>
        ISSN:<span class="NLM_cas:issn">0065-2598</span>.
    </div><div class="casAbstract">Curcuma spp. contain turmerin, essential oils, and curcuminoids, including curcumin.  Curcumin [1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione] is regarded as the most biologically active constituent of the spice turmeric and it comprises 2-8% of most turmeric preparations.  Preclinical data from animal models and phase I clinical studies performed with human volunteers and patients with cancer have demonstrated low systemic bioavailability following oral dosing.  Efficient first-pass metabolism and some degree of intestinal metabolism, particularly glucuronidation and sulfation of curcumin, might explain its poor systemic availability when administered via the oral route.  A daily oral dose of 3.6 g of curcumin is compatible with detectable levels of the parent compound in colorectal tissue from patients with cancer.  The levels demonstrated might be sufficient to exert pharmacological activity.  There appears to be negligible distribution of the parent drug to hepatic tissue or other tissues beyond the gastrointestinal tract.  Curcumin possesses wide-ranging anti-inflammatory and anticancer properties.  Many of these biological activities can be attributed to its potent antioxidant capacity at neutral and acidic pH, its inhibition of cell signaling pathways at multiple levels, its diverse effects on cellular enzymes, and its effects on cell adhesion and angiogenesis.  In particular, curcumin's ability to alter gene transcription and induce apoptosis in preclinical models advocates its potential utility in cancer chemoprevention and chemotherapy.  With regard to considerable public and scientific interest in the use of phytochemicals derived from dietary components to combat or prevent human diseases, curcumin is currently a leading agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTNHoLsb061FisZ1x6zOs0vfW6udTcc2eYC-OSjdk8rxbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2szlslGnuw%253D%253D&md5=0538b10f53ceca35fedfd9ec76428b10</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2F978-0-387-46401-5_20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-0-387-46401-5_20%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DR.%2BA.%26aulast%3DSteward%26aufirst%3DW.%2BP.%26aulast%3DGescher%26aufirst%3DA.%2BJ.%26atitle%3DPharmacokinetics%2520and%2520pharmacodynamics%2520of%2520curcumin%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D2007%26volume%3D595%26spage%3D453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Ji, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H. L.</span><span> </span><span class="NLM_article-title">Curcumin and its formulations: potential anti-cancer agents</span> <span class="citation_source-journal">Anti-Cancer Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">210</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=210&author=J.+L.+Jiauthor=X.+F.+Huangauthor=H.+L.+Zhu&title=Curcumin+and+its+formulations%3A+potential+anti-cancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DJ.%2BL.%26aulast%3DHuang%26aufirst%3DX.%2BF.%26aulast%3DZhu%26aufirst%3DH.%2BL.%26atitle%3DCurcumin%2520and%2520its%2520formulations%253A%2520potential%2520anti-cancer%2520agents%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2011%26volume%3D12%26spage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Sun, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J. K.</span><span> </span><span class="NLM_article-title">Cycle arrest and apoptosis in MDA-MB-231/Her2 cells induced by curcumin</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">690</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.1016%2Fj.ejphar.2012.05.036" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=690&publication_year=2010&pages=22-30&author=S.+H.+Sunauthor=H.+C.+Huangauthor=C.+Huangauthor=J.+K.+Lin&title=Cycle+arrest+and+apoptosis+in+MDA-MB-231%2FHer2+cells+induced+by+curcumin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2012.05.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2012.05.036%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%2BH.%26aulast%3DHuang%26aufirst%3DH.%2BC.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DJ.%2BK.%26atitle%3DCycle%2520arrest%2520and%2520apoptosis%2520in%2520MDA-MB-231%252FHer2%2520cells%2520induced%2520by%2520curcumin%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D690%26spage%3D22%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Epelbaum, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vizel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badmaev, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Sela, G.</span><span> </span><span class="NLM_article-title">Curcumin and gemcitabine in patients with advanced pancreatic cancer</span> <span class="citation_source-journal">Nutr. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1137</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.1080%2F01635581.2010.513802" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm4002692&amp;key=21058202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlyku7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=1137&author=R.+Epelbaumauthor=M.+Schafferauthor=B.+Vizelauthor=V.+Badmaevauthor=G.+Bar-Sela&title=Curcumin+and+gemcitabine+in+patients+with+advanced+pancreatic+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer</span></div><div class="casAuthors">Epelbaum, Ron; Schaffer, Moshe; Vizel, Bella; Badmaev, Vladimir; Bar-Sela, Gil</div><div class="citationInfo"><span class="NLM_cas:title">Nutrition and Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1137-1141</span>CODEN:
                <span class="NLM_cas:coden">NUCADQ</span>;
        ISSN:<span class="NLM_cas:issn">0163-5581</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Curcumin has a potent antiproliferative activity and can also potentiate the antitumor effect of gemcitabine.  This study was undertaken to evaluate the activity and feasibility of gemcitabine in combination with curcumin in patients with advanced pancreatic cancer.  Seventeen patients were enrolled in the study and received 8,000 mg of curcumin by mouth daily, concurrently with gemcitabine 1,000 mg/m2 IV weekly × 3 of 4 wk; 5 patients (29%) discontinued curcumin after a few days to 2 wk due to intractable abdominal fullness or pain, and the dose of curcumin was reduced to 4,000 mg/day because of abdominal complaints in 2 other patients.  One of 11 evaluable patients (9%) had partial response, 4 (36%) had stable disease, and 6 (55%) had tumor progression.  Time to tumor progression was 1-12 mo (median 21/2), and overall survival was 1-24 mo (median 5).  Low compliance for curcumin at a dose of 8,000 mg/day, when taken together with systemic gemcitabine, may prevent the use of high doses of oral curcumin needed to achieve systemic effect.  Further studies should be conducted to evaluate the ability of other formulations of curcumin to enhance the effect of chemotherapy in cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOd34cVcMfrbVg90H21EOLACvtfcHk0lhuWKa08VvBDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlyku7vE&md5=5f41cd5ceb8bb015a2a313e94701afc0</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1080%2F01635581.2010.513802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F01635581.2010.513802%26sid%3Dliteratum%253Aachs%26aulast%3DEpelbaum%26aufirst%3DR.%26aulast%3DSchaffer%26aufirst%3DM.%26aulast%3DVizel%26aufirst%3DB.%26aulast%3DBadmaev%26aufirst%3DV.%26aulast%3DBar-Sela%26aufirst%3DG.%26atitle%3DCurcumin%2520and%2520gemcitabine%2520in%2520patients%2520with%2520advanced%2520pancreatic%2520cancer%26jtitle%3DNutr.%2520Cancer%26date%3D2010%26volume%3D62%26spage%3D1137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Bayet-Robert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwiatkowski, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leheurteur, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gachon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Planchat, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrial, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouret-Reynier, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durando, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barthomeuf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chollet, P.</span><span> </span><span class="NLM_article-title">Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer</span> <span class="citation_source-journal">Cancer Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.4161%2Fcbt.9.1.10392" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm4002692&amp;key=19901561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1Wjtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=8&author=M.+Bayet-Robertauthor=F.+Kwiatkowskiauthor=M.+Leheurteurauthor=F.+Gachonauthor=E.+Planchatauthor=C.+Abrialauthor=M.+A.+Mouret-Reynierauthor=X.+Durandoauthor=C.+Barthomeufauthor=P.+Chollet&title=Phase+I+dose+escalation+trial+of+docetaxel+plus+curcumin+in+patients+with+advanced+and+metastatic+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer</span></div><div class="casAuthors">Bayet-Robert, Mathilde; Kwiatkowski, Fabrice; Leheurteur, Marianne; Gachon, Francoise; Planchat, Eloise; Abrial, Catherine; Mouret-Reynier, Marie-Ange; Durando, Xavier; Barthomeuf, Chantal; Chollet, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8-14</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Background: Since the improvement of chemotherapy with safe mols. is needed for a better efficacy without supplementary toxicity, we investigated the feasibility and tolerability of the combination of docetaxel and curcumin, a polyphenolic deriv. extd. from Curcuma longa root.  Results: Fourteen patients were accrued in this open-label phase I trial.  At the last dose level of curcumin, three dose-limiting toxicities were obsd. and two out of three patients at this dose level refused to continue treatment, leading us to define the maximal tolerated dose of curcumin at 8,000 mg/d.  Eight patients out of 14 had measurable lesions according to RECIST criteria, with five PR and three SD.  Some improvements as biol. and clin. responses were obsd. in most patients.  Patients and Methods: Patients with advanced or metastatic breast cancer were eligible.  Docetaxel (100 mg/m2) was administered as a 1 h i.v. infusion every 3 w on d 1 for six cycles.  Curcumin was orally given from 500 mg/d for seven consecutive d by cycle (from d-4 to d+2) and escalated until a dose-limiting toxicity should occur.  The primary endpoint of this study was to det. the maximal tolerated dose of the combination of dose-escalating curcumin and std. dose of docetaxel chemotherapy in advanced and metastatic breast cancer patients.  Secondary objectives included toxicity, safety, vascular endothelial growth factor and tumor markers measurements and assessment of objective and clin. responses to the combination therapy.  Conclusion: The recommended dose of curcumin is 6,000 mg/d for seven consecutive d every 3 w in combination with a std. dose of docetaxel.  From the encouraging efficacy results, a comparative Phase II trial of this regimen plus docetaxel vs. docetaxel alone is ongoing in advanced and metastatic breast cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3p0dnfRr3ALVg90H21EOLACvtfcHk0lhuWKa08VvBDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1Wjtrc%253D&md5=95710a301381b5dc60aa5ad970fe893a</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.4161%2Fcbt.9.1.10392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.9.1.10392%26sid%3Dliteratum%253Aachs%26aulast%3DBayet-Robert%26aufirst%3DM.%26aulast%3DKwiatkowski%26aufirst%3DF.%26aulast%3DLeheurteur%26aufirst%3DM.%26aulast%3DGachon%26aufirst%3DF.%26aulast%3DPlanchat%26aufirst%3DE.%26aulast%3DAbrial%26aufirst%3DC.%26aulast%3DMouret-Reynier%26aufirst%3DM.%2BA.%26aulast%3DDurando%26aufirst%3DX.%26aulast%3DBarthomeuf%26aufirst%3DC.%26aulast%3DChollet%26aufirst%3DP.%26atitle%3DPhase%2520I%2520dose%2520escalation%2520trial%2520of%2520docetaxel%2520plus%2520curcumin%2520in%2520patients%2520with%2520advanced%2520and%2520metastatic%2520breast%2520cancer%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2010%26volume%3D9%26spage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Taylor, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, M. C.</span><span> </span><span class="NLM_article-title">Curcumin for inflammatory bowel disease: a review of human studies</span> <span class="citation_source-journal">Altern. Med. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm4002692&amp;key=21649456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A280%3ADC%252BC3MrotlemsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=152&author=R.+A.+Taylorauthor=M.+C.+Leonard&title=Curcumin+for+inflammatory+bowel+disease%3A+a+review+of+human+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Curcumin for inflammatory bowel disease: a review of human studies</span></div><div class="casAuthors">Taylor Rebecca A; Leonard Mandy C</div><div class="citationInfo"><span class="NLM_cas:title">Alternative medicine review : a journal of clinical therapeutic</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">152-6</span>
        ISSN:<span class="NLM_cas:issn">1089-5159</span>.
    </div><div class="casAbstract">OBJECTIVE:  To evaluate the use of curcumin in inflammatory bowel disease.  DATA SOURCES:  ALTMEDEX, Comprehensive Database of Natural Medicines, MEDLINE/PubMed were searched from January 1980 through May 2009 using the terms curcumin, turmeric, ulcerative colitis, Crohn's disease, Curcuma longa, Curcuma domestica, Indian saffron, inflammatory bowel disease.  Data was limited to human trials.  References of identified articles were reviewed.  DATA SYNTHESIS:  Data evaluating the use of curcumin in inflammatory bowel disease (including ulcerative colitis and Crohn's disease) is limited to two studies comprising data for only 99 patients.  Curcumin in conjunction with mainstream therapy, consisting of sulfasalazine (SZ) or mesalamine (5-aminosalicylic acid [5-ASA] derivatives) or corticosteroids was shown to improve patient symptoms and allow for a decrease in the dosage of corticosteroids or 5-ASA derivatives.  In one small study of 10 patients, some patients even stopped taking corticosteroids or 5-ASA.  CONCLUSIONS:  Although two small studies have shown promising results, all authors conclude that larger-scale, double-blind trials need to be conducted to establish a role for curcumin in the treatment of ulcerative colitis.  In addition to improving results when used in conjunction with conventional medications for UC, curcumin may pose a less-expensive alternative.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTKiSytaz4fsUcLvDNbOD4DfW6udTcc2eZO-pKaZyIYm7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MrotlemsA%253D%253D&md5=31869a0c484718eb37bc0a9c0fff858e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DR.%2BA.%26aulast%3DLeonard%26aufirst%3DM.%2BC.%26atitle%3DCurcumin%2520for%2520inflammatory%2520bowel%2520disease%253A%2520a%2520review%2520of%2520human%2520studies%26jtitle%3DAltern.%2520Med.%2520Rev.%26date%3D2011%26volume%3D16%26spage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Gupta, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patchva, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aggarwal, B. B.</span><span> </span><span class="NLM_article-title">Therapeutic roles of curcumin: lessons learned from clinical trials</span> <span class="citation_source-journal">Am. Assoc. Pharm. Sci. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">218</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=195-218&author=S.+C.+Guptaauthor=S.+Patchvaauthor=B.+B.+Aggarwal&title=Therapeutic+roles+of+curcumin%3A+lessons+learned+from+clinical+trials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DS.%2BC.%26aulast%3DPatchva%26aufirst%3DS.%26aulast%3DAggarwal%26aufirst%3DB.%2BB.%26atitle%3DTherapeutic%2520roles%2520of%2520curcumin%253A%2520lessons%2520learned%2520from%2520clinical%2520trials%26jtitle%3DAm.%2520Assoc.%2520Pharm.%2520Sci.%2520J.%26date%3D2013%26volume%3D15%26spage%3D195%26epage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span>National Institutes of Health. <a href="http://www.clinicaltrials.gov/ct2/results?term=curcumin&amp;Search=Search" class="extLink">http://www.clinicaltrials.gov/ct2/results?term=curcumin&Search=Search</a> (last accessed Feb 10,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=National+Institutes+of+Health.+http%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fresults%3Fterm%3Dcurcumin%26Search%3DSearch+%28last+accessed+Feb+10%2C+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Adams, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferstl, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herold, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurtkaya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camalier, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollingshead, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sausville, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rickles, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoji, M.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">3871</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.1016%2Fj.bmc.2004.05.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm4002692&amp;key=15210154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltVKisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=3871&author=B.+K.+Adamsauthor=E.+M.+Ferstlauthor=M.+C.+Davisauthor=M.+Heroldauthor=S.+Kurtkayaauthor=R.+F.+Camalierauthor=M.+G.+Hollingsheadauthor=G.+Kaurauthor=E.+A.+Sausvilleauthor=F.+R.+Ricklesauthor=J.+P.+Snyderauthor=D.+C.+Liottaauthor=M.+Shoji&title=Synthesis+and+biological+evaluation+of+novel+curcumin+analogs+as+anti-cancer+and+anti-angiogenesis+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents</span></div><div class="casAuthors">Adams, Brian K.; Ferstl, Eva M.; Davis, Matthew C.; Herold, Marike; Kurtkaya, Serdar; Camalier, Richard F.; Hollingshead, Melinda G.; Kaur, Gurmeet; Sausville, Edward A.; Rickles, Frederick R.; Snyder, James P.; Liotta, Dennis C.; Shoji, Mamoru</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3871-3883</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of novel curcumin analogs were synthesized and screened for anti-cancer and anti-angiogenesis activities at Emory University and at the National Cancer Institute (NCI).  These compds. are sym. α,β-unsatd. and satd. ketones.  The majority of the analogs demonstrated a moderate degree of anti-cancer activity.  Three Compds. exhibited a high degree of cytotoxicity in the NCI in vitro anti-cancer cell line screen.  In addn., this screen revealed that these compds. inhibit tumor cell growth with a higher potency than the commonly used chemotherapeutic drug, cisplatin.  In independent in vitro screens conducted at Emory, 5 compds. exhibited a high degree of cytotoxicity to tumor cells.  Analogs that were effective in the anti-cancer screens were also effective in in vitro anti-angiogenesis assays.  In the assays conducted by the NCI, I was almost as potent as the anti-angiogenic drug TNP-470, which has undergone clin. trials.  Based on the favorable in vitro anti-cancer and anti-angiogenesis results with I, further in vivo tests were conducted.  This compd. effectively reduced the size of human breast tumors grown in female athymic nude mice and showed little toxicity.  This data, coupled with the remarkable in vitro data, suggests that I may potentially be an effective chemotherapeutic agent.  As a follow-up, a 3D quant. structure relation based on I has been developed.  It shows a cross-validated r2(q2)=0.83 and a predictive r2(p2)=0.71.  COMPARE anal. suggests the compd. to be a possible RNA/DNA antimetabolite, but also implies that the compd.'s cytotoxicity may arise from a presently unknown mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwmpU3h4OlGrVg90H21EOLACvtfcHk0livPQuuFaoCnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltVKisr8%253D&md5=94f8cdb257139ec0dcd3a742a90b9252</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2004.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2004.05.006%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DB.%2BK.%26aulast%3DFerstl%26aufirst%3DE.%2BM.%26aulast%3DDavis%26aufirst%3DM.%2BC.%26aulast%3DHerold%26aufirst%3DM.%26aulast%3DKurtkaya%26aufirst%3DS.%26aulast%3DCamalier%26aufirst%3DR.%2BF.%26aulast%3DHollingshead%26aufirst%3DM.%2BG.%26aulast%3DKaur%26aufirst%3DG.%26aulast%3DSausville%26aufirst%3DE.%2BA.%26aulast%3DRickles%26aufirst%3DF.%2BR.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DShoji%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520curcumin%2520analogs%2520as%2520anti-cancer%2520and%2520anti-angiogenesis%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D3871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Sun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoji, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span> </span><span class="NLM_article-title">Curcumin analog cytotoxicity against breast cancer cells: exploitation of a redox-dependent mechanism</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6627</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=6627&author=A.+Sunauthor=Y.+J.+Luauthor=H.+Huauthor=M.+Shojiauthor=D.+C.+Liottaauthor=J.+P.+Snyder&title=Curcumin+analog+cytotoxicity+against+breast+cancer+cells%3A+exploitation+of+a+redox-dependent+mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DA.%26aulast%3DLu%26aufirst%3DY.%2BJ.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DShoji%26aufirst%3DM.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26atitle%3DCurcumin%2520analog%2520cytotoxicity%2520against%2520breast%2520cancer%2520cells%253A%2520exploitation%2520of%2520a%2520redox-dependent%2520mechanism%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D6627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Avonto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taglialatela-Scafati, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollastro, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minassi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marzo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Petrocellis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appendino, G.</span><span> </span><span class="NLM_article-title">An NMR spectroscopic method to identify and classify thiol-trapping agents: revival of michael acceptors for drug discovery?</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">467</span><span class="NLM_x">–</span> <span class="NLM_lpage">471</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=467-471&author=C.+Avontoauthor=O.+Taglialatela-Scafatiauthor=F.+Pollastroauthor=A.+Minassiauthor=V.+Di+Marzoauthor=L.+De+Petrocellisauthor=G.+Appendino&title=An+NMR+spectroscopic+method+to+identify+and+classify+thiol-trapping+agents%3A+revival+of+michael+acceptors+for+drug+discovery%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAvonto%26aufirst%3DC.%26aulast%3DTaglialatela-Scafati%26aufirst%3DO.%26aulast%3DPollastro%26aufirst%3DF.%26aulast%3DMinassi%26aufirst%3DA.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DDe%2BPetrocellis%26aufirst%3DL.%26aulast%3DAppendino%26aufirst%3DG.%26atitle%3DAn%2520NMR%2520spectroscopic%2520method%2520to%2520identify%2520and%2520classify%2520thiol-trapping%2520agents%253A%2520revival%2520of%2520michael%2520acceptors%2520for%2520drug%2520discovery%253F%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2011%26volume%3D50%26spage%3D467%26epage%3D471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Usta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wortelboer, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vervoort, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boersma, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rietjens, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Bladeren, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cnubben, N. H.</span><span> </span><span class="NLM_article-title">Human glutathione <i>S</i>-transferase-mediated glutathione conjugation of curcumin and efflux of these conjugates in Caco-2 cells</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1895</span><span class="NLM_x">–</span> <span class="NLM_lpage">1902</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx7002245" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2007&pages=1895-1902&author=M.+Ustaauthor=H.+M.+Wortelboerauthor=J.+Vervoortauthor=M.+G.+Boersmaauthor=I.+M.+Rietjensauthor=P.+J.+van+Bladerenauthor=N.+H.+Cnubben&title=Human+glutathione+S-transferase-mediated+glutathione+conjugation+of+curcumin+and+efflux+of+these+conjugates+in+Caco-2+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Ftx7002245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx7002245%26sid%3Dliteratum%253Aachs%26aulast%3DUsta%26aufirst%3DM.%26aulast%3DWortelboer%26aufirst%3DH.%2BM.%26aulast%3DVervoort%26aufirst%3DJ.%26aulast%3DBoersma%26aufirst%3DM.%2BG.%26aulast%3DRietjens%26aufirst%3DI.%2BM.%26aulast%3Dvan%2BBladeren%26aufirst%3DP.%2BJ.%26aulast%3DCnubben%26aufirst%3DN.%2BH.%26atitle%3DHuman%2520glutathione%2520S-transferase-mediated%2520glutathione%2520conjugation%2520of%2520curcumin%2520and%2520efflux%2520of%2520these%2520conjugates%2520in%2520Caco-2%2520cells%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2007%26volume%3D20%26spage%3D1895%26epage%3D1902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Wortelboer, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Velde, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boersma, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spenkelink, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Zanden, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rietjens, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Bladeren, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cnubben, N. H.</span><span> </span><span class="NLM_article-title">Interplay between MRP inhibition and metabolism of MRP inhibitors: the case of curcumin</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1642</span><span class="NLM_x">–</span> <span class="NLM_lpage">1651</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx034101x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2003&pages=1642-1651&author=H.+M.+Wortelboerauthor=M.+Ustaauthor=A.+E.+van+der+Veldeauthor=M.+G.+Boersmaauthor=B.+Spenkelinkauthor=J.+J.+van+Zandenauthor=I.+M.+Rietjensauthor=P.+J.+van+Bladerenauthor=N.+H.+Cnubben&title=Interplay+between+MRP+inhibition+and+metabolism+of+MRP+inhibitors%3A+the+case+of+curcumin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Ftx034101x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx034101x%26sid%3Dliteratum%253Aachs%26aulast%3DWortelboer%26aufirst%3DH.%2BM.%26aulast%3DUsta%26aufirst%3DM.%26aulast%3Dvan%2Bder%2BVelde%26aufirst%3DA.%2BE.%26aulast%3DBoersma%26aufirst%3DM.%2BG.%26aulast%3DSpenkelink%26aufirst%3DB.%26aulast%3Dvan%2BZanden%26aufirst%3DJ.%2BJ.%26aulast%3DRietjens%26aufirst%3DI.%2BM.%26aulast%3Dvan%2BBladeren%26aufirst%3DP.%2BJ.%26aulast%3DCnubben%26aufirst%3DN.%2BH.%26atitle%3DInterplay%2520between%2520MRP%2520inhibition%2520and%2520metabolism%2520of%2520MRP%2520inhibitors%253A%2520the%2520case%2520of%2520curcumin%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2003%26volume%3D16%26spage%3D1642%26epage%3D1651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Awasthi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandya, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singhal, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiviyanathan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seifert, W. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awasthi, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ansari, G. A.</span><span> </span><span class="NLM_article-title">Curcumin–glutathione interactions and the role of human glutathione <i>S</i>-transferase P1-1</span> <span class="citation_source-journal">Chem.-Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.1016%2FS0009-2797%2800%2900185-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm4002692&amp;key=10996298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtlOlsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2000&pages=19&author=S.+Awasthiauthor=U.+Pandyaauthor=S.+S.+Singhalauthor=J.+T.+Linauthor=V.+Thiviyanathanauthor=W.+E.+Seifertauthor=Y.+C.+Awasthiauthor=G.+A.+Ansari&title=Curcumin%E2%80%93glutathione+interactions+and+the+role+of+human+glutathione+S-transferase+P1-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Curcumin-glutathione interactions and the role of human glutathione S-transferase P1-1</span></div><div class="casAuthors">Awasthi, S.; Pandya, U.; Singhal, S. S.; Lin, J. T.; Thiviyanathan, V.; Seifert, W. E.; Awasthi, Y. C.; Ansari, G. A. S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-38</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">Curcumin (diferuloylmethane), a yellow pigment of turmeric with antioxidant properties has been shown to be a cancer preventative in animal studies.  It contains two electrophilic α, β-unsatd. carbonyl groups, which can react with nucleophilic compds. such as glutathione (GSH), but formation of the GSH-curcumin conjugates has not previously been demonstrated.  In the present studies, we investigated the reactions of curcumin with GSH and the effect of recombinant human glutathione S-transferase(GST)P1-1 on reaction kinetics.  Glutathionylated products of curcumin identified by FAB-MS and MALDI-MS included mono- and di-glutathionyl-adducts of curcumin as well as cyclic rearrangement products of GSH adducts of feruloylmethylketone (FMK) and feruloylaldehyde (FAL).  The presence of GSTP1-1 significantly accelerated the initial rate of GSH-mediated consumption of curcumin in 10 mM potassium phosphate, pH 7.0, and 1 mM GSH.  GSTP1-1 kinetics detd. using HPLC indicated substrate inhibition (apparent Km for curcumin of 25±11 μM, and apparent Ki for curcumin of 8±3 μM).  GSTP1-1 was also shown to catalyze the reverse reaction leading to the formation of curcumin from GSH adducts of FMK and FAL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeKW1kajK1EbVg90H21EOLACvtfcHk0lju77LtAlmg4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtlOlsL4%253D&md5=749797f39e599cefdd3282b4016b71f4</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS0009-2797%2800%2900185-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0009-2797%252800%252900185-X%26sid%3Dliteratum%253Aachs%26aulast%3DAwasthi%26aufirst%3DS.%26aulast%3DPandya%26aufirst%3DU.%26aulast%3DSinghal%26aufirst%3DS.%2BS.%26aulast%3DLin%26aufirst%3DJ.%2BT.%26aulast%3DThiviyanathan%26aufirst%3DV.%26aulast%3DSeifert%26aufirst%3DW.%2BE.%26aulast%3DAwasthi%26aufirst%3DY.%2BC.%26aulast%3DAnsari%26aufirst%3DG.%2BA.%26atitle%3DCurcumin%25E2%2580%2593glutathione%2520interactions%2520and%2520the%2520role%2520of%2520human%2520glutathione%2520S-transferase%2520P1-1%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2000%26volume%3D128%26spage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Targeting cancer with small molecule kinase inhibitors</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.1038%2Fnrc2559" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm4002692&amp;key=19104514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1yg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=28-39&author=J.+Zhangauthor=P.+L.+Yangauthor=N.+S.+Gray&title=Targeting+cancer+with+small+molecule+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cancer with small molecule kinase inhibitors</span></div><div class="casAuthors">Zhang, Jianming; Yang, Priscilla L.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-39</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Deregulation of kinase activity has emerged as a major mechanism by which cancer cells evade normal physiol. constraints on growth and survival.  To date, 11 kinase inhibitors have received US Food and Drug Administration approval as cancer treatments, and there are considerable efforts to develop selective small mol. inhibitors for a host of other kinases that are implicated in cancer and other diseases.  Herein we discuss the current challenges in the field, such as designing selective inhibitors and developing strategies to overcome resistance mutations.  This Review provides a broad overview of some of the approaches currently used to discover and characterize new kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriSM3BN_uEz7Vg90H21EOLACvtfcHk0lgUJvgxehT_Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1yg&md5=35bc38f414cd21eef5e61ce181b580fb</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnrc2559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2559%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DP.%2BL.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DTargeting%2520cancer%2520with%2520small%2520molecule%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26spage%3D28%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Kothari, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shanker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalyana-Sundaram, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vats, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasso, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simeone, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnaiyan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar-Sinha, C.</span><span> </span><span class="NLM_article-title">Outlier kinase expression by RNA sequencing as targets for precision therapy</span> <span class="citation_source-journal">Cancer Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=1-14&author=V.+Kothariauthor=I.+Weiauthor=S.+Shankerauthor=S.+Kalyana-Sundaramauthor=L.+Wangauthor=L.+W.+Maauthor=P.+Vatsauthor=C.+S.+Grassoauthor=D.+R.+Robinsonauthor=Y.+M.+Wuauthor=X.+Caoauthor=D.+M.+Simeoneauthor=A.+M.+Chinnaiyanauthor=C.+Kumar-Sinha&title=Outlier+kinase+expression+by+RNA+sequencing+as+targets+for+precision+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKothari%26aufirst%3DV.%26aulast%3DWei%26aufirst%3DI.%26aulast%3DShanker%26aufirst%3DS.%26aulast%3DKalyana-Sundaram%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DMa%26aufirst%3DL.%2BW.%26aulast%3DVats%26aufirst%3DP.%26aulast%3DGrasso%26aufirst%3DC.%2BS.%26aulast%3DRobinson%26aufirst%3DD.%2BR.%26aulast%3DWu%26aufirst%3DY.%2BM.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DSimeone%26aufirst%3DD.%2BM.%26aulast%3DChinnaiyan%26aufirst%3DA.%2BM.%26aulast%3DKumar-Sinha%26aufirst%3DC.%26atitle%3DOutlier%2520kinase%2520expression%2520by%2520RNA%2520sequencing%2520as%2520targets%2520for%2520precision%2520therapy%26jtitle%3DCancer%2520Discovery%26date%3D2013%26volume%3D3%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Adams, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herold, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoji, M.</span><span> </span><span class="NLM_article-title">EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redox-dependent mechanism</span> <span class="citation_source-journal">Anti-Cancer Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=263&author=B.+K.+Adamsauthor=J.+Caiauthor=J.+Armstrongauthor=M.+Heroldauthor=Y.+J.+Luauthor=A.+Sunauthor=J.+P.+Snyderauthor=D.+C.+Liottaauthor=D.+P.+Jonesauthor=M.+Shoji&title=EF24%2C+a+novel+synthetic+curcumin+analog%2C+induces+apoptosis+in+cancer+cells+via+a+redox-dependent+mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DB.%2BK.%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DArmstrong%26aufirst%3DJ.%26aulast%3DHerold%26aufirst%3DM.%26aulast%3DLu%26aufirst%3DY.%2BJ.%26aulast%3DSun%26aufirst%3DA.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DJones%26aufirst%3DD.%2BP.%26aulast%3DShoji%26aufirst%3DM.%26atitle%3DEF24%252C%2520a%2520novel%2520synthetic%2520curcumin%2520analog%252C%2520induces%2520apoptosis%2520in%2520cancer%2520cells%2520via%2520a%2520redox-dependent%2520mechanism%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D2005%26volume%3D16%26spage%3D263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Kasinski, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khuri, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoji, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, H.</span><span> </span><span class="NLM_article-title">Inhibition of IkappaB kinase-nuclear factor-kappaB signaling pathway by 3,5-bis(2-flurobenzylidene)piperidin-4-one (EF24), a novel monoketone analog of curcumin</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">654</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2008&pages=654&author=A.+L.+Kasinskiauthor=Y.+Duauthor=S.+L.+Thomasauthor=J.+Zhaoauthor=S.+Y.+Sunauthor=F.+R.+Khuriauthor=C.+Y.+Wangauthor=M.+Shojiauthor=A.+Sunauthor=J.+P.+Snyderauthor=D.+Liottaauthor=H.+Fu&title=Inhibition+of+IkappaB+kinase-nuclear+factor-kappaB+signaling+pathway+by+3%2C5-bis%282-flurobenzylidene%29piperidin-4-one+%28EF24%29%2C+a+novel+monoketone+analog+of+curcumin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKasinski%26aufirst%3DA.%2BL.%26aulast%3DDu%26aufirst%3DY.%26aulast%3DThomas%26aufirst%3DS.%2BL.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DS.%2BY.%26aulast%3DKhuri%26aufirst%3DF.%2BR.%26aulast%3DWang%26aufirst%3DC.%2BY.%26aulast%3DShoji%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DA.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DLiotta%26aufirst%3DD.%26aulast%3DFu%26aufirst%3DH.%26atitle%3DInhibition%2520of%2520IkappaB%2520kinase-nuclear%2520factor-kappaB%2520signaling%2520pathway%2520by%25203%252C5-bis%25282-flurobenzylidene%2529piperidin-4-one%2520%2528EF24%2529%252C%2520a%2520novel%2520monoketone%2520analog%2520of%2520curcumin%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D74%26spage%3D654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Thomas, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purcell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khuri, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, H.</span><span> </span><span class="NLM_article-title">Activation of the p38 pathway by a novel monoketone curcumin analog, EF24, suggests a potential combination strategy</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">1309</span><span class="NLM_x">–</span> <span class="NLM_lpage">1316</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2010&pages=1309-1316&author=S.+L.+Thomasauthor=J.+Zhaoauthor=Z.+Liauthor=B.+Louauthor=Y.+Duauthor=J.+Purcellauthor=J.+P.+Snyderauthor=F.+R.+Khuriauthor=D.+Liottaauthor=H.+Fu&title=Activation+of+the+p38+pathway+by+a+novel+monoketone+curcumin+analog%2C+EF24%2C+suggests+a+potential+combination+strategy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DS.%2BL.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLou%26aufirst%3DB.%26aulast%3DDu%26aufirst%3DY.%26aulast%3DPurcell%26aufirst%3DJ.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DKhuri%26aufirst%3DF.%2BR.%26aulast%3DLiotta%26aufirst%3DD.%26aulast%3DFu%26aufirst%3DH.%26atitle%3DActivation%2520of%2520the%2520p38%2520pathway%2520by%2520a%2520novel%2520monoketone%2520curcumin%2520analog%252C%2520EF24%252C%2520suggests%2520a%2520potential%2520combination%2520strategy%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2010%26volume%3D80%26spage%3D1309%26epage%3D1316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Olivera, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shim, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcus, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pace, T. W.</span><span> </span><span class="NLM_article-title">Inhibition of the NF-kappaB signaling pathway by the curcumin analog, 3,5-bis(2-pyridinylmethylidene)-4-piperidone (EF31): anti-inflammatory and anti-cancer properties</span> <span class="citation_source-journal">Int. Immunopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">368</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.1016%2Fj.intimp.2011.12.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm4002692&amp;key=22197802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A528%3ADC%252BC38XitVWkt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=368&author=A.+Oliveraauthor=T.+W.+Mooreauthor=F.+Huauthor=A.+P.+Brownauthor=A.+Sunauthor=D.+C.+Liottaauthor=J.+P.+Snyderauthor=Y.+Yoonauthor=H.+Shimauthor=A.+I.+Marcusauthor=A.+H.+Millerauthor=T.+W.+Pace&title=Inhibition+of+the+NF-kappaB+signaling+pathway+by+the+curcumin+analog%2C+3%2C5-bis%282-pyridinylmethylidene%29-4-piperidone+%28EF31%29%3A+anti-inflammatory+and+anti-cancer+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the NF-κB signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): Anti-inflammatory and anti-cancer properties</span></div><div class="casAuthors">Olivera, Anlys; Moore, Terry W.; Hu, Fang; Brown, Andrew P.; Sun, Aiming; Liotta, Dennis C.; Snyder, James P.; Yoon, Younghyoun; Shim, Hyunsuk; Marcus, Adam I.; Miller, Andrew H.; Pace, Thaddeus W. W.</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">368-377</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nuclear factor kappa B (NF-κB) is a key signaling mol. in the elaboration of the inflammatory response.  Data indicate that curcumin, a natural ingredient of the curry spice turmeric, acts as a NF-κB inhibitor and exhibits both anti-inflammatory and anti-cancer properties.  Curcumin analogs with enhanced activity on NF-κB and other inflammatory signaling pathways were developed including the synthetic monoketone compd. 3,5-Bis(2-fluorobenzylidene)-4-piperidone (EF24).  3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31) is a structurally-related curcumin analog whose potency for NF-κB inhibition has yet to be detd.  To examine the activity of EF31 compared to EF24 and curcumin, mouse RAW264.7 macrophages were treated with EF31, EF24, curcumin (1-100 μM), or vehicle (DMSO 1%) for 1 h.  NF-κB pathway activity was assessed following treatment with lipopolysaccharide (LPS) (1 μg/mL).  EF31 (IC50 ∼ 5 μM) exhibited significantly more potent inhibition of LPS-induced NF-κB DNA binding compared to both EF24 (IC50 ∼ 35 μM) and curcumin (IC50 > 50 μM).  In addn., EF31 exhibited greater inhibition of NF-κB nuclear translocation as well as the induction of downstream inflammatory mediators including pro-inflammatory cytokine mRNA and protein (tumor necrosis factor-α, interleukin-1β, and interleukin-6).  Regarding the mechanism of these effects on NF-κB, EF31 (IC50 ∼ 1.92 μM) exhibited significantly greater inhibition of IκB kinase β compared to EF24 (IC50 ∼ 131 μM).  Finally, EF31 demonstrated potent toxicity in NF-κB-dependent cancer cell lines while having minimal and reversible toxicity in RAW264.7 macrophages.  These data indicate that EF31 is a more potent inhibitor of NF-κB activity than either EF24 or curcumin while exhibiting both anti-inflammatory and anticancer activities.  Thus, EF31 represents a promising curcumin analog for further therapeutic development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2ep39PwkqobVg90H21EOLACvtfcHk0liEdFzJQyJG9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitVWkt7c%253D&md5=9c422de1325e9b1d376098f3f9e2d3fe</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2011.12.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2011.12.009%26sid%3Dliteratum%253Aachs%26aulast%3DOlivera%26aufirst%3DA.%26aulast%3DMoore%26aufirst%3DT.%2BW.%26aulast%3DHu%26aufirst%3DF.%26aulast%3DBrown%26aufirst%3DA.%2BP.%26aulast%3DSun%26aufirst%3DA.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DYoon%26aufirst%3DY.%26aulast%3DShim%26aufirst%3DH.%26aulast%3DMarcus%26aufirst%3DA.%2BI.%26aulast%3DMiller%26aufirst%3DA.%2BH.%26aulast%3DPace%26aufirst%3DT.%2BW.%26atitle%3DInhibition%2520of%2520the%2520NF-kappaB%2520signaling%2520pathway%2520by%2520the%2520curcumin%2520analog%252C%25203%252C5-bis%25282-pyridinylmethylidene%2529-4-piperidone%2520%2528EF31%2529%253A%2520anti-inflammatory%2520and%2520anti-cancer%2520properties%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2012%26volume%3D12%26spage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Yamaguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoji, M.</span><span> </span><span class="NLM_article-title">Novel curcumin analogue UBS 109 potently stimulates osteoblastogenesis and suppresses osteoclastogenesis: involvement in Smad activation and NF-κB inhibition</span> <span class="citation_source-journal">Integr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">905</span><span class="NLM_x">–</span> <span class="NLM_lpage">913</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.1039%2Fc2ib20045g" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWntLzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=905-913&author=M.+Yamaguchiauthor=T.+W.+Mooreauthor=A.+Sunauthor=J.+P.+Snyderauthor=M.+Shoji&title=Novel+curcumin+analogue+UBS+109+potently+stimulates+osteoblastogenesis+and+suppresses+osteoclastogenesis%3A+involvement+in+Smad+activation+and+NF-%CE%BAB+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Novel curcumin analogue UBS109 potently stimulates osteoblastogenesis and suppresses osteoclastogenesis: involvement in Smad activation and NF-κB inhibition</span></div><div class="casAuthors">Yamaguchi, Masayoshi; Moore, Terry W.; Sun, Aiming; Snyder, James P.; Shoji, Mamoru</div><div class="citationInfo"><span class="NLM_cas:title">Integrative Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">905-913</span>CODEN:
                <span class="NLM_cas:coden">IBNIFL</span>;
        ISSN:<span class="NLM_cas:issn">1757-9694</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Bone homeostasis is maintained through a balance between osteoblastic bone formation and osteoclastic bone resorption.  Bone loss is induced due to decreased osteoblastic bone formation and increased osteoclastic bone resorption with various pathol. states.  Osteoporosis with its accompanying decrease in bone mass is widely recognized as a major public health problem.  Pharmacol. and functional food factors may play a role in the prevention of bone loss with aging.  This study was undertaken to det. the effect of curcumin analogs (curcumin, EF31, ECMN909, and UBS109), which were newly synthesized, on osteoblastogenesis and osteoclastogenesis in vitro.  Among these compds., UBS109 had a unique stimulatory effect on osteoblastic differentiation and mineralization.  UBS109 stimulated both basal and bone morphogenic protein-2 (BMP2)-increased Smad-luciferase activity, the Smad signaling of which is related to osteoblastogenesis.  Such an effect was not seen with other compds.  Moreover, UBS109 potently suppressed tumor necrosis factor-α (TNF-α)-increased osteoblastic nuclear factor kappa B (NF-κB)-luciferase activity.  In addn., EF31, ECMN909, and UBS109 had a suppressive effect on osteoclastogenesis as compared with that of curcumin.  ECMN909 and UBS109 potently inhibited the receptor activator of NF-κB (RANK) ligand (RANKL)-increased preosteoclastic NF-κB-luciferase activity, in which NF-κB signaling plays a pivotal role in osteoclastogenesis.  In the present study, curcumin analog UBS109 was found to have a stimulating effect on osteoblastogenesis and a suppressive effect on osteoclastogenesis in vitro, suggesting an anabolic effect of the compd. on bone mass.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrq_TFEfPM6ebVg90H21EOLACvtfcHk0liEdFzJQyJG9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWntLzN&md5=67d9d431ae9e41e99bf8237f8dde3eb8</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1039%2Fc2ib20045g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2ib20045g%26sid%3Dliteratum%253Aachs%26aulast%3DYamaguchi%26aufirst%3DM.%26aulast%3DMoore%26aufirst%3DT.%2BW.%26aulast%3DSun%26aufirst%3DA.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DShoji%26aufirst%3DM.%26atitle%3DNovel%2520curcumin%2520analogue%2520UBS%2520109%2520potently%2520stimulates%2520osteoblastogenesis%2520and%2520suppresses%2520osteoclastogenesis%253A%2520involvement%2520in%2520Smad%2520activation%2520and%2520NF-%25CE%25BAB%2520inhibition%26jtitle%3DIntegr.%2520Biol.%26date%3D2012%26volume%3D4%26spage%3D905%26epage%3D913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Landis, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarroll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiddingh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turker, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoatlin, M. E.</span><span> </span><span class="NLM_article-title">Monoketone analogs of curcumin, a new class of potent Fanconi anemia pathway inhibitors</span> <span class="citation_source-journal">Mol. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">133</span><span class="NLM_x">) </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm4002692&amp;key=19128456" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=1-13&issue=133&author=I.+Landisauthor=M.+McCarrollauthor=C.+Yangauthor=A.+Sunauthor=S.+Hiddinghauthor=M.+S.+Turkerauthor=J.+P.+Snyderauthor=M.+E.+Hoatlin&title=Monoketone+analogs+of+curcumin%2C+a+new+class+of+potent+Fanconi+anemia+pathway+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLandis%26aufirst%3DI.%26aulast%3DMcCarroll%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DA.%26aulast%3DHiddingh%26aufirst%3DS.%26aulast%3DTurker%26aufirst%3DM.%2BS.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DHoatlin%26aufirst%3DM.%2BE.%26atitle%3DMonoketone%2520analogs%2520of%2520curcumin%252C%2520a%2520new%2520class%2520of%2520potent%2520Fanconi%2520anemia%2520pathway%2520inhibitors%26jtitle%3DMol.%2520Cancer%26date%3D2009%26volume%3D8%26issue%3D133%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Thomas, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malik, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannakakou, P.</span><span> </span><span class="NLM_article-title">EF24, a novel curcumin analog, disrupts the microtubule cytoskeleton and inhibits HIF-1</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2409</span><span class="NLM_x">–</span> <span class="NLM_lpage">2417</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=2409-2417&author=S.+L.+Thomasauthor=D.+Zhongauthor=W.+Zhouauthor=S.+Malikauthor=D.+Liottaauthor=J.+P.+Snyderauthor=E.+Hamelauthor=P.+Giannakakou&title=EF24%2C+a+novel+curcumin+analog%2C+disrupts+the+microtubule+cytoskeleton+and+inhibits+HIF-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DS.%2BL.%26aulast%3DZhong%26aufirst%3DD.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DMalik%26aufirst%3DS.%26aulast%3DLiotta%26aufirst%3DD.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DGiannakakou%26aufirst%3DP.%26atitle%3DEF24%252C%2520a%2520novel%2520curcumin%2520analog%252C%2520disrupts%2520the%2520microtubule%2520cytoskeleton%2520and%2520inhibits%2520HIF-1%26jtitle%3DCell%2520Cycle%26date%3D2008%26volume%3D7%26spage%3D2409%26epage%3D2417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Zhu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morii, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culver, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrendale, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sica, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khuri, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoji, M.</span><span> </span><span class="NLM_article-title">Synthetic curcumin analog EF31 inhibits the growth of head and neck squamous cell carcinoma xenografts</span> <span class="citation_source-journal">Integr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">633</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.1039%2Fc2ib20007d" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvVOqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=633&author=S.+Zhuauthor=T.+W.+Mooreauthor=X.+Linauthor=N.+Moriiauthor=A.+Manciniauthor=R.+B.+Howardauthor=D.+Culverauthor=R.+F.+Arrendaleauthor=P.+Reddyauthor=T.+J.+Eversauthor=H.+Zhangauthor=G.+Sicaauthor=Z.+G.+Chenauthor=A.+Sunauthor=H.+Fuauthor=F.+R.+Khuriauthor=D.+M.+Shinauthor=J.+P.+Snyderauthor=M.+Shoji&title=Synthetic+curcumin+analog+EF31+inhibits+the+growth+of+head+and+neck+squamous+cell+carcinoma+xenografts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic curcumin analog EF31 inhibits the growth of head and neck squamous cell carcinoma xenografts</span></div><div class="casAuthors">Zhu, Shijun; Moore, Terry W.; Lin, Xiaoqian; Morii, Nao; Mancini, Alessandra; Howard, Randy B.; Culver, Deborah; Arrendale, Richard F.; Reddy, Prabhakar; Evers, Taylor J.; Zhang, Hongzheng; Sica, Gabriel; Chen, Zhuo G.; Sun, Aiming; Fu, Haian; Khuri, Fadlo R.; Shin, Dong M.; Snyder, James P.; Shoji, Mamoru</div><div class="citationInfo"><span class="NLM_cas:title">Integrative Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">633-640</span>CODEN:
                <span class="NLM_cas:coden">IBNIFL</span>;
        ISSN:<span class="NLM_cas:issn">1757-9694</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Objectives are to examine the efficacy, pharmacokinetics, and toxicol. of a synthetic curcumin analog EF31 in head and neck squamous cell carcinoma.  The synthesis of EF31 was described for the first time.  Soly. of EF24 and EF31 was compared using nephelometric anal.  Human head and neck squamous cell carcinoma Tu212 xenograft tumors were established in athymic nude mice and treated with EF31 i.p. once daily five days a week for about 5-6 wk.  The long term effect of EF31 on the NF-κB signaling system in the tumors was examd. by Western blot anal.  EF31 at 25 mg kg-1, i.p. inhibited tumor growth almost completely.  Solubilities of EF24 and EF31 are <10 and 13 μg mL-1 or <32 and 47 μM, resp.  The serum chem. profiles of treated mice were within the limits of normal, they revealed a linear increase of Cmax.  EF31 decreased the level of phosphorylation of NF-κB p65.  In conclusion, the novel synthetic curcumin analog EF31 is efficacious in inhibiting the growth of Tu212 xenograft tumors and may be useful for treating head and neck squamous cell carcinoma.  The long term EF31 treatment inhibited NF-κB p65 phosphorylation in xenografts, implicating downregulation of cancer promoting transcription factors such as angiogenesis and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhDK76kX4njLVg90H21EOLACvtfcHk0lh0UuDJHIISaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvVOqt70%253D&md5=8930c4c94e3baa169179eb876c33e368</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1039%2Fc2ib20007d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2ib20007d%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DMoore%26aufirst%3DT.%2BW.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DMorii%26aufirst%3DN.%26aulast%3DMancini%26aufirst%3DA.%26aulast%3DHoward%26aufirst%3DR.%2BB.%26aulast%3DCulver%26aufirst%3DD.%26aulast%3DArrendale%26aufirst%3DR.%2BF.%26aulast%3DReddy%26aufirst%3DP.%26aulast%3DEvers%26aufirst%3DT.%2BJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DSica%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DZ.%2BG.%26aulast%3DSun%26aufirst%3DA.%26aulast%3DFu%26aufirst%3DH.%26aulast%3DKhuri%26aufirst%3DF.%2BR.%26aulast%3DShin%26aufirst%3DD.%2BM.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DShoji%26aufirst%3DM.%26atitle%3DSynthetic%2520curcumin%2520analog%2520EF31%2520inhibits%2520the%2520growth%2520of%2520head%2520and%2520neck%2520squamous%2520cell%2520carcinoma%2520xenografts%26jtitle%3DIntegr.%2520Biol.%26date%3D2012%26volume%3D4%26spage%3D633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Zhu, S.; Moore, T. W.; Snyder, J. P.; Shoji, M.</span> Manuscript in preparation.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Zhu%2C+S.%3B+Moore%2C+T.+W.%3B+Snyder%2C+J.+P.%3B+Shoji%2C+M.+Manuscript+in+preparation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DS." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span>IPA, Ingenuity Systems, Inc. (1700 Seaport Blvd, 3rd Floor, Redwood City, CA 94063). <a href="http://www.ingenuity.com/" class="extLink">http://www.ingenuity.com/</a> (accessed Sep 20,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=IPA%2C+Ingenuity+Systems%2C+Inc.+%281700+Seaport+Blvd%2C+3rd+Floor%2C+Redwood+City%2C+CA+94063%29.+http%3A%2F%2Fwww.ingenuity.com%2F+%28accessed+Sep+20%2C+2012%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Zhu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morii, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culver, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrendale, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sica, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khuri, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoji, M.</span><span> </span><span class="NLM_article-title">Synthetic curcumin analog EF31 inhibits the growth of head and neck squamous cell carcinoma xenografts</span> <span class="citation_source-journal">Integr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">633</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.1039%2Fc2ib20007d" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvVOqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=633&author=S.+Zhuauthor=T.+W.+Mooreauthor=X.+Linauthor=N.+Moriiauthor=A.+Manciniauthor=R.+B.+Howardauthor=D.+Culverauthor=R.+F.+Arrendaleauthor=P.+Reddyauthor=T.+J.+Eversauthor=H.+Zhangauthor=G.+Sicaauthor=Z.+G.+Chenauthor=A.+Sunauthor=H.+Fuauthor=F.+R.+Khuriauthor=D.+M.+Shinauthor=J.+P.+Snyderauthor=M.+Shoji&title=Synthetic+curcumin+analog+EF31+inhibits+the+growth+of+head+and+neck+squamous+cell+carcinoma+xenografts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic curcumin analog EF31 inhibits the growth of head and neck squamous cell carcinoma xenografts</span></div><div class="casAuthors">Zhu, Shijun; Moore, Terry W.; Lin, Xiaoqian; Morii, Nao; Mancini, Alessandra; Howard, Randy B.; Culver, Deborah; Arrendale, Richard F.; Reddy, Prabhakar; Evers, Taylor J.; Zhang, Hongzheng; Sica, Gabriel; Chen, Zhuo G.; Sun, Aiming; Fu, Haian; Khuri, Fadlo R.; Shin, Dong M.; Snyder, James P.; Shoji, Mamoru</div><div class="citationInfo"><span class="NLM_cas:title">Integrative Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">633-640</span>CODEN:
                <span class="NLM_cas:coden">IBNIFL</span>;
        ISSN:<span class="NLM_cas:issn">1757-9694</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Objectives are to examine the efficacy, pharmacokinetics, and toxicol. of a synthetic curcumin analog EF31 in head and neck squamous cell carcinoma.  The synthesis of EF31 was described for the first time.  Soly. of EF24 and EF31 was compared using nephelometric anal.  Human head and neck squamous cell carcinoma Tu212 xenograft tumors were established in athymic nude mice and treated with EF31 i.p. once daily five days a week for about 5-6 wk.  The long term effect of EF31 on the NF-κB signaling system in the tumors was examd. by Western blot anal.  EF31 at 25 mg kg-1, i.p. inhibited tumor growth almost completely.  Solubilities of EF24 and EF31 are <10 and 13 μg mL-1 or <32 and 47 μM, resp.  The serum chem. profiles of treated mice were within the limits of normal, they revealed a linear increase of Cmax.  EF31 decreased the level of phosphorylation of NF-κB p65.  In conclusion, the novel synthetic curcumin analog EF31 is efficacious in inhibiting the growth of Tu212 xenograft tumors and may be useful for treating head and neck squamous cell carcinoma.  The long term EF31 treatment inhibited NF-κB p65 phosphorylation in xenografts, implicating downregulation of cancer promoting transcription factors such as angiogenesis and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhDK76kX4njLVg90H21EOLACvtfcHk0lh0UuDJHIISaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvVOqt70%253D&md5=8930c4c94e3baa169179eb876c33e368</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1039%2Fc2ib20007d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2ib20007d%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DMoore%26aufirst%3DT.%2BW.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DMorii%26aufirst%3DN.%26aulast%3DMancini%26aufirst%3DA.%26aulast%3DHoward%26aufirst%3DR.%2BB.%26aulast%3DCulver%26aufirst%3DD.%26aulast%3DArrendale%26aufirst%3DR.%2BF.%26aulast%3DReddy%26aufirst%3DP.%26aulast%3DEvers%26aufirst%3DT.%2BJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DSica%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DZ.%2BG.%26aulast%3DSun%26aufirst%3DA.%26aulast%3DFu%26aufirst%3DH.%26aulast%3DKhuri%26aufirst%3DF.%2BR.%26aulast%3DShin%26aufirst%3DD.%2BM.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DShoji%26aufirst%3DM.%26atitle%3DSynthetic%2520curcumin%2520analog%2520EF31%2520inhibits%2520the%2520growth%2520of%2520head%2520and%2520neck%2520squamous%2520cell%2520carcinoma%2520xenografts%26jtitle%3DIntegr.%2520Biol.%26date%3D2012%26volume%3D4%26spage%3D633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craigen, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, D. J.</span><span> </span><span class="NLM_article-title">Nek1 regulates cell death and mitochondrial membrane permeability through phosphorylation of VDAC1</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=257&author=Y.+Chenauthor=W.+J.+Craigenauthor=D.+J.+Riley&title=Nek1+regulates+cell+death+and+mitochondrial+membrane+permeability+through+phosphorylation+of+VDAC1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DCraigen%26aufirst%3DW.%2BJ.%26aulast%3DRiley%26aufirst%3DD.%2BJ.%26atitle%3DNek1%2520regulates%2520cell%2520death%2520and%2520mitochondrial%2520membrane%2520permeability%2520through%2520phosphorylation%2520of%2520VDAC1%26jtitle%3DCell%2520Cycle%26date%3D2009%26volume%3D8%26spage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Sa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, T.</span><span> </span><span class="NLM_article-title">Anti cancer effects of curcumin: cycle of life and death</span> <span class="citation_source-journal">Cell Div.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">14</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.1186%2F1747-1028-3-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm4002692&amp;key=18834508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A280%3ADC%252BD1cnot1KntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=14&author=G.+Saauthor=T.+Das&title=Anti+cancer+effects+of+curcumin%3A+cycle+of+life+and+death"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Anti cancer effects of curcumin: cycle of life and death</span></div><div class="casAuthors">Sa Gaurisankar; Das Tanya</div><div class="citationInfo"><span class="NLM_cas:title">Cell division</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">14</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract"> Increasing knowledge on the cell cycle deregulations in cancers has promoted the introduction of phytochemicals, which can either modulate signaling pathways leading to cell cycle regulation or directly alter cell cycle regulatory molecules, in cancer therapy.  Most human malignancies are driven by chromosomal translocations or other genetic alterations that directly affect the function of critical cell cycle proteins such as cyclins as well as tumor suppressors, e.g., p53.  In this respect, cell cycle regulation and its modulation by curcumin are gaining widespread attention in recent years.  Extensive research has addressed the chemotherapeutic potential of curcumin (diferuloylmethane), a relatively non-toxic plant derived polyphenol.  The mechanisms implicated are diverse and appear to involve a combination of cell signaling pathways at multiple levels.  In the present review we discuss how alterations in the cell cycle control contribute to the malignant transformation and provide an overview of how curcumin targets cell cycle regulatory molecules to assert anti-proliferative and/or apoptotic effects in cancer cells.  The purpose of the current article is to present an appraisal of the current level of knowledge regarding the potential of curcumin as an agent for the chemoprevention of cancer via an understanding of its mechanism of action at the level of cell cycle regulation.  Taken together, this review seeks to summarize the unique properties of curcumin that may be exploited for successful clinical cancer prevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRvj4eQtgbgB9NTrvPZP1IpfW6udTcc2eaZMnvJGQk_Drntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cnot1KntQ%253D%253D&md5=550176cb9633822d465928f653b994ad</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1186%2F1747-1028-3-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1747-1028-3-14%26sid%3Dliteratum%253Aachs%26aulast%3DSa%26aufirst%3DG.%26aulast%3DDas%26aufirst%3DT.%26atitle%3DAnti%2520cancer%2520effects%2520of%2520curcumin%253A%2520cycle%2520of%2520life%2520and%2520death%26jtitle%3DCell%2520Div.%26date%3D2008%26volume%3D3%26spage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span>GraphPad Software, Inc., 2236 Avenida de la Playa, La Jolla, CA 92037, U.S.; <a href="http://www.graphpad.com/" class="extLink">http://www.graphpad.com/</a> (accessed Sep 20,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=GraphPad+Software%2C+Inc.%2C+2236+Avenida+de+la+Playa%2C+La+Jolla%2C+CA+92037%2C+U.S.%3B+http%3A%2F%2Fwww.graphpad.com%2F+%28accessed+Sep+20%2C+2012%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="note"><p class="first last">Global analysis is a nonlinear regression treatment for multiple curves corresponding to different inhibitor concentrations. The <i>K</i><sub>m</sub>, <i>V</i><sub>max</sub>, and <i>K</i><sub>i</sub> parameters for each curve are adjusted for the best global fit of the data using GraphicPad<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> but constrained to the same value for each curve. Thus, for example, the resulting <i>V</i><sub>max</sub> in a competitive model is forced to be shared across all curves.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="note"><p class="first last">The parameter α derived from the global analysis of the data in GraphPad Prism<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> differs from the similarly named variables α and α′ in the classic Michaelis–Menten equations.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><div class="note"><p class="first last">Compound <b>3</b> has also been shown to exhibit reversibility by the NMR method of Appendino et al.:<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></p></div><span class="NLM_contrib-group">Moore, T.; Snyder, J. P.</span> Unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Compound+3+has+also+been+shown+to+exhibit+reversibility+by+the+NMR+method+of+Appendino+et+al.%3A%2817%29Moore%2C+T.%3B+Snyder%2C+J.+P.+Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DT." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niwa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirata, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noyori, R.</span><span> </span><span class="NLM_article-title">Chemical implications for antitumor and antiviral prostaglandins: reaction of Δ7-prostaglandin A1 and prostaglandin A1 methyl esters with thiols</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">2376</span><span class="NLM_x">–</span> <span class="NLM_lpage">2385</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja9628359" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1997&pages=2376-2385&author=M.+Suzukiauthor=M.+Moriauthor=T.+Niwaauthor=R.+Hirataauthor=K.+Furutaauthor=T.+Ishikawaauthor=R.+Noyori&title=Chemical+implications+for+antitumor+and+antiviral+prostaglandins%3A+reaction+of+%CE%947-prostaglandin+A1+and+prostaglandin+A1+methyl+esters+with+thiols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fja9628359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9628359%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DMori%26aufirst%3DM.%26aulast%3DNiwa%26aufirst%3DT.%26aulast%3DHirata%26aufirst%3DR.%26aulast%3DFuruta%26aufirst%3DK.%26aulast%3DIshikawa%26aufirst%3DT.%26aulast%3DNoyori%26aufirst%3DR.%26atitle%3DChemical%2520implications%2520for%2520antitumor%2520and%2520antiviral%2520prostaglandins%253A%2520reaction%2520of%2520%25CE%25947-prostaglandin%2520A1%2520and%2520prostaglandin%2520A1%2520methyl%2520esters%2520with%2520thiols%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1997%26volume%3D119%26spage%3D2376%26epage%3D2385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Yamakoshi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanoh, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muroi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satake, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohori, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishioka, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oshima, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiba, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwabuchi, Y.</span><span> </span><span class="NLM_article-title">KSRP/FUBP2 is a binding protein of GO-Y086, a cytotoxic curcumin analogue</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">–</span> <span class="NLM_lpage">276</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml1000454" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=273-276&author=H.+Yamakoshiauthor=N.+Kanohauthor=C.+Kudoauthor=A.+Satoauthor=K.+Uedaauthor=M.+Muroiauthor=S.+Konauthor=M.+Satakeauthor=H.+Ohoriauthor=C.+Ishiokaauthor=Y.+Oshimaauthor=H.+Osadaauthor=N.+Chibaauthor=H.+Shibataauthor=Y.+Iwabuchi&title=KSRP%2FFUBP2+is+a+binding+protein+of+GO-Y086%2C+a+cytotoxic+curcumin+analogue"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fml1000454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml1000454%26sid%3Dliteratum%253Aachs%26aulast%3DYamakoshi%26aufirst%3DH.%26aulast%3DKanoh%26aufirst%3DN.%26aulast%3DKudo%26aufirst%3DC.%26aulast%3DSato%26aufirst%3DA.%26aulast%3DUeda%26aufirst%3DK.%26aulast%3DMuroi%26aufirst%3DM.%26aulast%3DKon%26aufirst%3DS.%26aulast%3DSatake%26aufirst%3DM.%26aulast%3DOhori%26aufirst%3DH.%26aulast%3DIshioka%26aufirst%3DC.%26aulast%3DOshima%26aufirst%3DY.%26aulast%3DOsada%26aufirst%3DH.%26aulast%3DChiba%26aufirst%3DN.%26aulast%3DShibata%26aufirst%3DH.%26aulast%3DIwabuchi%26aufirst%3DY.%26atitle%3DKSRP%252FFUBP2%2520is%2520a%2520binding%2520protein%2520of%2520GO-Y086%252C%2520a%2520cytotoxic%2520curcumin%2520analogue%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D273%26epage%3D276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Serafimova, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pufall, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maglathlin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFarland, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frodin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taunton, J.</span><span> </span><span class="NLM_article-title">Reversible targeting of noncatalytic cysteines with chemically tuned electrophiles</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">471</span><span class="NLM_x">–</span> <span class="NLM_lpage">476</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.1038%2Fnchembio.925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm4002692&amp;key=22466421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvVKitrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=471-476&author=I.+M.+Serafimovaauthor=M.+A.+Pufallauthor=S.+Krishnanauthor=K.+Dudaauthor=M.+S.+Cohenauthor=R.+L.+Maglathlinauthor=J.+M.+McFarlandauthor=R.+M.+Millerauthor=M.+Frodinauthor=J.+Taunton&title=Reversible+targeting+of+noncatalytic+cysteines+with+chemically+tuned+electrophiles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Reversible targeting of noncatalytic cysteines with chemically tuned electrophiles</span></div><div class="casAuthors">Serafimova, Iana M.; Pufall, Miles A.; Krishnan, Shyam; Duda, Katarzyna; Cohen, Michael S.; Maglathlin, Rebecca L.; McFarland, Jesse M.; Miller, Rand M.; Froedin, Morten; Taunton, Jack</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">471-476</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Targeting noncatalytic cysteine residues with irreversible acrylamide-based inhibitors is a powerful approach for enhancing pharmacol. potency and selectivity.  Nevertheless, concerns about off-target modification motivate the development of reversible cysteine-targeting strategies.  Here we show that electron-deficient olefins, including acrylamides, can be tuned to react with cysteine thiols in a rapidly reversible manner.  Installation of a nitrile group increased the olefins' intrinsic reactivity, but, paradoxically, eliminated the formation of irreversible adducts.  Incorporation of these electrophiles into a noncovalent kinase-recognition scaffold produced slowly dissocg., covalent inhibitors of the p90 ribosomal protein S6 kinase RSK2.  A cocrystal structure revealed specific noncovalent interactions that stabilize the complex by positioning the electrophilic carbon near the targeted cysteine.  Disruption of these interactions by protein unfolding or proteolysis promoted instantaneous cleavage of the covalent bond.  Our results establish a chem.-based framework for engineering sustained covalent inhibition without accumulating permanently modified proteins and peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlcv3GjPOB6rVg90H21EOLACvtfcHk0liEtbp7OxmWQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvVKitrw%253D&md5=6455a9a029714beb317286f71ac1326b</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.925%26sid%3Dliteratum%253Aachs%26aulast%3DSerafimova%26aufirst%3DI.%2BM.%26aulast%3DPufall%26aufirst%3DM.%2BA.%26aulast%3DKrishnan%26aufirst%3DS.%26aulast%3DDuda%26aufirst%3DK.%26aulast%3DCohen%26aufirst%3DM.%2BS.%26aulast%3DMaglathlin%26aufirst%3DR.%2BL.%26aulast%3DMcFarland%26aufirst%3DJ.%2BM.%26aulast%3DMiller%26aufirst%3DR.%2BM.%26aulast%3DFrodin%26aufirst%3DM.%26aulast%3DTaunton%26aufirst%3DJ.%26atitle%3DReversible%2520targeting%2520of%2520noncatalytic%2520cysteines%2520with%2520chemically%2520tuned%2520electrophiles%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2012%26volume%3D8%26spage%3D471%26epage%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Lee, C.-U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossmann, T. N.</span><span> </span><span class="NLM_article-title">Reversible covalent inhibition of a protein target</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">8699</span><span class="NLM_x">–</span> <span class="NLM_lpage">8700</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.1002%2Fanie.201203341" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVehtLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=8699-8700&author=C.-U.+Leeauthor=T.+N.+Grossmann&title=Reversible+covalent+inhibition+of+a+protein+target"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Reversible covalent inhibition of a protein target</span></div><div class="casAuthors">Lee, Chang-Uk; Grossmann, Tom N.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">8699-8700</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Electron-deficient Michael acceptors can be used in reversible addn./elimination reactions with thiols.  These electrophiles have been used by J. Taunton and colleagues [M. S. Cohen et al. (2005)] to convert a known irreversible protein kinase inhibitor into a covalent reversible inhibitor.  Such an approach might provide high-affinity binders with increased selectivity without the toxicol. risks assocd. with irreversible protein modifications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8c9MUbShnWLVg90H21EOLACvtfcHk0lgptzOHHFspdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVehtLrM&md5=af55c6ca399146709faaaf23532b784a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fanie.201203341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201203341%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DC.-U.%26aulast%3DGrossmann%26aufirst%3DT.%2BN.%26atitle%3DReversible%2520covalent%2520inhibition%2520of%2520a%2520protein%2520target%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26spage%3D8699%26epage%3D8700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Targeting cancer with small molecule kinase inhibitors</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.1038%2Fnrc2559" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm4002692&amp;key=19104514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1yg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=28-39&author=J.+Zhangauthor=P.+L.+Yangauthor=N.+S.+Gray&title=Targeting+cancer+with+small+molecule+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cancer with small molecule kinase inhibitors</span></div><div class="casAuthors">Zhang, Jianming; Yang, Priscilla L.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-39</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Deregulation of kinase activity has emerged as a major mechanism by which cancer cells evade normal physiol. constraints on growth and survival.  To date, 11 kinase inhibitors have received US Food and Drug Administration approval as cancer treatments, and there are considerable efforts to develop selective small mol. inhibitors for a host of other kinases that are implicated in cancer and other diseases.  Herein we discuss the current challenges in the field, such as designing selective inhibitors and developing strategies to overcome resistance mutations.  This Review provides a broad overview of some of the approaches currently used to discover and characterize new kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriSM3BN_uEz7Vg90H21EOLACvtfcHk0lgptzOHHFspdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1yg&md5=35bc38f414cd21eef5e61ce181b580fb</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fnrc2559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2559%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DP.%2BL.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DTargeting%2520cancer%2520with%2520small%2520molecule%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26spage%3D28%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Hu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span> </span><span class="NLM_article-title">Models for predicting IKKA and IKKB blockade</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">310</span><span class="NLM_x">–</span> <span class="NLM_lpage">3199</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=310-3199&author=H.+Huauthor=J.+P.+Snyder&title=Models+for+predicting+IKKA+and+IKKB+blockade"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DH.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26atitle%3DModels%2520for%2520predicting%2520IKKA%2520and%2520IKKB%2520blockade%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2012%26volume%3D52%26spage%3D310%26epage%3D3199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Yang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.-D.</span><span> </span><span class="NLM_article-title">Targeting the BMK1 MAP kinase pathway in cancer therapy</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3527</span><span class="NLM_x">–</span> <span class="NLM_lpage">3532</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.1158%2F1078-0432.CCR-10-2504" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm4002692&amp;key=21385929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvFCqtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=3527-3532&author=Q.+Yangauthor=J.-D.+Lee&title=Targeting+the+BMK1+MAP+kinase+pathway+in+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the BMK1 MAP Kinase Pathway in Cancer Therapy</span></div><div class="casAuthors">Yang, Qingkai; Lee, Jiing-Dwan</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3527-3532</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  The big mitogen activated protein kinase 1 (BMK1) pathway is the most recently discovered and least-studied mammalian mitogen-activated protein (MAP) kinase cascade, ubiquitously expressed in all types of cancer cells tested so far.  Mitogens and oncogenic signals strongly activate this cellular MAP kinase pathway, thereby passing down proliferative, survival, chemoresistance, invasive, and angiogenic signals in tumor cells.  Recently, several pharmacol. small mol. inhibitors of this pathway have been developed.  Among them, the BMK1 inhibitor XMD8-92 blocks cellular BMK1 activation and significantly suppresses tumor growth in lung and cervical tumor models and is well tolerated in animals.  On the other hand, MEK5 inhibitors, BIX02188, BIX02189, and compd. 6, suppress cellular MEK5 activity, but no data exist to date on their effectiveness in animals.  Clin Cancer Res; 17(11); 3527-32.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWXXWpsDjbRbVg90H21EOLACvtfcHk0lgptzOHHFspdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvFCqtbY%253D&md5=33b8e8f71e4406a50a4ebc216e008989</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-10-2504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-10-2504%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DLee%26aufirst%3DJ.-D.%26atitle%3DTargeting%2520the%2520BMK1%2520MAP%2520kinase%2520pathway%2520in%2520cancer%2520therapy%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2011%26volume%3D17%26spage%3D3527%26epage%3D3532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheffler, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroeze, W. K.</span><span> </span><span class="NLM_article-title">Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.1038%2Fnrd1346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm4002692&amp;key=15060530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A528%3ADC%252BD2cXis1Gkt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=353&author=B.+L.+Rothauthor=D.+J.+Shefflerauthor=W.+K.+Kroeze&title=Magic+shotguns+versus+magic+bullets%3A+selectively+non-selective+drugs+for+mood+disorders+and+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia</span></div><div class="casAuthors">Roth, Bryan L.; Sheffler, Douglas J.; Kroeze, Wesley K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">353-359</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Most common central nervous system disorders - such as depression, bipolar disorder, and schizophrenia - seem to be polygenic in origin, and the most effective medications have exceedingly complex pharmacologies.  Attempts to develop more effective treatments for diseases such as schizophrenia and depression by discovering drugs selective for single mol. targets (i.e., 'magic bullets') have, not surprisingly, been largely unsuccessful.  Here the authors propose that designing selectively non-selective drugs (i.e., 'magic shotguns') that interact with several mol. targets will lead to new and more effective medications for a variety of central nervous system disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnSsuUXzmbirVg90H21EOLACvtfcHk0lgptzOHHFspdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXis1Gkt78%253D&md5=77196583acccca65457fec7a67218463</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2Fnrd1346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1346%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DSheffler%26aufirst%3DD.%2BJ.%26aulast%3DKroeze%26aufirst%3DW.%2BK.%26atitle%3DMagic%2520shotguns%2520versus%2520magic%2520bullets%253A%2520selectively%2520non-selective%2520drugs%2520for%2520mood%2520disorders%2520and%2520schizophrenia%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Fojo, T.</span><span> </span><span class="NLM_article-title">Commentary: Novel therapies for cancer: why dirty might be better</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=277&author=T.+Fojo&title=Commentary%3A+Novel+therapies+for+cancer%3A+why+dirty+might+be+better"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFojo%26aufirst%3DT.%26atitle%3DCommentary%253A%2520Novel%2520therapies%2520for%2520cancer%253A%2520why%2520dirty%2520might%2520be%2520better%26jtitle%3DOncologist%26date%3D2008%26volume%3D13%26spage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span> </span><span class="NLM_article-title">Drug discovery: predicting promiscuity</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">462</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.1038%2F462167a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm4002692&amp;key=19907483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVSjsrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=462&publication_year=2009&pages=167&author=A.+L.+Hopkins&title=Drug+discovery%3A+predicting+promiscuity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Drug discovery: Predicting promiscuity</span></div><div class="casAuthors">Hopkins, Andrew L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">462</span>
        (<span class="NLM_cas:issue">7270</span>),
    <span class="NLM_cas:pages">167-168</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Computational methods that reliably predict the biol. activities of compds. have long been sought.  The validation of one such method suggests that in silico predictions for drug discovery have come of age.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQeKOdE7MUxLVg90H21EOLACvtfcHk0lhhKDx-aU_xjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVSjsrnI&md5=d7a2f49900632ba698ed3790f3b3c4d5</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1038%2F462167a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F462167a%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26atitle%3DDrug%2520discovery%253A%2520predicting%2520promiscuity%26jtitle%3DNature%26date%3D2009%26volume%3D462%26spage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">von Eichborn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murgueitio, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunkel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koerner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourne, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preissner, R.</span><span> </span><span class="NLM_article-title">PROMISCUOUS: a database for network-based drug-repositioning</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">D1060</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=D1060&author=J.+von+Eichbornauthor=M.+S.+Murgueitioauthor=M.+Dunkelauthor=S.+Koernerauthor=P.+E.+Bourneauthor=R.+Preissner&title=PROMISCUOUS%3A+a+database+for+network-based+drug-repositioning"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvon%2BEichborn%26aufirst%3DJ.%26aulast%3DMurgueitio%26aufirst%3DM.%2BS.%26aulast%3DDunkel%26aufirst%3DM.%26aulast%3DKoerner%26aufirst%3DS.%26aulast%3DBourne%26aufirst%3DP.%2BE.%26aulast%3DPreissner%26aufirst%3DR.%26atitle%3DPROMISCUOUS%253A%2520a%2520database%2520for%2520network-based%2520drug-repositioning%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2011%26volume%3D39%26spage%3DD1060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Lee, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. Y. J.</span><span> </span><span class="NLM_article-title">Exploiting the promiscuity of imatinib</span> <span class="citation_source-journal">J. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">30.1</span><span class="NLM_x">–</span> <span class="NLM_lpage">30.4</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=30.1-30.4&author=S.+J.+Leeauthor=J.+Y.+J.+Wang&title=Exploiting+the+promiscuity+of+imatinib"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DWang%26aufirst%3DJ.%2BY.%2BJ.%26atitle%3DExploiting%2520the%2520promiscuity%2520of%2520imatinib%26jtitle%3DJ.%2520Biol.%26date%3D2009%26volume%3D8%26spage%3D30.1%26epage%3D30.4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><a href="http://en.wikipedia.org/wiki/Imatinib" class="extLink">http://en.wikipedia.org/wiki/Imatinib</a> (accessed Sep 21,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fen.wikipedia.org%2Fwiki%2FImatinib+%28accessed+Sep+21%2C+2012%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overington, J. P.</span><span> </span><span class="NLM_article-title">Can we rationally design promiscuous drugs?</span> <span class="citation_source-journal">Curr. Opin. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.1016%2Fj.sbi.2006.01.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm4002692&amp;key=16442279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFOjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=127-136&author=A.+L.+Hopkinsauthor=J.+S.+Masonauthor=J.+P.+Overington&title=Can+we+rationally+design+promiscuous+drugs%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Can we rationally design promiscuous drugs?</span></div><div class="casAuthors">Hopkins, Andrew L.; Mason, Jonathan S.; Overington, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Structural Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-136</span>CODEN:
                <span class="NLM_cas:coden">COSBEF</span>;
        ISSN:<span class="NLM_cas:issn">0959-440X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Structure-based drug design is now used widely in modern medicinal chem.  The application of structural biol. to medicinal chem. has heralded the 'rational drug design' vision of discovering exquisitely selective ligands.  However, recent advances in post-genomic biol. are indicating that polypharmacol. may be a necessary trait for the efficacy of many drugs, therefore questioning the 'one drug, one target' assumption of current rational drug design.  By combining advances in chemoinformatics and structural biol., it might be possible to rationally design the next generation of promiscuous drugs with polypharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQWdh60x9AHrVg90H21EOLACvtfcHk0lhhKDx-aU_xjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFOjsrc%253D&md5=8f9e95a41976b8e3ac790f2fff2c406f</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.sbi.2006.01.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.sbi.2006.01.013%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DMason%26aufirst%3DJ.%2BS.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26atitle%3DCan%2520we%2520rationally%2520design%2520promiscuous%2520drugs%253F%26jtitle%3DCurr.%2520Opin.%2520Struct.%2520Biol.%26date%3D2006%26volume%3D16%26spage%3D127%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Besnard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruda, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setola, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abecassis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguiz, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norval1, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sassano, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simeons, F. R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stojanovski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidah, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Constam, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bickerton, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetsel, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, I. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, A. L.</span><span> </span><span class="NLM_article-title">Automated design of ligands to polypharmacological profiles</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">492</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">222</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm4002692&amp;key=10.1038%2Fnature11691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm4002692&amp;key=23235874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVamurfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=492&publication_year=2012&pages=215-222&author=J.+Besnardauthor=G.+F.+Rudaauthor=V.+Setolaauthor=K.+Abecassisauthor=R.+M.+Rodriguizauthor=X.-P.+Huangauthor=S.+Norval1author=M.+F.+Sassanoauthor=A.+I.+Shinauthor=L.+A.+Websterauthor=F.+R.+C.+Simeonsauthor=L.+Stojanovskiauthor=A.+Pratauthor=N.+G.+Seidahauthor=D.+B.+Constamauthor=G.+R.+Bickertonauthor=K.+D.+Readauthor=W.+C.+Wetselauthor=I.+H.+Gilbertauthor=B.+L.+Rothauthor=A.+L.+Hopkins&title=Automated+design+of+ligands+to+polypharmacological+profiles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Automated design of ligands to polypharmacological profiles</span></div><div class="casAuthors">Besnard, Jeremy; Ruda, Gian Filippo; Setola, Vincent; Abecassis, Keren; Rodriguiz, Ramona M.; Huang, Xi-Ping; Norval, Suzanne; Sassano, Maria F.; Shin, Antony I.; Webster, Lauren A.; Simeons, Frederick R. C.; Stojanovski, Laste; Prat, Annik; Seidah, Nabil G.; Constam, Daniel B.; Bickerton, G. Richard; Read, Kevin D.; Wetsel, William C.; Gilbert, Ian H.; Roth, Bryan L.; Hopkins, Andrew L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">492</span>
        (<span class="NLM_cas:issue">7428</span>),
    <span class="NLM_cas:pages">215-220</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The clin. efficacy and safety of a drug is detd. by its activity profile across many proteins in the proteome.  However, designing drugs with a specific multi-target profile is both complex and difficult.  Therefore methods to design drugs rationally a priori against profiles of several proteins would have immense value in drug discovery.  Here is described a new approach for the automated design of ligands against profiles of multiple drug targets.  The method is demonstrated by the evolution of an approved acetylcholinesterase inhibitor drug donepezil (I) into brain-penetrable ligands with either specific polypharmacol. or exquisite selectivity profiles for G-protein-coupled receptors.  Overall, 800 ligand-target predictions of prospectively designed ligands were tested exptl., of which 75% were confirmed to be correct.  Target engagement in vivo is also demonstrated.  The approach can be a useful source of drug leads when multi-target profiles are required to achieve either selectivity over other drug targets or a desired polypharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNu5bwrBD3tbVg90H21EOLACvtfcHk0lhLXcld4kuGFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVamurfN&md5=ace6cced250cf968d327b482a5bf1798</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1038%2Fnature11691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11691%26sid%3Dliteratum%253Aachs%26aulast%3DBesnard%26aufirst%3DJ.%26aulast%3DRuda%26aufirst%3DG.%2BF.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DAbecassis%26aufirst%3DK.%26aulast%3DRodriguiz%26aufirst%3DR.%2BM.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DNorval1%26aufirst%3DS.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DShin%26aufirst%3DA.%2BI.%26aulast%3DWebster%26aufirst%3DL.%2BA.%26aulast%3DSimeons%26aufirst%3DF.%2BR.%2BC.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DPrat%26aufirst%3DA.%26aulast%3DSeidah%26aufirst%3DN.%2BG.%26aulast%3DConstam%26aufirst%3DD.%2BB.%26aulast%3DBickerton%26aufirst%3DG.%2BR.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DWetsel%26aufirst%3DW.%2BC.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26atitle%3DAutomated%2520design%2520of%2520ligands%2520to%2520polypharmacological%2520profiles%26jtitle%3DNature%26date%3D2012%26volume%3D492%26spage%3D215%26epage%3D222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><a href="http://www.discoverx.com/kinases/adp-quest_adp-quest-hs.php" class="extLink">http://www.discoverx.com/kinases/adp-quest_adp-quest-hs.php</a> (accessed Sep 21,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.discoverx.com%2Fkinases%2Fadp-quest_adp-quest-hs.php+%28accessed+Sep+21%2C+2012%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><a href="http://www.millipore.com/catalogue/item/12-331" class="extLink">http://www.millipore.com/catalogue/item/12-331</a> (accessed Sep 21,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.millipore.com%2Fcatalogue%2Fitem%2F12-331+%28accessed+Sep+21%2C+2012%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><a href="http://www.invitrogen.com/site/us/en/home/Products-and-Services/Applications/Drug-Discovery/Target-and-Lead-Identification-and-Validation/KinaseBiology/Kinase-Activity-Assays/Z-LYTE.html?CID=fl-zlyte" class="extLink">http://www.invitrogen.com/site/us/en/home/Products-and-Services/Applications/Drug-Discovery/Target-and-Lead-Identification-and-Validation/KinaseBiology/Kinase-Activity-Assays/Z-LYTE.html?CID=fl-zlyte</a> (accessed Sep 21,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.invitrogen.com%2Fsite%2Fus%2Fen%2Fhome%2FProducts-and-Services%2FApplications%2FDrug-Discovery%2FTarget-and-Lead-Identification-and-Validation%2FKinaseBiology%2FKinase-Activity-Assays%2FZ-LYTE.html%3FCID%3Dfl-zlyte+%28accessed+Sep+21%2C+2012%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><a href="http://www.invitrogen.com/site/us/en/home/Products-and-Services/Services/custom-services/Screening-and-Profiling-Services/SelectScreen-Profiling-Service/SelectScreen-Kinase-Profiling-Service.html" class="extLink">http://www.invitrogen.com/site/us/en/home/Products-and-Services/Services/custom-services/Screening-and-Profiling-Services/SelectScreen-Profiling-Service/SelectScreen-Kinase-Profiling-Service.html</a> (accessed Sep 21,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.invitrogen.com%2Fsite%2Fus%2Fen%2Fhome%2FProducts-and-Services%2FServices%2Fcustom-services%2FScreening-and-Profiling-Services%2FSelectScreen-Profiling-Service%2FSelectScreen-Kinase-Profiling-Service.html+%28accessed+Sep+21%2C+2012%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Khopde, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priyadarsini, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palit, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukherjee, T.</span><span> </span><span class="NLM_article-title">Effect of solvent on the excited-state photophysical properties of curcumin</span> <span class="citation_source-journal">Photochem. Photobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">625</span><span class="NLM_x">–</span> <span class="NLM_lpage">631</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2000&pages=625-631&author=S.+M.+Khopdeauthor=K.+I.+Priyadarsiniauthor=D.+K.+Palitauthor=T.+Mukherjee&title=Effect+of+solvent+on+the+excited-state+photophysical+properties+of+curcumin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKhopde%26aufirst%3DS.%2BM.%26aulast%3DPriyadarsini%26aufirst%3DK.%2BI.%26aulast%3DPalit%26aufirst%3DD.%2BK.%26aulast%3DMukherjee%26aufirst%3DT.%26atitle%3DEffect%2520of%2520solvent%2520on%2520the%2520excited-state%2520photophysical%2520properties%2520of%2520curcumin%26jtitle%3DPhotochem.%2520Photobiol.%26date%3D2000%26volume%3D72%26spage%3D625%26epage%3D631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span> <span class="citation_source-book">Maestro</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span><a href="http://www.schrodinger.com/products/14/12/" class="extLink">http://www.schrodinger.com/products/14/12/</a> (accessed Sep 20,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Maestro%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2009%3B+http%3A%2F%2Fwww.schrodinger.com%2Fproducts%2F14%2F12%2F+%28accessed+Sep+20%2C+2012%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMaestro%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2009%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61a"><span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halgren, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klicic, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainz, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repasky, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knoll, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenkin, P. S.</span><span> </span><span class="NLM_article-title">Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1739</span><span class="NLM_x">–</span> <span class="NLM_lpage">1749</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0306430" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61a&amp;dbid=32&amp;doi=10.1021%2Fjm4002692&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1739-1749&author=R.+A.+Friesnerauthor=J.+L.+Banksauthor=R.+B.+Murphyauthor=T.+A.+Halgrenauthor=J.+J.+Klicicauthor=D.+T.+Mainzauthor=M.+P.+Repaskyauthor=E.+H.+Knollauthor=D.+E.+Shawauthor=M.+Shelleyauthor=J.+K.+Perryauthor=P.+Francisauthor=P.+S.+Shenkin&title=Glide%3A+a+new+approach+for+rapid%2C+accurate+docking+and+scoring.+1.+Method+and+assessment+of+docking+accuracy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61aR"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy</span></div><div class="casAuthors">Friesner, Richard A.; Banks, Jay L.; Murphy, Robert B.; Halgren, Thomas A.; Klicic, Jasna J.; Mainz, Daniel T.; Repasky, Matthew P.; Knoll, Eric H.; Shelley, Mee; Perry, Jason K.; Shaw, David E.; Francis, Perry; Shenkin, Peter S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1739-1749</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Unlike other methods for docking ligands to the rigid 3D structure of a known protein receptor, Glide approximates a complete systematic search of the conformational, orientational, and positional space of the docked ligand.  In this search, an initial rough positioning and scoring phase that dramatically narrows the search space is followed by torsionally flexible energy optimization on an OPLS-AA nonbonded potential grid for a few hundred surviving candidate poses.  The very best candidates are further refined via a Monte Carlo sampling of pose conformation; in some cases, this is crucial to obtaining an accurate docked pose.  Selection of the best docked pose uses a model energy function that combines empirical and force-field-based terms.  Docking accuracy is assessed by redocking ligands from 282 cocrystd. PDB complexes starting from conformationally optimized ligand geometries that bear no memory of the correctly docked pose.  Errors in geometry for the top-ranked pose are less than 1 Å in nearly half of the cases and are greater than 2 Å in only about one-third of them.  Comparisons to published data on rms deviations show that Glide is nearly twice as accurate as GOLD and more than twice as accurate as FlexX for ligands having up to 20 rotatable bonds.  Glide is also found to be more accurate than the recently described Surflex method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPuigu31qMMLVg90H21EOLACvtfcHk0lhLXcld4kuGFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D&md5=8cc2f0022318b12dd972e9c493375bf9</span></div><a href="/servlet/linkout?suffix=cit61a&amp;dbid=16384&amp;doi=10.1021%2Fjm0306430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0306430%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DKlicic%26aufirst%3DJ.%2BJ.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DKnoll%26aufirst%3DE.%2BH.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DShelley%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DFrancis%26aufirst%3DP.%26aulast%3DShenkin%26aufirst%3DP.%2BS.%26atitle%3DGlide%253A%2520a%2520new%2520approach%2520for%2520rapid%252C%2520accurate%2520docking%2520and%2520scoring.%25201.%2520Method%2520and%2520assessment%2520of%2520docking%2520accuracy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1739%26epage%3D1749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit61b"><span>Schrödinger, LLC, New York, NY: <a href="http://www.schrodinger.com/products/14/5/" class="extLink">http://www.schrodinger.com/products/14/5/</a> (accessed Sep 20,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Schr%C3%B6dinger%2C+LLC%2C+New+York%2C+NY%3A+http%3A%2F%2Fwww.schrodinger.com%2Fproducts%2F14%2F5%2F+%28accessed+Sep+20%2C+2012%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3E88" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3E88','PDB','3E88'); return false;">PDB: 3E88</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MVH" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MVH','PDB','3MVH'); return false;">PDB: 3MVH</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QAD" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QAD','PDB','3QAD'); return false;">PDB: 3QAD</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4B9D" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4B9D','PDB','4B9D'); return false;">PDB: 4B9D</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3A60" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3A60','PDB','3A60'); return false;">PDB: 3A60</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3AQV" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3AQV','PDB','3AQV'); return false;">PDB: 3AQV</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2I0E" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2I0E','PDB','2I0E'); return false;">PDB: 2I0E</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YEX" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YEX','PDB','2YEX'); return false;">PDB: 2YEX</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XIR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XIR','PDB','2XIR'); return false;">PDB: 2XIR</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3W2M" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3W2M','PDB','3W2M'); return false;">PDB: 3W2M</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QF9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QF9','PDB','3QF9'); return false;">PDB: 3QF9</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OIC" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OIC','PDB','2OIC'); return false;">PDB: 2OIC</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UA2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UA2','PDB','1UA2'); return false;">PDB: 1UA2</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3G0E" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3G0E','PDB','3G0E'); return false;">PDB: 3G0E</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1RW8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1RW8','PDB','1RW8'); return false;">PDB: 1RW8</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XMY" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XMY','PDB','2XMY'); return false;">PDB: 2XMY</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3BEL" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3BEL','PDB','3BEL'); return false;">PDB: 3BEL</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3THB" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3THB','PDB','3THB'); return false;">PDB: 3THB</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PP0" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PP0','PDB','3PP0'); return false;">PDB: 3PP0</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i27"><a href="/doi/suppl/10.1021/jm4002692">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_34426"></div></div></div></div></div><hr /></hr><p class="last">Ingenuity pathway analysis interaction network for the 12 most inhibited kinases. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm4002692/suppl_file/jm4002692_si_001.pdf">jm4002692_si_001.pdf (411.22 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm4002692&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-9%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm4002692" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm4002692" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677ae1d79dd93d5a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
